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Abstract 
Bicyclams which bind the target co-receptor CXCR4, represent a new class 
of highly potent and selective HIV inhibitors. The most active bicyclam is 
AMD3 100 (1,1 '-( 1 ,4-phenylenebismethylene)-bis- 1,4,8,11 -tetraazacyclotetradecane 
octahydrochioride dihydrate). In order to elucidate the mechanism of action of 
AMD3 100 and aid the design of more effective drugs, AMD3 100 and 15N-labelled 
cyclam, and their Zn(II), Cd(II) (NMR-active "Cd) complexes have been 
synthesised. 
1D and 2D 'H, '3C and '5N NMR studies revealed that Zn cyclam complexes 
exist in three configurations in aqueous solution: trans-I, trans-Ill and cis-V. Crystal 
structures of [Zn(cyclam)(H20)2] (OAc)2 and [Zn(cyc1am)(phtha1ate)}(CH30H)2 
were obtained and indicate that in the solid state the Zn cyclam complexes adopt the 
trans-Ill conformation in which six membered-rings are in the chair conformation 
and five membered-rings are in the gauche conformation. However, the trans-Ill 
configuration, which is the most stable conformation for small metal ions, is no 
longer stable for large metals, e.g., Cd(II), and only the configurations trans-I and 
cis-V were detected using 'H, '3C, 	and "Cd NMR spectroscopy for chloride and 
perchlorate Cd cyclam complexes in solution. The Cd cyclam perchlorate complex 
was shown to fix atmospheric CO2 and [Cd3(cyclam)3(CO3)](C104)4 3H20 was 
crystallised. This complex shows bidentate C032 coordination to three Cd cyclam 
units and adopts a cis-I configuration in the solid state, the first example for 
unsubstituted cyclam complexes. The 3J(H,H) and 3J('H,' "Cd) coupling constants 
II 
were determined and used to derive structural information using a Karplus 
relationship. The six-membered rings adopt the chair conformation in solution as in 
the solid state, and the five-membered rings adopt eclipsed conformations in solution 
for the trans-I configuration. 
1D and 2D 1 H, 3C and 5N NMR studies also revealed that the cyclam rings 
of Zn bicyclam AMD3 100 adopt three configurations, trans-I, trans-Ill and cis-V, in 
aqueous solution. The mixture of trans-I/trans-I, trans-I/trans-Ill, trans-I/cis-V, 
trans-Ill/trans-Ill, trans-III/cis-V and cis-V/cis-V configurations was shown to exist 
in water. Only two types of the cyclam ring (trans-I and cis-V) predominate for the 
Zn acetate complex, while trans-I and trans-Ill predominate for the Zn perchiorate 
complex. X-ray crystallographic studies showed that both cyclam rings in the Zn 
bicyclam acetate complex, [Zn2(bicyclam)(OAc)2] (OAc)2 2CH3OH, adopt the cis-V 
configuration in the solid state. 
Anions affect the distribution of the three configurations in solution. The cis-
V configuration predominates for Zn (bi)cyclam complexes in the presence of water. 
Titrations of Zn (bi)cyclam complexes with acetate also confirmed that carboxylates 
readily increase the proportion of the cis-V configuration. 
The interaction between the model target protein lysozyme and 
Zn2bicyclam4 was confirmed by ESI-MS and attempts were made to cocrystallise 
lysozyme with Zn2bicyclam4. 
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Chapter 1 Introduction 
Chapter 1 
Introduction - Zinc, Cyclams and the CXCR4 
Co-receptor 
1.1 Zinc 
Zinc, atomic number 30 and atomic weight of 65.38, is the last element in the 
first transition series, in group 12 together with cadmium and mercury.' While only 
the 25"  element in order of abundance, zinc is very widely distributed over the 
earth's surface. The abundance of zinc varies from 0.02 to 0.0005% (w/w) in the 
crust, and from 0.001 to 0.0001% (wlw) in vegetable and animal matter. Some 
organisms accumulate zinc: thus oysters gathered from the Atlantic are reported to 
contain an average of 0.04% Zn. Zinc has two valence electrons 3d'°4s2 and its 
common oxidation state is +2. The Pauling ionic radius for Zn(II) is 0.74 A. Its 
coordination number can vary from 4, 5, to 6.2  Zinc has an extensive coordination 
chemistry, though less so than that of some of the preceding 3d elements. Zinc does 
not form stable, discrete fluoro complexes, although it is octahedrally six-
coordinated in ZnF21  which has the rutile structure, and in K7-nF3 (perovskite 
structure), but discrete complex anions of the other halides are readily obtained and 
may be isolated as solids using the standard technique of precipitation using a large 
cation such as [Ph4As] or [Co(NH3)6]3 .3 Tetrahedral complexes are particularly 
readily formed with a variety of 0-donors, such as [Zn(OMe)4]2 and more stable 
ones are formed with N-donors such as NH3, amines, and N-heterocycles; 
complexation to phosphines is limited. Complexes with S-donors are common and 
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several have unusual structural features? There are relatively few five-coordinate 
complexes; typically zinc complexes have a (distorted) trigonal bipyramidal shape.' 
For example, ZnC12(terpyridyl) has the tridentate ligand occupying one equatorial 
and the two axial positions of the trigonal bipyramid.4 
1.2 Metallodrugs 
Medical inorganic chemistry developed greatly, since the discovery of the 
anticancer activity of cisplatin, cis-[Pt(NH3)2C12] in the 1960s by Rosenberg.' Today, 
cisplatin is still one of the three most widely clinically-used anticancer drugs.6 Since 
the introduction of cisplatin, thousands of Pt compounds have been synthesised and 
evaluated as potential anticancer agents. Three injectable Pt(II) compounds have 
been approved and several other cis diam(m)ine complexes are on clinical trials, 
including an oral Pt(IV) complex.' The established structure-activity rules are being 
broken: active Pt complexes without coordinated NH groups and active trans 
complexes are emerging. With appropriate choice of ligands, it is possible to change 
the mode of Pt binding to DNA and to circumvent acquired resistance of cancer cells 
to cisplatin; a trinuclear Pt complex with two monofunctional Pt centres has recently 
been found to exhibit an intriguing new mode of DNA binding and has entered 
clinical trials.' 
Metallocenes are another important class of agents with promising anticancer 
activity. While these compounds were initially tested as possible analogues of 
cisplatin, the effectiveness of Cp2TiCl2 against platinum-resistant cell lines indicates 
a different mechanism of action that may lead to new therapeutic options against 
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ovarian cancer.' Two Ti(IV) complexes are on clinical trial, an acetylacetonate 
derivative (budotitane)'° and titanocene dichloride". 
Injectable Au(I) thiolates and an oral Au(I) phosphine complex are widely 
used for the treatment of rheumatoid arthritis. Au(I) has a high affinity for sulfur and 
selenium ligands, which suggests that proteins, including enzymes and transport 
proteins, will be critical in vivo targets.12 In addition, extracellular gold in the blood 
is primarily protein bound, suggesting protein-mediated transport of gold during 
therapy. The recent discovery that oxidation of administered Au(I) compounds to 
Au(III) may be responsible for some of the side-effects of gold therapy" has 
highlighted interests in the biological redox chemistry of gold, including possible 
stabilisation of Au(III) by peptides and proteins. 
Many complexes of manganese have been reported to be capable of 
functioning as superoxide dismutase (SOD) enzyme. The native enzymes catalyse 
the dismutation of superoxide to oxygen and hydrogen peroxide. Therefore, it is 
critical that SOD mimics must act as a true catalyst. Three general classes of 
vanadium-containing compounds are of interest for their utility as insulin-mimetic 
agents in the treatment of human diabetes mellitus." 
The injection of gram quantities of Gd(III) complexes to provide contrast in 
magnetic resonance images (MRT) of the body illustrates how the toxicity of metal 
ions and their targeting can be finely controlled by the appropriate choice of the 
ligands.7 Four Gd(III) complexes and a Mn(II) complex are currently in clinical use. 
Relaxation and contrast can be optimised via control of the number of metal-bound 
H20 molecules, their exchange rate with bulk water, and the tumbling time of the 
complex. Radioactive metal ions can be used in diagnosis and therapy, or for both 
3 
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Figure 1.1 Some examples of metallodrugs 
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(e.g. 67Cu). 99mTc  has optimum radioemission and half-life properties for diagnosis 
and with the appropriate choice of oxidation state and ligands can be targeted to 
many different organs; its chemistry is rich with oxidation states ranging from -1 to 
+7 and coordination numbers from 4 to 7. More than twenty 99mTc  complexes are 
currently in clinical use. Metal-tagged antibodies offer promise for specific targeting 
to tumour cells. Exciting is the potential use of activatable radioactive or 
paramagnetic complexes to probe biological functions, for example specific 
diastereomers of Tc complexes can be trapped in the brain via biotransformation 
mechanisms, and the ability of certain Gd(III) complexes to produce MRI contrast 
can be switched on by enzymes. 
The strong relationship between metals and some organic drugs is becoming 
apparent.' Some are activated or biotransformed by metal ions. The organic 
anticancer drug, Batimastat, for example, is a chelating agent targeted to a zinc 
metalloenzyme, bleomycin requires iron for activation, and complexation of 
anthracyclines with Ca(II) can inhibit their oral adsorption. Metalloenzyme inhibitors 
in particular will provide new generations of novel drugs. 
1.3 Cyclam and bicyclam 
Saturated macrocyclic polyamines have been known for a long time.'5 Until 
the early 1970's, macrocyclic polyamines had been used mostly as chelating agents 
for transition metal ions for the study of basic coordination chemistry. As the study 
has developed, these macrocyclic polyamines were discovered to possess some 
5 
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biofunctional properties. Accordingly, macrocyclic polyamines are highly protonated 
and bind transition metal ions and some other metal ions strongly. Moreover, upon 
cyclisation, polyamines gain new properties beyond those anticipated from mere 
assemblies of amines or linear polyamines. This is best illustrated by their behaviour 
towards protons and metal ions. For macrocyclic polyamines, due to their restricted 
conformation, the nitrogen lone pairs may overlap to bring about higher electron 
densities in the macrocyclic cavities. Thus, the proton affinities at the initial stage are 
unusually high, i.e. pK values are higher than ca 10, a value common for ordinary, 
isolated secondary amines. Once protons are incorporated into the macrocyclic 
cavities, the already protonated amines are so close (due to the macrocyclic 
conformational restraint) that the proton affinities for the last two steps are extremely 
weak. This is apparent from the protonation constants (pK) for cyclam (Figure 
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Figure 1.2 Protonation constants pK for cyclam (1) (ref. 15) 
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Macrocyclic structures are also extremely favourable for metal complexation. 
In terms of the entropy factor, this may be viewed as an extension of the "chelate 
effect" that is a major contribution to an increase in complex stability as the number 
of chelate rings increases. 
While macrocyclic polyamines thus act as host molecules for protons and 
metal cations, upon protonation (at neutral pH) polyamines can form complexes with 
nH+  
(at neutral pH) 
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Figure 1.3 Characteristic properties of macrocyclic polyamines and their applications 
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The polyamine host-guest interaction can develop into more highly advanced 
chemical functions for (1) design of more sophisticated hosts for more selective and 
efficient uptake of wider ranges of guest molecules and ions, (2) selective separation, 
dissolution and membrane transport of guests, (3) information input or output upon 
host-guest interaction, (4) new functions as complex assemblies, (5) new chemical 
reactants or catalysis due to host-guest interactions, and (6) recognition of external 
stimulus and/or messages to initiate above functions (i.e. attachment of robotic 
functions). 
The 14-membered macrocycle 1,4,8,1 l-tetraazacyclotetradecane (cyclam, 
[14]aneN4) is one of the most commonly studied and used macrocycles.'7 Cyclam 
was first synthesised in 1937,18  and new uses for this macrocycle and its derivatives 
continue to be found. They have applications in a variety of areas, including 
catalysis, bioinorganic, biomimetic, and coordination chemistry. 
Macrocyclic polyamines can complex with virtually all kinds of transition 
metal ions and some other metal ions." However, these complexes are generally so 
stable (logK > 15) that they are of no practical use as selective metal chelating 
agents. Comparing the values of logK for Cu(II), Ni(II), Zn(II), and Cd(II) 
complexes with cyclam shows, that the stability of the cyclam complexes depends on 
the sizes of the metal ions (Table 1.1) but also on the configuration of the cyclam 
complexes. 
The importance of nitrogen configurational isomers in the chemistry of metal 
complexes of tetraaza macrocyclic ligands is becoming more and more apparent.19  
Depending on the spatial alignment of the NH protons there are five possible 
configurational isomers of planar complexes of the macrocyclic ligand cyclam 
(1,4,8,11-tetraazacyclotetradecane): RSRS (trans-1), RSRR (trans-11), RRSS (trans-
III), RSSR (trans-IV), and RRRR (trans-V) (Figure 1.4)." 
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Table 1.1 Stability constants for cyclam complexes and ionic radii 
M2 r (A) log K Ref. 
Cu2 0.72 27.2a 21 
Ni2 0.69 22.2 b 22 
Zn2 0.74 15.0C or 155d 23 and 24 
CO2  0.75 12.7e 25 
Cd2 0.97 11.7' 26 
aIO2M at298K;b01M at298K;cTO2M at 298Kby pH-metric 
method. d = 0.2 M at 298 K by polarographic method; C  I = 0.2 M at 298 K; 









Figure 1.4 Schematic picture of the five possible configurational isomers of planar 
trans coordinated cyclam complexes 
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For the more labile metal ions, extensive ligand N- or C-substitution makes 
isomerization more sluggish and has permitted the isolation of thermodynamically 
unstable configurational isomers." Semiquantitative estimates of the relative strain 
energies of the five isomers of cyclam by Bosnich et a!27 and later by Whimp et a!28 
have indicated that the trans-Ill form is the most stable in octahedral coordination and 
is the lowest energy configuration available for Ni(II) cyclam. After analysis of all the 
nickel complexes containing the cyclam backbone in the Cambridge Structural 
Database (CSD), Donnelly and Zimmer reported that the most commonly found 
configuration is the trans-Ill configuration.'7 The same result was obtained in this 
project for Cu(II) complexes with a cyclam backbone (Table 1.2). 
Table 1.2 Configurational distribution   of cyclam complexes in the CSD (amide-
containing macrocycles not included; data for Ni(II) complexes from ref. 17) 
overall Oct Spl Spy Tbp 
Ni Cu Ni Cu Ni Cu Ni Cu Ni Cu 
noofstructs 138 64 75 42 58 12 4 5 1 5 
trans-1 20.3 9.4 9.3 2.4 29.3 8.3 75.0 80.0 100 0.0 
trans-111 57.2 87.5 52.0 97.6 67.2 91.7 25.0 20.0 0.0 60.0 
trans-V 1.5 3.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 40.0 
cis-V 21.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
a  Oct =octahedral; Spl = square-planar; Spy = square-pyramidal; Thp = trigonal 
bipyramidal 
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Molecular mechanics calculations have shown that the trans-1 configuration 
becomes more stable relative to the trans-Ill configuration in going from octahedral 
Ni(II) cyclam complexes to a square-planar analogue. 29 The occurrence of trans-1 
macrocycles was higher for square-planar complexes than for octahedral complexes. 
This is due to the non-bonded interactions between the atoms/substituents at positions 
1,4,8,11 and the nonmacrocyclic coordinating ligands (Figure 1.5).' 
Figure 1.5 The trans-1 configuration becomes less stable relative to trans-Ill in 
octahedral geometry since there is repulsion by an axial ligand to four NH protons on the 
same side (Ref. 17). 
This effect is enhanced for nitrogen-substituted macrocycles. Wagner and 
Barefield have isolated complexes of Ni(H) with cyclam in both the trans-HI (RRSS) 
and the trans-1 (RSRS) geometries. 
30  Moore and co-workers have shown that the two 
isomers equilibrate readily in donor solvents, presumably via an intermediate trans-il 
(RSRR) isomer. 31 The RSRR isomer has been detected by NMR.31'32 The most common 
conformation reported for Zn complexes with cyclam is trans-Ill, in which two N-H 
bonds are oriented up and two down as shown in Figure 1.4. The trans-Ill 
conformation was found in the octahedral complex [Zn(cyclam)(C104)2],33 and 
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[Zn(cyclam)(NCS)2].34 Alcock and co-workers reported that the product of the 
reaction of ZnC12 and cyclam comprises infinite —Cl—[Zn(cyclam)]2 —Cl— chains 
interspersed with [ZnCl4]2 ions.35 However, the cyclam molecule shows the same 
trans-Ill conformation in this complex. '3C NMR spectra show that the complex 
undergoes a slow isomerisation in aqueous solution. [ZnCl(cyclam)] in nitromethane 
solution is probably derived from the break up of the chloride chain, i.e. with the 
trans-Ill conformation and with an axially coordinated chloride ligand. In aqueous 
solution, an analogous trans-Ill structure is likely upon first dissolution of the 
complex, probably with water replacing the axial chloride, but a minor isomer forms 
after 24 hours. This isomer has the same number of resonances as the original species, 
and only the trans-I isomer satisfies this requirement. It is likely that in the trans-I 
complex, Zn(II) is five coordinate, with the axial position occupied by a water 
molecule or chloride ion. In water, the trans-Ill form is most probably six-coordinate 
with two axially bonded water molecules. 
Kato and Ito reported that the Zn(II)-cyclam complex 2 yielded a carbonate 
monoester-bound product 4 in a CH30H solution through which CO2 had been 
bubbled.36 CO2 was evidently fixed between Zn(II) and CH30 bonding at the axial 
position as a possible intermediate 3 (Figure 1.6). 
Kimura and co-workers gained insight into the acidic properties of Zn(II) 
cyclam .37 They determined the pK value for the H20 that is in the fifth (axial) site in 
complex 5. The pK value of 9.8 (298 K and I = 0.1 M) for Zn(II)-cyclam was 
determined by potentiometry.38 For the Ni(II) and Cu(II) complexes, proton 
dissociation did not occur until pH 11. Zn(II) can be a stronger acid than Cu(II) 
under certain circumstances. Zn(II) in the square-planar cyclam N4 cavity exerts the 
most acidic effect towards an axial direction. The deprotonation is shown in Figure 
1.7. 
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Figure 1.6 Carbon dioxide fixation by Zn(II)-cyclam in MeOH (Ref. 36) 
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Figure 1.7 Deprotonation equilibrium for Zn(II)-cyclam 
The Zn(II) ion coordinated to cyclam in MeOH is acidic enough to permit 
proton dissociation from MeOH to form the axial Me0 on the Zn(II) ion that is 
presumably the reaction intermediate for CO2 fixation. 
Kimura and co-workers used [Zn(cyclam)](TfO)2 (TfO = CF3S03 ) as a model 
for catalytically active Zn(II) in liver alcohol dehydrogenase.39 Shelton and Morrow 
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have studied catalytic transesterification and hydrolysis of RNA by a cyclam 
complex with Zn(NO3)2.4° Compared with Zn(II) complexes with other cyclic 
polyamines, Zn(II) complexes with cyclam are inactive in these reactions. 
Bicyclams in which two monocyclam rings are connected by a bridging unit 
can be divided into two classes. First, two monocyclam units can be linked together 
by bridging the carbon atoms of the cyclam backbone. An early example of this 
r"**) 	ro'~) 
(NH 
:: :>-cNH  :
~~j 	~j 
class, complex 7, was obtained as a side product during the template synthesis of 
cyclam.4' Two cyclam units are linked through a C-C covalent bond. The dimeric 
structure of the product as a Ni(II) salt was confirmed by an X-ray diffraction study. 
The ligand has not been isolated free of its Ni" ion. The eq-eq (equatorial-equatorial) 
and ax-ax (axial-axial) linkage modes were found for the Co(III) complex with 8, 
although three 
C
NH HN - NH HND 
NH HN:::)~ 	NH HN 
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complexes with eq-eq, ax-eq (axial-equatorial) and ax-ax C-C linkage modes 
between two monocyclam units were proposed.42 Two complex cations, [CO 2(eq-
eq)Cl4]2 and [CO2(ax-ax)C14]2 , are isomers due to the difference in the C-C linkage 
mode between the two monocyclam units. Each monocyclam adopts the trans-Ill 
configuration and all the Co(III) ions are six-coordinate with chloride ions in both 






ligand 9 comprises two cyclam units bridged by a xylyl group.43 Both Ni2 and Zn2 
complexes of 9 adopt the most stable conformation, trans-Ill. In both crystal 
structures, the two cyclam rings are arranged in a face-to-face manner, and the two 
metallic sites are connected by a bridging ligand, Br in the Ni2 complex, and C032 
in the Zn 21  complex. 
Secondly, two monocyclam units can be linked together by bridging the 
amine nitrogen atoms of the cyclam backbone. The redox chemistry of some of these 
dinickel(II) and dicopper(II) complexes has been investigated with regard to 
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oxidation of M(II) to M(III).44 However, no crystals or NMR studies have been 
reported. 
1.4 Current Clinical Drugs for the treatment of HIV 
Pandemic HIV-1 infection has led to an intensive search for antiviral agents 
to control this disease. Theoretically, any stage in the viral replication cycle could be 
a target for anti-viral therapy (see Figure 1 9)45  In reality, only a few virus-specific 
events could function as targets for chemotherapeutic intervention. Limited classes 
of drugs have already been demonstrated to be effective in the treatment of HIV-1 
disease. The current clinical drugs act either at the substrate binding site of the 
reverse transcriptase (Zidovudine, Didanosine, Zalcitabine, Stavudine, Lamivudine) 
or a non-substrate binding site of the reverse transcriptase (Nevirapine, Delavirdine), 
or the viral protease (Saquinavir, Ritonavir, Indinavir, Nelfinavir).46 
1.4.1 Nucleoside reverse transcriptase Inhibitors 
The majority of available antiviral agents are nucleoside analogues.47 They 
inhibit the replication of HIV by blocking the synthesis of proviral DNA. They are 
first activated in the cell via several phosphorylation steps by cell enzymes to form 
the corresponding triphosphate nucleotide. The phosphorylated metabolite is the 
active compound that inhibits the reverse transcriptase enzyme and viral DNA 
synthesis. In addition, some analogues can be incorporated into the nucleic acid and 
block further synthesis or alter its function. The clinical use of such compounds 
depends on a high therapeutic ratio, so that the benefit of viral inhibition outweighs 
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the inherent toxicity. Zidovudine (AZT) was the first antiretrovirus drug approved 
for the treatment of HIV infection (1987). 
1.4.2 Non-nucleoside reverse transcriptase inhibitors 
Unlike the nucleoside analogues, these inhibitors are not DNA chain-
terminators." Instead, these structurally diverse compounds cripple the reverse-
transcriptase enzyme by binding near to and changing the conformation of its 
catalytic site. Resistant virus mutants arise rapidly, so these drugs are recommended 
for use in combination therapies. Nevirapine is the first member of this class of 
nonnucleoside reverse transcriptase inhibitors. It was approved in 1996. 
1.4.3 Protease inhibitors 
Saquinavir was the first protease inhibitor to be approved (1995) for 
treatment of HIV infection.49 It was designed by computer modelling as a molecule 
that would fit into the active site of the HIV protease enzyme. It inhibits the viral 
protease that is required during the late stage of the replicative cycle. This protease 
cleaves the viral structural proteins to form the mature virion core and activate the 
reverse transcriptase that will be used in the next round of infection. Inhibition of the 
protease yields noninfectious virus particles. Protease inhibitors are often used in 
combination with other classes of antiretrovirus drugs. 
1.5 Antiviral activity of cyclams 
1.5.1 HIV life cycle 
Viral spikes (as seen in Figure 1.8) are formed by the two major viral 
envelope proteins, gpl2O and gp4l.5° The HIV-1 lipid bilayer is also studded with a 
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acquired during virion budding. The core of HIV-1 contains four nucleocapsid 
proteins, p24, p17, p9, and p7, each of which is proteolytically cleaved from a 
precursor by the HIV-1 protease. The phosphorylated p24 polypeptide forms the 
chief component of the inner shell of the nucleocapsid, whereas the myristylated p17 
protein is associated with the inner surface of the lipid bilayer and probably 
stabilises the exterior and interior components of the virion. The p7 protein binds 
directly to the genomic RNA through a zinc-finger structural motif and, together 
with p9, forms the nucleoid core. Importantly, this retroviral core also contains two 
copies of the single-stranded HIV-1 genomic RNA that are associated with the 
various viral enzymes, including the reverse transcriptase, integrase, and protease. 
Figure 1.8 Icosahedral structure of the I-IIV-1 virion containing 72 external spikes 
As shown in Figure 1.9, the replicative cycle of HIV includes the following 
steps. The initial phase of the cycle involves binding of specific epitopes of the 
CD4 molecule on the surface of the target cell to defined regions of gp 1 2O 1 and 
fusion of the virus envelope with the cell membrane. Virus-cell fusion 
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Figure 1.9 The replicative cycle of HIV virus (ref. 52) 
co-receptor. 53  As a result, the virion loses its integrity and characteristic 
morphology. Genomic RNA is released into the cytoplasm within the virus core, 
which includes molecules of reverse transcriptase. Viral RNA is then used as a 
template by reverse transcriptase to make a minus-strand DNA copy, thus forming 
an RNA-DNA hybrid. Soon thereafter, the RNA strand is degraded by the 
ribonuclease H activity of reverse transcriptase. A positive DNA strand is 
synthesized, and the linear double-stranded DNA molecule changes conformation 
to become circular. Some of this DNA migrates to the nucleus and subsequently 
becomes integrated into the cellular DNA to form the HIV provirus, through the 
interaction of the viral integrase. In the "productive phase", viral DNA is 
transcribed into messenger RNA by host cell RNA polymerase. After transcription, 
some of these viral RNA molecules are used as messengers for the synthesis of viral 
proteins. Others become incorporated as genomes into progeny viral particles. The 
replication cycle continues with the translation of viral genomic RNA and viral 
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proteins from unspliced, single spliced, and multiply spliced mRNA species. These 
proteins undergo post-translational protein cleavage and glycosylation. Within the 
cytoplasm the final stage of assembly of viral proteins occurs and is followed by the 
budding of the mature virion through the cell membrane, with simultaneous 
acquisition of envelope. 
As illustrated in Figure 1.10, the HIV envelope contains two glycoproteins, 
surface gpl2O and transmembrane gp4l to which it is noncovalently attached .'4 The 
initial step in infection is the binding of the viral envelope glycoprotein gp 120 to 
CD4 molecules on the target cell membrane. This binding leads to an important 
conformational change that results in the formation of a new recognition site on 
gpl2O for the co-receptors CCR5 or CXCR4. 
HIV strains can be classified into two groups on the basis of their ability to 
infect macrophages and CD4+T Cells. Macrophage-tropic (M-tropic) strains, their 
name notwithstanding, can infect both monocytes/macrophages and freshly isolated 
peripheral blood T cells (but not in vitro propagated T-cell lines). The T-cell tropic 
gp120 	ConforrrahOaI 	qpl2O 
CD4 charge 	 CD4 	
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Figure 1.10 HIV entry into host cell (ref. 54) 
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strains can infect only T cells, both freshly isolated and retained in culture. M-tropic 
strains use CCR5, whereas T-tropic strains bind to the CXCR4 receptor. Because 
CCR5 is expressed on both monocytes and T cells, they succumb to infection by M-
tropic strains; CXCR4 is expressed on T cells but not on monocytes/macrophages, 
and hence T cells but not macrophages are susceptible to infection with T-tropic 
strains. Primary T cells (freshly isolated) express both CCR5 and CXCR4 and hence 
can be infected by either of the two viral types. 
The next step involves conformational changes in the gp4l protein; these 
changes result in the insertion of a fusion peptide at the tip of gp4 1 into the cell 
membrane of the target T cells or macrophages. After fusion, the virus core 
containing the HIV genome enters the cytoplasm of the cell. Molecular details of 
this fatal binding between HIV glycoproteins and their cell surface receptors are 
important because they may provide the basis of anti-HIV therapy. 
1.5.2 CXCR4 co-receptor 
The migration of leukocytes can be activated and directed by chemokines 
through G-protein-coupled seven-transmembrane receptors. CXCR4 is a G-protein-
coupled, 7-transmembrane domain receptor whose physiological ligand is the 
stromal cell-derived factor-i (SDF-l) chemokine, which is also used by distinct 
strains of HIV-1 as cofactors for viral entry (Figure 1. 1i).55'56 
Crump and co-workers have determined the three-dimensional structure of 
SDF-1 by NMR spectroscopy. 17  As for other chemokines, the N-terminal amino 
acids KPVSLSYR before the first two cysteines form an essential part of the binding 
site. The residues RFFESH (12-17) immediately downstream to the second Cys are 
also an important part of the binding site. A model for SDF-1 and CXCR4 
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interaction in which the RFFESH motif is the initial docking site with CXCR4 and 
the N-terminal residues are responsible for signalling has been proposed. 
Figure 1.11 Helical wheel (A) and serpentine diagram (B) of the CXCR4 receptor. 
White letters in red circles represent residues substituted with Ala or Asn probing the 
binding site of AMID3 100 (ref, 58) 
The general conclusion from studies on the determinants of the CXCR4 co-
receptor function is that the CXCR4 amino-terminal domain (Nt) and the second 
extracellular (ECL2) are essential for its co-receptor activity. 
59 Studies of CXCR4 
point mutants have delineated more precisely a region of CXCR4 that plays a pivotal 
role in virus fusion and entry. Several mutations enable CXCR4 to mediate weak 
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fusion and entry of R5 strains, including conversion of Asp l87 to a neutral residue," 
alanine substitutions of Arg30 and Asp193,` and removal of an N-linked 
glycosylation site in the CXCR4 Nt.62 Charged residues Asp193, Arg183 and Arg188 
in ECL2 were shown to affect differently the entry of various HIV-1 strains; for 
example, only HIV-1NDK was sensitive to substitutions of Asp193, whereas all 
other test strains are sensitive to changes in Arg 183 and Arg 188.63  In a recent report, 
Glul5 and Glu32 in the Nt, Asp97 in ECL1 and Arg 188 in ECL2 were found to be 
involved in CXCR4-mediated entry of X4 and R5X4 isolates .6' Another study found 
that multiple substitutions of Tyr7, Asp 10, Tyrl2, Asp20, Tyr2l, Asp22, Ser23 and 
Glu26 in the Nt and Asp182, Tyr184, Asp187, Tyr190 and Asp193 in ECL2 
influence HIV-1 entry, albeit in an isolate-dependent manner. 14  No clear patterns of 
CXCR4 amino acid usage by X4 and R5X4 isolates, taken as phenotypic groups, 
were observed.64 A study by Brelot eta! confirms the role of Tyr7, Tyr12 and Tyr2l 
in the Nt, as well as Asp193 in ECL2 and Asp262 in ECL3, in CXCR4 co-receptor 
function. Presumably, Tyr, Asp and Glu residues important for CXCR4-mediated 
virus entry are implicated in gp120 binding.65 It should be noted here that the 
CXCR4 Nt is sulfated, presumably due to the presence of sulfotyrosines. Inhibition 
of cellular sulfation pathways, including tyrosine sulfation, blocks CXCR4-mediated 
HIV-1 entry. It is therefore probable that, like gp120 binding to CCR5, gp120 
binding to CXCR4 requires the presence of sulfotyrosines. 
The use of Mabs (monoclonal antibodies), chemokines and their derivatives, 
peptides and small molecules (<1 kDa) that inhibit CXCR4-mediated HIV-1 entry 
has provided further insight into the structure—function relationships of this co-
receptor. Little is known, however, about the mechanisms of action of these agents. 
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Lack of a practical and reproducible binding assay has made it difficult to determine 
whether inhibitors of CXCR4-mediated entry block gp 120 binding to the co-
receptor. Also, surprisingly few anti-CXCR4 Mabs have been generated and only 
one has been extensively characterized. Mab 12G5 recognises an epitope in ECL2 
and inhibits HIV-1 fusion and entry both in an isolate- and a cell type-specific 
manner. 66  Differences in gp 120 affinities for CXCR4 and post-translational 
modifications of CXCR4 in different cell types could account for these 
discrepancies. Other anti-CXCR4 Mabs, whose epitopes remain to be determined, 
also variably inhibit the entry of the HIV- 1NL-43 isolate.67 
1.5.3 Anti-HIV activity of bicyclams 
Bicyclam 
The co-receptor has been identified as a cell surface protein which is called 
fusin due to its pivotal role in helping HIV fuse with CD4 cells. The discovery of 
fusin is considered a breakthrough because it reveals a new target for anti-HIV 
drugs. Bicyclams are a new class of highly potent and selective HIV inhibitors 
which interact with the receptor CXCR4, the main co-receptor used by T-cell tropic 
strains of HI V.68 
Bicyclam activity originated from the serendipitous discovery of anti-HIV 
activity in a monocyclam preparation that contained bicyclam as a contaminant.69 
Starting from this lead compound, several bicyclam derivatives were prepared that 
showed increased anti-HIV activity. Unlike the non-nucleoside type of HIV-1-
specific reverse transcriptase inhibitors, which are inhibitory to HIV-1 but not HIV- 
The bicyclams are active against both HIV-1 and HIV-2.68 
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The most active of this series is AMD3 iOo °, being on clinical trial", which 
has been found to inhibit HIV-induced cytopathicity at a concentration of a few 
nanograms per ml, while not being toxic to the host cells at concentrations up to 500 
jig/ml, thus achieving a selectivity index of 100,000 or higher (Table 1.3). It is active 
against both laboratory strains and clinical isolates of HIV in T4 lymphocytes and 
monocytes. Finally, it acts additively when combined with di deoxynucleo side 
analogues such as AZT or DDI. 
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Table 1.3 Anti-HIV activity of bicyciam AMD3 100 (data from ref. 75) 
Virus Strain Cell line EC54ig/mi) CC50(tg/mi) Selectivity index 
CC5 / EC5 
HIV-1 "b MT-4 0.005 >500 >100000 
HIV-i RF MT-4 0.001 >500 >500000 
HIV-1 HE MT-4 0.003 >500 >16700 
HIV.-2 ROD MT-4 0.007 >500 >71400 
HIV-2 EHO MT-4 0.004 >500 >125000 
Sly MAC251 MT-4 >100 >100 
Sly AGM3 MOLT-4 >100 >100 
Sly MNDGB1 MOLT-4 >100 >100 
The compound AMD3 100 did not lead to development of resistance (as 
measured by viral cytopathicity) following at least 14 to 30 passages (49 to 105 
days) of HIV-1 (111B)in  CEM cells in the presence of various drug concentrations. 
However, full resistance to the bicyclams AMD2763 and AMD2987 was observed.68 
The anti-HIV activity exhibited by bicyclams is particularly intriguing due to 
the possibility that binding to the molecular target at the HIV-inhibitory step is 
transition metal-mediated .6' For example, Mallick and co-workers72 have proposed 
that bis-transition metal complexes of AMD3 100 can provide complementary 
coordinating sites for the chelating amino acid residues on a protein surface. This 
type of mechanism is plausible since AMD3 100 will almost certainly complex free 
transition metals in vitro, and a variety of preformed transition metal complexes of 
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AMD3 100 and several other bicyclams exhibit antiviral activity." In this manner, 
AMD3 100 could be viewed as a prodrug for a transition metal complex in a similar 
manner to the antitumour agent bleomycin.74 
A series of bicyclam analogues connected through a heteroaromatic linker 
have been synthesized and evaluated for their inhibitory effects on HIV- 1 (TuB) and 
HIV-2 (ROD) replication in MT-4 cells.63 The activity of pyridine- and pyrazine-
linked bicyclams was found to be highly dependent upon the substitution of the 
heteroaromatic linker connecting the cyclam rings. For example, 2,6- and 3,5-
pyridine-linked bicyclams were potent inhibitors of HIV-1 and HIV-2 replication, 
whereas the 2,5- and 2,4-substituted pyridine-linked compounds exhibited 
substantially reduced activity and, in addition, were found to be highly toxic to MT-4 
cells. Subsequent discovery also showed that amino-substituted linkers also have the 
potential to deactivate phenylenebis(methylene)-linked bicyclams. A model has been 
proposed to explain the deactivating effects of the pyridine group in certain 
substitution patterns based on the ability of the pyridine nitrogen to participate in 
pendant conformations (complexation) with the adjacent azamacrocyclic ring, which 
may involve hydrogen bonding or coordination to a transition metal. The 
introduction of a sterically hindering group such as phenyl at the 6-position of the 
2,4-substituted pyridine-linked bicyclam appears to prevent pendant conformations, 
providing an analogue with comparable anti-HIV-1 and anti-HIV-2 activities to the 
parent m-phenylenebis(methylene)-linked bicyclam. The results of this study have 
been used to develop a quantitative structure-activity relationship model with 
improved predictive capability in order to aid the design of antiviral bis-
azamacrocyclic analogues.70 
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2. Bicyclam complexes 
The initial events (virus adsorption and fusion with the cells) in the 
replicative cycle of human immunodificiency virus (HIV) can serve as targets for the 
antiviral action of metal-binding compounds such as polyanionic compounds, 
bicyclams and G-octet-forming oligonucleotides.75 
Table 1.4 Inhibitory effects of different bicyclam-metal complexes on HIV-induced 
cytopathicity and syncytium formation (see p24 for the structures of compounds 
AMD3 100 etc; data from ref. 75) 	 - 
Compound Complexing metal 	 BC50 (jig/ml) 
Viral cytopathicity 	Syncytium formation 
HIV-1(111B) HIV-2(ROD) HIV-1(111B)  HIV-2(ROD) 
AMD3100 0.009 0.021 0.1 1.8 
AMD3479 Zn 0.008 0.025 0.1 0.2 
AMD3462 Ni 0.017 0.028 0.3 0.3 
AMD3469 Cu 0.048 0.21 1.5 2.4 
AMD3461 Co 0.74 18.21 62.5 125 
AMD3158 Pd 68.62 >250 >250 >250 
Chapter 1 Introduction 
Zn may play a key role in the anti-HIV activity of the bicyclams, as is evident 
from Table 1.4. Only the zinc complex with the bicyclam AMD3 100 (i.e. 
AMD3479) is equipotent to AMD3 100. The other metal bicyclam complexes 
(AMD3462, AMD3469, AMD3461, and AMD3 158) containing Ni, Cu, Co, and Pd, 
showed gradual loss in activity, the Pd complex being inactive as an anti-HIV 
compound. Furthermore, the early events in HIV infection are known, i.e. virus 
adsorption to the cells and virus cell fusion, and have been shown to be the points of 
attack for zinc complexes of bicyclam. 
A recent study also reached a similar conclusion. 16  The Zn(II) complex 
(AMD3479) was slightly more active (10-fold) than AMD3 100; the Ni(II) complex 
(AMD3462) was as active as AMD3100 in its capacity to inhibit 12G5 binding 
(Table 1.5). The Cu2 (AMD3469) and CO3 (AMD3461) complexes were 5-fold and 
2220-fold less active, respectively, than AMD3 100. The Pd 21  complex (AMD3 158) 
was virtually inactive. Similar differential inhibitory effects were noted for the metal 
complexes on the binding of the Mab with CXCR4; the IC50 for 12G5 binding to 
SUP-Ti cells closely paralleled the EC50 for anti-HIV activity. Similarly, the EC50 
for anti-viral activity of metal complexes correlated with the IC,, for inhibition of the 
Ca 21  flux induced by SDF- 1 a indicating the dependence on the interaction of metal-
complexed bicyclams with CXCR4 for their respective anti-HIV activity. 
We 
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Table 1.5 Anti-HIV activity, inhibition of 12G5 Mab binding and inhibition of 
[Ca 2 ]1  flux of AMD3 100 and its different transition metal complexes (data from ref. 
76) 
Compound 	EC50a for HIV-1 	IC50b 12G5 	
IC [Ca2 ] (bound metal) (Ilib) 	Binding (jig/mi) 
AMD3100 	 0.009 0.01 	 0.005 
AMD3479 (Zn) 0.008 0.001 0.003 
AMD3462 (Ni) 0.008 0.016 0.002 
AMD3469 (Cu) 0.048 0.2 0.05 
AMD3461(Co) 0.74 0.5 0.6 
AMD3158(Pd) 68.62 12.5 70 
a  EC50 as measured by the MTT assay. 
b IC50: 50% inhibitory concentration, or concentration of the compound required to 
inhibit by 50% the binding of 12G5 Mab to CXCR4+ SUP-Ti cells. 
IC50 [Ca 2 ]1  by SDF-la in SUP-Ti cells. (NB: Cells were first stimulated with 
dilution buffer (control) or test compound at different concentrations. SDF-ia was 
used as a second stimulus to induce [Ca2 ]1 increase; it was added 100 s after the first 
stimulus. The compound concentration required to inhibit the [Ca2 ]1 increase by 50% 
(IC50 [Ca2+]i)  was calculated. 
1.5.4 Mechanism of action of bicyclams 
Bicyclam derivatives exhibit a mode of anti-HIV action that is clearly 
different from those of any of the other anti-HIV agents that are presently used or 
considered for use in the treatment of HIV infections.68 They are not inhibitory to 
either HIV reverse transcriptase or HIV protease,68 and they do not inhibit virus 
binding to cells.77 
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The bicyclams inhibit a specific event that is involved in viral uncoating and 
represent the first compounds that have been postulated to affect the uncoating of the 
retrovirus.68  Time-of-addition experiments have revealed that the bicyclams interact 
at a stage following virus adsorption but preceding reverse transcription. The 
possibility that this stage may be associated with the uncoating process was then 
assessed by experiments in which the sensitivity of the viral RNA to degradation by 
ribonuclease A was determined. It was reasoned that as long as uncoating had not 
taken place, the viral RNA would be protected by the capsid proteins against 
degradation by RNase A. These experiments revealed that the bicyclams, i.e., 
AMD2763 and AMD3 100, but not any of the reverse transcriptase inhibitors or 
protease inhibitors, protected the viral RNA against degradation. Because of the 
intervention of the bicyclams, the capsid proteins remained associated with and thus 
could not be uncoated from the viral RNA. 
Inhibitors of the uncoating (disassembly) process might also be expected to 
interfere with the opposite process, namely, assembly. In support of such an 
assumption, the bicyclam AMD3 100 was found to inhibit (at an EC50 of 0.02 jig/ml) 
the production of infectious HIV particles from the chronically infected Jurkat/IIIB  
cell line, whereas p24 antigen production by this cell line was not affected by 
AMD3 100 at concentrations up to 1 ig/ml. The mechanism of this late effect of the 
bicyclams may well be associated with an interference with virus assembly, and 
therefore bear resemblance to the mechanism of their inhibitory action on virus 
uncoating. 
It was demonstrated recently that AMD3 100 inhibits HIV entry through the 
co-receptor CXCR4 but not through the co-receptor CCR5.78 AMD3 100 completely 
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blocked HIV- 1 infection mediated by a mutant CXCR4 bearing a deletion of most of 
the amino-terminal extracellular domain. Relative resistance to AMD3 100 was 
conferred by different single amino acid substitutions in the second extracellular 
loop (ECL2), or in the adjacent membrane-spanning domain, TM4. Only 
substitutions of a neutral residue for aspartic acid and of a non-aromatic residue for 
phenylalanine (Phe) were associated with drug resistance.78 This suggests a direct 
interaction of AMD3 100 with these amino acids rather than indirect effects of their 
mutation on CXCR4 structure. Bicyclams are strongly basic due to the presence of 
four secondary amines in each cyclam unit and might interact with a negatively-
charged domain of CXCR4, in particular ECL2 (5 acidic residues; net charge, -3), 
which might block HIV-1 entry by preventing electrostatic interactions between 
CXCR4 and the HIV-1 envelope protein gp120. Other features of AMD3 100 must 
account for its high antiviral activity, in particular the presence of an aromatic linker 
between the cyclam units. This aromatic group might engage in hydrophobic 
interactions with the Phe-X-Phe motifs of ECL2 or TM4. 
When the supposedly main binding site for the free cyclam moiety was 
eliminated in the D171N mutation, the affinity of the monocyclam was determined to 
be ca 400 tiM. This could possibly represent the affinity of the cyclam at the Asp262 
site, which could have been confirmed by the D171N/D262N double mutation.58 
However, the low expression level of this construct unfortunately prohibited this. 
Another possibility is that although cyclam binds to Asp262, this binding could be 
silent with respect to the effect on SDF- 1 binding. Nevertheless, the fact that the 
binding of bicyclam AMD3 100 clearly is dependent on both Asp 171 and Asp262 
and the fact that cyclarn has a strong propensity to interact with carboxylate indicate 
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that each of the cyclam moieties of the bicyclam binds to each of these two Asp 
residues located in TM-IV and TM-VI, respectively. 
1.6 Aims of this thesis 
As described above, the CXCR4 co-receptor antagonist bicyclam AMD3 100 
has recently been on phase II clinical trial against AIDS and may be active in vivo as 
a Zn(II) complex. The aim of this thesis was therefore to investigate structural and 
dynamic properties of metal cyclam and bicyclam complexes as a potential aid to the 
design of more active anti-HIV agents. Specific aims were as follows: 
To synthesise and characterise Zn(II) and Cd(II) cyclam and xylylbicyclam 
complexes both in the solid state and in solution, particularly using X-ray 
crystallography and multinuclear and multidimensional NMR spectroscopy. 
To investigate synthetic routes to '5N-labelled cyclam and (xylylbicyclam) which 
might allow detailed '5N NMR studies to be undertaken in order to probe the 
interaction of cyclam complexes with biomolecules. 
To investigate the factors which control the configurations of metal (bi)cyclam 
complexes in solution and relate them to the interaction of metal (bi)cyclam 
complexes and its receptor protein CXCR4. 
To investigate the interaction of Zn(II) xylylbicyclam with lysozyme as a model 
protein for the co-receptor CXCR4. 
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Materials and Methods 
2.1 Chemicals and Instruments 
Chemicals 
Cyclam (1,4,8,11 -tetraazacyclotetradecane), TBTU (o-(benzotriazol- 1 -yl)-N,N,N',N'-
tetramethyluronium tetrafluoroborate), trityichioride, BH3 THF, butanedione, 
hexamethyiphosphoric triamide, 1, 4-bis-bromomethyl-benzene, zinc chloride (Acros 
Chemical Co.), hen egg white lysozyme (Sigma Chemical Co.), potassium 
phthalimide-15  N  (98%), g1ycine 5N (99%), sodium carbonate-1 3C (99%), cadmium 
chloride, cadmium perchlorate hydrate, zinc perchiorate hexahydrate, zinc acetate 
dihydrate (Aldrich Chemical Co.), 1 ,3-dibromopropane (Koch-light Laboratories 
Ltd.), zinc oxide (BDH Ltd.), and phthalic acid (Fisons Scientific Apparatus Ltd.) 
were used as received. All other chemicals were A.R. grade. Dry solvents were 
prepared by standard methods. NMR solvents, deuterium oxide (Aldrich, 99.9%), 
chloroform-d (Apollo, 99.8%), acetonitrile-d3 (Acros, 99%) and methyl-d3 alcohol-d 
(Acros, 100%) were also used as received. 
IR spectroscopy Infrared spectra were recorded as KBr pellets in the range 4000 - 
400 cm' on a Perkin-Elmer Paragon 1000 Fourier-transform spectrometer. 
NMR spectroscopy NMR spectra were recorded on either Bruker DMX 500 ('H, 
500.13 MHz; 13C, 125.72 MHz; '5N, 50.66 MHz; "Cd, 106.03 MHz) or Varian 
unitYINOJ7A ('H, 599.82 MHz; 13C, 150.86 MHz; '5N, 60.80 MHz; '11Cd, 127.23 
MHz) NMR spectrometers using TBI ['H, 13C, X] or triple resonance ['H,'3C,'5N] 
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probeheads, respectively, and equipped for z-field gradients. All spectra were 
acquired at the probe of 298 K using standard pulse sequences in 5 mm NMR tubes. 
1H and 13C shifts were referenced to sodium trimethylsilyipropionate (TSP), and '5N 
shifts to 1 M 15NH4C1 in 1.5 M HCl (external). NMR data were processed using 
Xwin-nmr (version 2.0, Bruker U.K. Ltd.). 
X-ray crystallography X-ray crystallographic studies were carried out on a Bruker 
SMART-APEX CCD Stadi-4 diffractorneter equipped with Oxford Cryosystems 
low-temperature devices by Dr. Simon Parsons, Dr. Robert 0. Gould, and Pamela A. 
McGregor. 
Electrospray lonisation-Mass Spectrometry (ESI-MS) Positive-ion electrospray 
ionisation mass spectra were obtained on a Platform II mass spectrometer 
(Micromass, Manchester, UK). Data were processed using Masslynx (0.5) 
Windows NT PC data system. 
Scanning Electron Microscope with Energy Dispersive X-ray Detector (SEM-
EDX) Elemental analysis of protein crystals were performed on a scanning-electron-
microscope (Philips XL30CP) with an energy dispersive X-ray detector and electron 
back scatter diffraction systems by Dr. Paula McDade in the Department of Geology. 
2.2 Crystallisation 
To grow crystals, molecules must be brought into a thermodynamically 
unstable state known as supersaturation. This is usually achieved by the gradual 
removal of solvent. Crystallogenesis is affected by a range of factors, such as pH, 
temperature, and concentration, etc. Protein crystals are rather small, usually < 10 
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mm 3.  They often have a high solvent content of around 20-80% making them rather 
brittle and fragile and have to be kept in a solvent-saturated environment. In the 
vapour diffusion methods a droplet of protein solution containing precipitant is 
equilibrated with a reservoir of precipitant containing a higher concentration of 
precipitant. The most common method is the hanging drop method. Variants of this 
include sitting drop and sandwich drop methods. 
Equilibration proceeds by diffusion of solvent from the drop to the reservoir 
until the vapour pressures in the drop and the reservoir are equal, thus achieving 
supersaturation in the drop. Such methods are very good for screening crystallisation 
conditions, commonly setting them up in multi-well "Linbro" boxes. 
2.3 N M R Simulations Spin system simulations were carried out using the 
program SpinWorks (version 1. 1, Kirk Marat, 1999).' 
2.4 Molecular Modelling Molecular models were built using the 
program Sybyl (version 6.3, Tripos Inc.) on a Silicon Graphics computer. WebLab 
ViewerPro 4 (Molecular Simulations Inc.) and MOLMOL (Version 2K. 1)2  were also 
used for modelling and graphics. 
2.5 NMR spectroscopy 
2.5.1 Nuclear spin 
44 
Chapter 2 Materials and Methods 
Nuclei possess magnetic moments when their spin quantum numbers are 
greater than 1/2. The spin states of such nuclei are characterised by the magnetic 
quantum numbers m = I, I-i, 1-2, , -I. Generally, for nuclei with even mass and 
atomic numbers, the even-even nuclei, I = 0, and for all other nuclei I ~! 1/2. I is an 
integral multiple of 1 for even-odd nuclei, and for odd-odd and odd-even nuclei it is 
an integral multiple of 1/2. The nuclei related to this study are listed in Table 2.1, 
with their properties that are relevant to nuclear magnetic resonance. 
The energy (and thus frequency) of an NMR transition depends on the 
magnetic-field strength and a proportionality factor for each nucleus called the 
magnetogyric ratio. The frequency of a transition is given by: 
V = -B0 	 (Equation 2.1) 2m 
where v is the frequency of the resonant radiation, y is the magnetogyric ratio and B0 
is the strength of the magnetic field. 
Table 2.1 Nuclear properties related to NMR studies in this thesis (data from ref. 3) 
Nucleus I 




(relative to 1 H) 
v 
'H 1/2 4.84 26.75 99.99 1.000 500.13 
'3c 1/2 1.22 6.73 1.10 0.016 125.72 
'5N 1/2 0.49 -2.71 0.37 0.001 50.66 
"Cd 1/2 1.03 -5.70 12.80 0.0095 106.03 
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2.5.2 Chemical shift and spin-spin coupling 
Chemical shift 
When an atom is placed in a magnetic field, its electrons circulate about the 
direction of the applied magnetic field (B0). This circulation causes a small magnetic 
field at the nucleus which opposes the externally applied field .4 
The magnetic field at the nucleus (the effective field, Be) is therefore 
generally less than the applied field by a fraction. This effect corresponds to a 
magnetic shielding of the nucleus that reduces B0 by an amount equal to aBO where 
is known as the shielding of the particular nucleus: 
Figure 2.1 The deshielding phenomenon in which the circulation of the electrons in 
the it orbits of an aromatic ring creates a magnetic field at the hydrogen nuclei which 
enhances the B0 field. 
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In some cases, such as the benzene molecule, the circulation of the electrons 
in the aromatic orbits creates a magnetic field at the hydrogen nuclei which enhances 
the B0  field (Figure 2.1). This phenomenon is called deshielding. 
Be = B0 (l -o) 	 (Equation 2.2) 
The electron density around each nucleus in a molecule varies according to 
the types of nuclei and bonds in the molecule. The opposing field and therefore the 
effective field at each nucleus will vary. This effect produces a shift of the resonance 
frequency, or more simply the chemical shift. 
The chemical shift of a nucleus is the difference between the resonance 
frequencies of the nucleus and a standard. This quantity is reported in ppm and given 
the symbol delta, 6. 
6 = (v - VREF) x106  / VREF 	 (Equation 2.3) 
In 'H NMR spectroscopy, standards are often tetramethylsilane, abbreviated 
TMS for non aqueous media and sodium trimethylsilylpropionate, abbreviated TSP 
for aqueous media. 
Spin-spin coupling 
Nonequivalent nuclei which are close to one another exert an influence on 
each other's effective magnetic field. If the distance between non-equivalent nuclei is 
less than or equal to three bond lengths, this effect is observable. This effect is called 
spin-spin coupling or J coupling. 
There is a total of four possible configurations for the two nuclei in a 
magnetic field (Figure 2.2). The vertical lines in this diagram represent the allowed 
transitions between energy levels. In NMR, an allowed transition is one where the 
spin of one nucleus changes from spin up to spin down, or spin down to spin up 
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Absorptions of energy where two or more nuclei change spin at the same time are not 
allowed. There are two absorption frequencies for the A nucleus and two for the X 
nucleus. 












A, 	A, 1 A2 
Figure 2.2 Nuclear magnetic energy level diagram for a two-spin system: (a) without 
spin-spin coupling, (b) with spin —spin coupling 
The NMR spectrum for nuclei A and X reflects the splittings observed in the 
energy level diagram. Both the A absorption line and the X absorption line are split 
into 2 absorption lines. The distance between the two split absorption lines is called 
the J coupling constant, or the spin-spin splitting constant, and is a measure of the 
magnetic interaction between two nuclei. Coupling occurs between nuclei because of 
the spin interaction of the nuclei with bonding electrons. Spin information between 
two nuclei is "transmitted" by the electrons in the bond(s). Because of this, the better 
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the orbital overlap between the nuclei (through intervening bonds) the stronger the 
coupling will be. The bond angle between two interacting nuclei will have a direct 
affect on the coupling constant. 
2.5.3 Karplus relationship 
Structural information from NMR experiments comes primarily from 
through-bond (scalar or J coupling) or through-space (the nuclear Overhauser effect, 
NOE) magnetisation transfer between pairs of protons. The value of a three-bond J 
coupling constant (3J) contains information about the intervening torsion angle. The 
relationship between dihedral angle and coupling constant is known as the Karplus 
relationship (Equation 2.4): 
3J— A + B cos4 + C cos2 	 (Equation 2.4) 
where A, B, and C are constants with the values 4.22, -0.5, and 4.5, respectively. 
Karplus curve is shown in Figure 2.3. 
3J 
20 40 60 70 80- 100 120 160 180 
(0) 
Figure 2.3 Dependence of the magnitude of the vicinal coupling constant on the 
dihedral angle. Line, theoretical curve; shade area, range of empirical results (ref. 4). 
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The relationship results from strong coupling when orbits are parallel and can 
overlap at the synperiplanar ( = 0 - 300) and antiperiplanar ( = 150 - 180°) 
geometries, and weak coupling when orbits are staggered or orthogonal ( = 60 - 
120°). The Karplus relationship has been shown to be dependent also on a variety of 
other molecular parameters, such as substitution, bond angles, and bond length.5  
Changes with bond lengths and bond angles, however, appeared to be minor,5 just as 
the effect of molecular vibrations is smal16 compared to the effect of 
electronegativity and relative position of substituents attached to the H-C-C-H 
fragment. In fact, ample experimental proof demonstrates that the latter effect is the 
second important factor, next to the dihedral angle dependence, in determining the 
magnitude of vicinal coupling constants.7 A great number of modified Karplus 
relationships were formulated .8  Haasnoot9 has set up a generalised and well-accepted 
Karplus-type relationship. In this case, the generalised Karplus equation takes the 
form shown in Equation 2.5: 
3J(1 H, 'H) = 13.89cos2HH - 0.98cosHH + Ax{ 1.02 - 
3.4cos2( 	+ 14.9 I Ay )} 	 (Equation 2.5) 
in which HH  (see Newman projection in Figure 2.3) is the Klyne-Prelog defined'0 
proton-proton torsion angle and AXi denotes the differences in electronegativity 
between the substituent Si and hydrogen on the Huggin's scale" corrected for the 
influence of P substituents 9 ; i takes on a value of +1 or —1 according to the 
orientation of the substituent Si with respect to the coupling proton on the same 
carbon atom.9 
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2.5.4 ID NMR spectroscopy 
1H NMR 
The basic 1D NMR experiment consists of exciting the nuclei with a single 
pulse then receiving the free induction decay (FID). The FID is then Fourier 
transformed to yield the spectrum. This is generally the type of experiment used for 
proton 'H NMR spectroscopy. The basic pulse sequence for a 'H NMR experiment is 
shown in Figure 2.4. The pulse sequence consists of the recycle delay followed by an 
RF pulse. Data are collected following the RF pulse. The pulse angle is, in practice, 
often chosen to be somewhat less than it/2. The two pulse sequence parameters 
shown in the Figure 2.4, d1 and p, correspond to the length of the recycle delay and 




Figure 2.4 'H One-pulse sequence 
1H decoupling in 13C and 111Cd NMR 
Extensive X-H coupling (large one-bond coupling 'Jxj and many smaller 
JXH and 3JxH) not only produces complex spectra, but also means that the overall 
sensitivity is seriously reduced.3 In order to solve these problems, it is normally 
necessary to apply proton decoupling. 'H decoupling is typically used to acquire 
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spectra of any nuclide other than 'H; this is designated by X{ 'H}, indicating that 
protons are being decoupled from nuclide X. 
The principles of spin decoupling can be simply illustrated by a consideration 
of the basic AB spin system. Nucleus A has two transitions due to the two possible 
orientations ((x and 0) of nucleus B. In the spin-decoupling experiment, nucleus A is 
observed with the normal weak RF field (the observe frequency) while 
simultaneously irradiating nucleus B with a second, much stronger, RF field (the 
decoupling freqency). The irradiation at B induces transitions between the two spin 
states of nucleus B ((x -> 13 and  13 -> a) and, if sufficient irradiating power is applied, 
then B flips backwards and forwards between the a and 13 states so rapidly that 
nucleus A can no longer distinguish the separate orientations of B, but 'see' only an 
average orientation. When this occurs, the coupling JAB between the two nuclei 
disappears and the doublet A-signal collapses to give a singlet line VA. 
In the simple heteronuclear decoupling experiment, as described above, a 
second channel is added and an individual proton signal is selected and irradiated 
with a strong RF field. Although this simplifies the spectrum by removing all the 
couplings to that specific proton, the spectrum will still be complicated by the 
couplings to other protons in the molecule. Though some of these may now be 
reduced in magnitude. If the decoupler is set to the centre of the proton region and 
then modulated using a 'noise generator' with a bandwidth wide enough to cover the 
complete proton region, then this equivalent to simultaneously irradiating every 
proton frequency and, consequently, results in the effective decoupling of all the 
protons in the molecule. However, there is an effect called the nuclear Overhauser 
effect (NOE) which changes the intensity of the '3C or 1 "Cd line. The NOE results in 
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the transfer of energy to attached '3C nuclei, resulting in a significant enhancement in 
the NMR signal. Therefore, integration is almost useless in such a spectrum. 
In some cases, decoupling reduces sensitivity such as 'H-decoupled '5N NMR 
or quantitative results are desired. In such cases the inverse gated pulse sequence 
minimizes the change in sensitivity while maintaining decoupling (Figure 2.5). The 
pulse width pw is set to 900  and the decoupler is turned on only during acquisition to 
prevent buildup of NOE enhancement. In this experiment the proton decoupler is 
pulsed to produce a spectrum where observed nuclei are decoupled, but the NOE 







Figure 2.5 Inverse-gated decoupled 1D NMR sequence 
2.5.5 2D NMR spectroscopy 
Heteronuclear Single Quantum Coherence (HSQC) 
The heteronuclear experiments are those which identify the chemical shifts of 
protons and X-nuclei that are directly coupled. One obvious use of this correlation 
information is to allow assignments already made for one nuclear species to be 
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transferred to the other. A more important but less obvious use is in overcoming 
problems caused by overlap in the proton spectrum: in the heteronuclear 2D 
spectrum the proton resonances are spread out according to the shifts of the 
heteronuclei to which they are coupled. 
The heteronuclear single quantum coherence (HSQC) technique belongs to 
the family of indirect (or inverse) detection techniques. An important feature of the 
experiment is that the proton magnetisation which is detected during t2 originated as 
proton magnetisation at the start of the sequence. The main advantage of this 
technique is the enhanced sensitivity, a theoretical maximum of [IyHl/'x]512  (306 for 
'5N) with respect to direct detection, and relatively short repetition time according to 
the T, of the protons and not of the X-nuclei.'2 By means of selective '5N labelling, 
this technique can also simplify a complicated spectrum in which only those protons 
directly attached to '5N atoms are detected. The basic HSQC pulse sequence is 
shown in Figure 2.6. 
Amine protons can be detected selectively by the use of the ['H, '5N] single 
quantum coherence (HSQC) pulse sequence. A 1D 'H spectrum containing only 
resonances from amine species is obtained by acquiring only the first increment in a 
two-dimensional experiment; resonances for CH and OH (including water) are 
eliminated. If '5N decoupling is employed, then each type of amine resonance 
appears as a singlet. In practice the water resonance is so intense that it is usually 
necessary to use additional solvent suppression techniques. A large improvement in 
water suppression is achieved by the use of pulsed field gradients for coherence 
selection, for example, by use of the HSQC sequences of Stonehouse et al. 13 
ME 
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R 	7tI2 	it 	 It 
IH J A J A 	 A A r_~ 
it 	7t/2 	 rcI2 	it 
X 
	
t1 	 GARP(dec.) 
Figure 2.6 Basic HSQC pulse sequence. The delays A and t are V4J and Y2J 
respectively, where J is the one-bond HX coupling constant. 
Correlated Spectroscopy (COSY) 
COSY is a two-dimensional homonuclear ('H,'H)-correlated NMR 
experiment which yields NMR spectra in which 'H chemical shifts along both 
frequency axes are correlated with each other. 14,15 It is the standard 2D experiment 
that can be used to identify pairs of protons that have scalar spin-spin coupling 
connectivities. There are two inherent drawbacks that limit its usefulness with 
macromolecules: one is that the fine-structure components that make up each cross-
peak appear in antiphase; the other is that the diagonal peaks and the cross-peaks are 
900 out of phase in both dimensions. These gives poor sensitivity and extremely 
harsh weighting functions must be used to give spectra with usable lineshapes which 
in turn gives a further reduction in sensitivity. 
More favourable lineshapes can be obtained by using the double-quantum 
filtered COSY sequence (DQF-COSY),'6 shown in Figure 2.7b. In this experiment 
the diagonal peaks and the cross-peaks all show the same antiphase absorption mode 
fine-structure. Although the double-quantum filtering attenuates the signals to some 
extent, this is more than offset by the gain resulting from not having to use resolution 
enhancement to impose acceptable lineshapes on the peaks. 
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Homonuclear Nuclear Overhauser Effect or Enhancement Spectroscopy 
(NOESY) 
Figure 2.7 Pulse sequences for two-dimensional (a) COSY, (b) DQF-COSY, and (c) 
NOESY experiments. tm is the mixing time. 
The NOESY experiment 17,18  is often used to identify pairs of protons that are 
undergoing cross-relaxation, i.e. protons that would show an NOE in 1D 
experiments. The characteristic feature of the NOESY pulse sequence (shown in 
Figure 2.7c) is the mixing time t. The cross-peaks are generated by magnetisation 
transfer that takes place during the mixing time so the length of this delay must be 
chosen according to the rate of the transfer process. In contrast to the COSY 
experiment, both cross-peaks and diagonal peaks in NOESY spectra can be obtained 
with absorption-mode lineshapes. The experiments are therefore eminently suitable 
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for studying macromolecules. If presaturation is used in a NOESY experiment it is 
usually also necessary to irradiate the solvent during the mixing time. A complicating 
factor is that the NOESY pulse sequence cannot distinguish between magnetisation 
transfer caused by cross-relaxation and magnetisation transfer by chemical exchange. 
In macromolecules, both give cross-peaks of the same sign as the diagonal. 
Total Correlation Spectroscopy (TOCSY) 
TOCSY provides a different mechanism of coherence transfer from COSY 
for 2D correlation spectroscopy.4"9  The cross peaks are generated between all 
members of a coupled spin network. An advantage is that the "net" coherence 
transfer produced can be arranged to create pure absorption mode spectra with 
positive intensity peaks (rather than "differential" coherence transfer which causes 
spectra with equal positive and negative intensities). In traditional COSY, cross-
peaks have zero integrated intensity and coherence transfer is restricted to directly 
spin-coupled nuclei. In TOCSY, oscillatory exchange is established which proceeds 
through the entire coupling network so that there can be net magnetisation transfer 
from one spin to another even without direct coupling. The isotropic mixing which 
occurs during the spin-lock period of the TOCSY sequence exchanges all in-phase as 
well as antiphase coherences. 
The coherence transfer period of the TOCSY sequence occurs during a 
multiple-pulse spin-lock period .4'19 The multiple-pulse spin-lock sequence most 
commonly used is MLEV-17 which contains a set of 17 90/1800  pulses whose 
duration represents the mixing time tm. The length of the spin-lock period determines 
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how "far" the spin coupling network will be probed. The TOCSY spectrum can be 
phased so that all cross peaks and diagonal peaks have positive intensity. 
tI2 	Spin lock 
cq 
di fl ti _ 	 I t2 
Figure 2.8 2D TOCSY pulse sequence 
2.6 IR spectroscopy 
There are two kinds of fundamental vibrations for molecules: stretching, in 
which the distance between two atoms increases or decreases, but the atoms remain 
on the same bond axis, and bending, in which the position of the atoms changes 
relative to the original bond axis.' 9,20  The various stretching and bending vibrations 
of a bond occur at certain quantized frequencies. When infrared light of the same 
frequency is incident on the molecule, energy is absorbed and the amplitude of that 
vibration is increased. A molecule can be said to resemble a system of balls of 
varying masses, corresponding to the atoms of a molecule, and springs of varying 
strengths, corresponding to the chemical bonds of a molecule. This model can be 
applied to account for fundamental vibrations occurring between the nonvibrating 
state and the vibrationally excited state in a simple diatomic molecule A-B. 
The vibrational frequency in cm-' is given by 
V = 	1I27w (k11-1) -2 
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where 	k is the force constant of the bond 
p is the reduced mass of the molecule defined by: 
P = mAmB/(mA+mB) 
Bending vibrations generally require less energy and occur at longer wavelength than 
stretching vibrations. Stretching vibrations are found to occur in the order of bond 
strengths. The triple bond (absorption at 2300 - 2000 cm') is stronger than the 
double bond (absorption at 1900 - 1500 cm 1 ), which in turn is stronger than the 
single bond (C - C, C - N, and C - 0 absorption at 1300 - 800 cm). When the 
single bond involves the very small proton (C - H, 0 - H, or N - H), stretching 
vibrations occur at much higher frequency (3700 - 2630 cm'). 
2.7 Electrospray ionisation-mass spectrometry (ESI-
MS) 
Mass spectrometry is an instrumental approach that allows for the gas phase 
generation of ions as well as their separation and detection. The five basic parts of 
any mass spectrometer include: a vacuum system, a sample introduction device, an 
ionisation source, a mass analyser, and an ion detector. A mass spectrometer 
determines the molecular weight of chemical compounds by ionising, separating, and 
measuring molecular ions according to their mass-to-charge ratio (mlz). The ions are 
generated in the ionisation source by inducing either the loss or the gain of a charge 
(e.g. electron ejection, protonation, or deprotonation). Once the ions are formed in 
the gas phase they can be electrostatically directed into a mass analyser, separated 
according to mass and finally detected. The result of ionisation, ion separation, and 
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detection is a mass spectrum that can provide molecular weight and even structural 
information. 
Electrospray ionisation is one of the most exciting ionisation techniques 
recently developed .2 ' EST generates ions directly from solution (usually an aqueous 
or aqueous/organic solvent system) by creating a fine spray of highly-charged 
droplets in the presence of a strong electric field (typically 3.5 kV). As the droplet 
decreases in size, the electric charge density on its surface increases. The mutual 
repulsion between like charges on this surface becomes so great that it exceeds the 
forces of surface tension, and ions begin to leave the droplet through what is known 
as a "Taylor cone". The ions are then electrostatically directed into the mass analyser. 
Vaporisation of these charged droplets results in the production of singly- or 
multiply-charged gaseous ions. The number of charges retained by an analyte can 
depend on such factors as the composition and pH of the electrosprayed solvent as 
well as the chemical nature of the sample. For small molecules (<2000 Daltons) EST 
typically generates singly or doubly charged ions while for large molecules (>2000 
Daltons) the EST process typically gives rise to a series of multiply charged species. 
Because mass spectrometers measure the mass-to-charge (mlz) ratio, the resultant 
EST mass spectrum contains multiple peaks corresponding to the different charged 
states. 
EST is a very sensitive technique and is ideally suited for the analysis of 
small, large and/or labile molecules including peptides, proteins, organometallics, 
oligosaccharides, and polymers. Another advantage of ESI-MS is that ions are 
formed directly from solution (usually an aqueous or aqueous/organic solvent 
system), a feature that has established the technique as a convenient mass detector 
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for liquid chromatography (LC) also known as high performance liquid 
chromatography (HPLC). 
28 Scanning electron microscope-energy dispersive 
X-ray detector spectrometer (SEM-EDX) 
The SEM microscope consists of a column, detectors, and a viewing console. 
The column is like the lenses in a light microscope.22 At the top of the column, a 
filament tip generates electrons (which are negatively charged). This is called the 
electron gun. The specimen is at the bottom of the column, in a complete vacuum. 
Magnets in the column direct and focus the electron beam to travel towards the 
specimen. Beam deflector coils make the beam of electrons swing across the sample 
(called rasterisation). Some electrons are reflected from the specimen and some are 
absorbed. Specialised detectors receive these electrons and process the signal. 
There are three types of detectors: secondary electron for topographical 
imaging, backscattered electrons for phase and chemical compositional imaging, 
energy dispersive X-ray spectroscopy for chemical elemental analysis. 
The scanning electron microscope is used to analyse the surface of specimens 
over a wide range of magnifications. A focused beam of electrons is either scanned 
across the surface of a specimen to form an image, or stopped on a fixed location to 
perform one of a variety of spectrographic or analytical functions. The interaction of 
the beam with the specimen results in the generation of secondary electrons, 
backscattered electrons, Auger electrons, characteristic X-rays, and photons of 
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various energies. Secondary electrons and backscattered electrons are collected by 
their respective detectors and their signals are amplified. 
The secondary electron signal comes from the top 20 - 50 A. Utilising very 
low instrument accelerating voltages for very shallow penetration, results in a true 
surface image. The backscattered electron signal comes from depths in the micron 
range and provides elemental information arising in the entire volume of specimen 
involved. The X-ray signal used to form spectra or element maps arises in a volume 
within the specimen on the order of microns in depth. Both qualitative and 
quantitative elemental analysis is possible. All elements heavier than B in the 
periodic table may be detected. The energy-dispersive X-ray spectrometer (EDS) 
detects X-rays from the sample excited by the highly focused, high-energy primary 
electron beam penetrating into the sample. When the high-energy electrons interact 
with the atoms of material in this "interaction volume," typically several microns in 
diameter, they generate characteristic X-rays which are fingerprints of the individual 
atoms encountered. These X-rays can penetrate through the material, allowing them 
to escape and be detected by the X-ray detector. Because the intensity of the 
individual X-ray is related to the quantity of the "parent atom" in the interaction 
volume, quantitative elemental analysis can be obtained from the sample with the aid 
of the computer and software analysis capabilities. "Standardless" quantitative 
analyses give an accuracy of 1-2%, while ultimate accuracy can be obtained by 
spectral comparison to known standards. Detection sensitivities are about 0.1 weight 
percent. Elemental maps of the sample as well as linescans, digitised secondary and 
backscattered electron images and more sophisticated analyses also can be collected 
by this method. 
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Chapter 3. Synthesis and Characterisation of 
15N-Labelled Cyclam 
3.1 Introduction 
Examination of less common nuclei has become prominent over recent years 
and, of these, 15N occupies a unique position because of its importance in biological 
systems.' Although 'H NMR resonances can be detected from NH protons with '4N 
present in natural abundance (99.6%), they are often broad because of the 
quadrupolar relaxation of '4N (1= 1).2  The low sensitivity of '5N (3.85 x 106  relative 
to 'H) to some extent limits its usefulness for directly detected 15N NMR studies. 
However, the sensitivity of detection can be improved by '5N isotopic enrichment 
(natural abundance '5N: only 0.37%) combined with the inverse ('H-detected) '5N 
methods. The major advantage of the inverse detection technique is the sensitivity of 
detection, which is enhanced by a theoretical maximum of 306 (IyHI/frNI512) with 
respect to directly detected '5N.2 These methods are widely applicable to any 
compounds which have a '5N atom with a measurable spin-spin coupling to 'H (i.e. 
ammine, primary and secondary amines, but not tertiary amines). In practice the best 
results are obtained with large one-bond couplings (about 73 Hz for 15 NH3). 
Introduction of '5N by synthetic labelling usually gives rise to a sharp 'H doublet for 
an amine group. In order to reveal the binding behaviour of bicyclam and the 
possible conformation of its transition metal complexes in solution by NMR, '5N-
labelled cyclam and its Zn cyclam complex were synthesised. Since the 
commercially available starting materials for syntheses of '5N-labelled compounds 
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are expensive, effective reactions are required for the synthesis of '5N-labelled 
compounds. A very convenient and efficient synthesis of ('5N)cyclam is presented 
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N = '5N; Tr = Trityl group; TBTU = 0-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 
Scheme 3.1 Preparation of 15N-cyclam from (15N)potassium phthalimide and 15N-
glycine 
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AMD3 100 has been extensively investigated because of its highly potent and 
selective inhibition of the human immunodeficiency virus (HIV). It is important to 
study the mechanism of action of bicyclams in order to aid the design of more 
effective anti-HIV antagonists. 
3.2 Experimental 
31.1 NMR spectroscopy for complexes 1-9 (scheme 3.1) 
Typically NMR data were acquired in 10% D20 / 90% H20 or CDC13 in 5 
mm tubes at a probe temperature of 298 K on 500 MHz NMR instrument. 'H 
chemical shifts were externally referenced to the methyl singlet of TSP (3-
trimethylsilyl- propionate-d6) at 0 ppm; 13C chemical shifts were referenced 
externally also using TSP, and '5N shifts were externally referenced to 1 M 15NH4C1 
in 1.5MHCL. 
1D 'H NMR data were acquired typically over a 'H frequency width of 5 kHz 
into 32 k data points (acquisition time = 3.28 s). The water resonance was suppressed 
by presaturation or via the WATERGATE pulsed-field-gradient sequence.3  
The '3C- {'H} NMR spectrum of '5N-6 was acquired at 150 MHz over a 
frequency width of 27.77 kHz into 16 k data points (acquisition time = 0.29 s). 
2D ['H, '3C] HSQC NMR data were acquired for '5N-6 over a 'H frequency 
width of 1 kHz and a 13C frequency width of 3.77 kHz (30 ppm) centred at 43 ppm. 
Data were acquired with 2 transients into 512 complex data points (acquisition time 
256 ms) for each of 128 t, increments. 
2D ['H, '3C] HSQC NMR data were acquired for '5N-7 over a 'H frequency 
width of 2.5 kHz and a 13C frequency width of 10 kHz (80 ppm) centred at 43 ppm. 
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Data were acquired with 32 transients into 1024 complex data points (acquisition 
time 205 ms) for each of 128 t, increments. 
2D ['H, '5N] HSQC NMR data for '5N-6 were acquired over a 'H frequency 
width of 5 kHz and a '5N frequency width of 4.06 kHz (80 ppm) centred at 10 ppm. 
Data were acquired with 140 transients into 2 k complex data points for each of 128 
t j increments. 
2D ['H, 'H] DQF-COSY data for '5N-6 were acquired over a 'H frequency 
width of 3 kHz. Data were acquired with 8 transients into 1024 complex data points 
(acquisition time 0.17 s) for each of 128 t, increments. 2D ['H, 'H] TOCSY data for 
'5N-6 were acquired over a 'H frequency width of 1.9 kHz. Data were acquired with 
8 transients into 1024 complex data points (acquisition time 0.14 s) for each of 128 t, 
increments. A spin-lock time of 60 ms was employed. 
2D ['H, 'H] TOCSY data for '5N-7 were acquired over a 'H frequency width 
of 5 kHz. Data were acquired with 16 transients into 2048 complex data points 
(acquisition time 0.21 s) for each of 512 t, increments. 21) ['H, 'H] TOCSY data for 
'5N-7 were acquired over a 'H frequency width of 1.9 kHz. Data were acquired with 
32 transients into 512 complex data points (acquisition time 0.14 s) for each of 128 t, 
increments. A spin-lock time of 60 ms was employed. 
Spin system simulations were carried out using the program Spinworks 
(version 1. 1, Kirk Marat, University of Manitoba, 1999). 
3.22 Synthesis of 15N-Iabelled cyclam 
('5 N)1 ,3-Diphthalimidopropane ('5 N-1). ('5N) 1,3 -Diphthalimidopropane was 
prepared by modification of the Gabriel synthesis.4 ('5N)Potassium phthalimide (15 
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mmol, 2.79 g), K2CO3 (7.5 mmol, 1.04 g, dried in vacuo at 130 °C for 5 h) and 1,3-
dibromopropane (7.5 mmol, 0.77 ml) were suspended in dry dimethylformamide (12 
ml) and heated under reflux for 4 h at 190 °C. The reaction mixture was further 
stirred at room temperature for 26.5 h. The volume of the solution was reduced under 
vacuum to about 2-3 ml. The mixture was stirred for 1.5 h after addition of 50 ml of 
H20 into the above solution. A pale yellow precipitate appeared and was collected by 
filtration and washed with small amounts of methanol and ether to give 15N-1,3-
diphthalimidopropane, '5N-1 (1.79 g, 79.6 %). 'H NMR (CDC13): 6 = 7.81 - 7.86 (m, 
4H, C6H4), 7.69 - 7.73 (m, 4H, C6H4, 3.71 (dt, 4H, 2J ("N, 'H) = 1.22 Hz, NCH2), 
2.04 (m, 2H, CH2CH2CH2); JR (KBr): v = 1712 (s, C=O) cm'; El MS 336 m/e (M). 
(15N) 1,3-Diaminopropane dihydrochloride ('5N-2). ('5N) 1,3 -Diaminopropane was 
prepared by a synthesis given in the literature .5  A suspension of 15N-1,3-
diphthalimidopropane and potassium hydroxide (2 g, 36 mmol) in H20 (12 ml) was 
stirred for 60 h at ambient temperature until a clear solution observed. The solution 
was distilled into 2 ml of concentrated aqueous solution of HC! under reduced 
pressure to dryness. After cooling to ambient temperature, 10 ml of water was added 
to the residue and distilled to dryness again. The procedure was repeated twice. 
Water was removed to give '5N-2 (0.89 g, 87.9%). 'H NMR (10% D20/ 90% H20, 
pH 4.6): 6 = 7.76 {d, 4H, 'J(' 5N, 'H) = 74.62 Hz, NH21, 3.15 (t, 4H, CH2), 2.10 (m, 
2H, CH2); JR (KBr): v = 3002 (s, br, 15  NH) cm'; El MS 149 m/e (M). 
(15N)Tritylglycine ('5N-3). (15N)Trityglycine was prepared by a modification of a 
synthesis given in the literature .6, 7 To a solution of 15N-glycine (1.53 g , 20.10 
mmol) in a mixture of 6 ml of diethylamine, 8 ml of water and 16 ml of isopropanol, 
tritylchloride (7.29 g, 26.2 mmol) was added every 15 minutes in 13 portions 
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altogether. After addition, the mixture was stirred for a further 12 h. Then, 50 ml of 
water was added and the white precipitate was collected and washed with 75 ml of 
water. The filtrate was acidified with concentrated acetic acid to pH 3 and the formed 
white precipitate was collected and washed with dilute acetic acid (pH 3). The 
combined product was dried under vacuum. Yield 4.91 g (77 %). 'H NMR (CD3OD): 
6 = 7.27 - 7.40 (m, 15H, C6H5), 3.17 (d, 2H, 2j(15  N, 1 H) = 0.46 Hz, CH2); '3C NMR 
(CD30D): 6 = 173.86, 144.74, 129.95, 129.51, 128.76, 73.83 {d, 'J ('5N, 13C) = 
5.091, 47.64 (d, 'J ("N, '3C) = 5.51); JR (KBr): v = 3312 (15  NH), 1721 (C=O) cm'; 
El MS 318 m/e (M). 
('5N)1 ,3-Bis-tritylglycylamnio-propane ('5N-4). Triethylamine (4.83 ml, 34.74 
mmol), 15N-tritylglycine (3.69 g, 11.58 mmol) and TBTU (3.72 g, 11.58 mmol) were 
added to a suspension of 15N-diaminopropane dihydrochioride (0.86 mg, 5.79 mmol) 
in dry acetonitrile (100 ml). The mixture was stirred at ambient temperature for 2 h. 
Then, water (5 ml) was added and the solution was evaporated to dryness under 
vacuum. The residue was re-crystallised from ethanol (140 ml) and the white product 
was collected and dried under vacuum. Yield 2.53 g (65 %). 'H NMR (CDC13): 6 = 
7.56 (t, 2H, NI]), 7.45-7.40 (m, 5H, C6H5), 7.31-7.25 (m, 5H, C6H5), 7.23-7.18 (m, 
5H, C6H5), 3.34 (m, 4H, CH2CH2CH2), 3.02 (s, 4H, CH2NH2), 1.70 (m, 2H, 
CH2CH2CH2); JR (KBr): v = 3312 ("NH), 1645 (s, C=O) cm'; El MS 677 m/e (M). 
(15N)N,N'-Bis(2-tritylaminoethyl)-1 ,3-propanediamine (' 5N-5) and (15N)N,N'-
Bis(2-aminoethyl)-1 ,3-propanediamine•4HC1 ('5N-6). A solution of BH3 THF (17 
ml, 1 M) in dry THF (80 ml) was added to a suspension of '5N-4 (2.48 g, 3.67 mmol) 
and stirred for 1.5 h at ambient temperature. Then, the mixture was heated under 
reflux for 24 h. After cooling to ambient temperature, dry methanol (40 ml) was 
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added carefully. The insoluble material was filtered off and the filtrate was 
evaporated to yield the yellowish sticky product '5N-5. 
Compound 15N.-5 was suspended in 5 N HC1 (50 ml) and heated under reflux 
for 5 h. A white precipitate was produced and filtered off. The volume of solution 
was reduced to 5 ml and ethanol (30 ml) was added. The white precipitate which 
formed was collected by filtration and washed with ether. Yield 0.97 g (85 % for 
steps 5 and 6). 'H NMR (10% D20/ 90% H20, pH 3.9): 6 = 3.44 (m, 4H, 
NCH2CH2N), 3.41 (m, 4H, NCH2CH2N), 3.25 (t, 4H, 3J = 7.93 Hz, CH2CH2CH2), 
2.18 (m, 2H, CH2CH2CH2); '3C NMR (10% D20/ 90% H20, pH 3.9): 6 = 47.69 ('J 
(13C, '5N) = 5.09 Hz, 3j  (13C, '5N) = 2.54 Hz), 47.13 ('J (' 3C, '5N) = 5.51 Hz), 38.27 
( Ii  (13C, 
15N) = 5.93 Hz), 25.46; '5N NMR NMR (10% D20/ 90% H20, pH 3.9) 6 = 
20.56; IR (KBr): v = 3425 (br, NH) cm'; El MS 165 m/e (Mt4HC1). 
(15N)9a,9b-Dimethyl-octahydro-1 ,3a,6a,9-tetraaza-phenalene ('5N-7). The pH of 
an aqueous solution of '5N-6 (400 mg, 1.29 mmol) was adjusted with NaOH pellets 
to pH >13 and distilled until dryness into 15 ml of water under reduced pressure. 
After cooling to ambient temperature, water (10 ml) was added to the residue and 
distilled to dryness again. This procedure was repeated twice. Water was removed to 
give the free tetraamine. The following reactions were carried out according to a 
literature method.8 Butanedione (112.08 jtl, 1.29 mmol) in a solution of CH3CN (2 
ml) was added dropwise to the cooled and stirred solution of the residue of free 
tetraamine of 15N-6 in CH3CN (5 ml). After completion of the reaction (2 h), the 
solvent was evaporated under reduced pressure to yield '5N-7 as a yellow product. 
The product was used without further purification in the next step. 'H NMR (CDCI3): 
6 = 3.58 (m, 1H, NCH2CH2N), 3.28 (m, 11-1, CH2CH2CH2), 3.21 (m, 1H, 
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NCH2CH2N), 3.11 (m, 1H, NCH2CH2N), 2.90 (m, 1H, 2J= 12.2 1, NCH2CH2N), 2.70 
(m, 1H, CH2CH2CH2), 2.59 (m, 1H, CH2CH2CH2), 2.58 (m, 1H, NCH2CH2N), 2.52 
(m, 1H, 2J = 14.34, CH2CH2CH2), 2.44 (m, 1H, NCH2CH2N), 2.32 (m, 1H, 
CH2CH2CH2), 2.27 (m, 1H, NCH2CH2N), 2.19 (dm, 1H, 2J = 10.07 Hz, 
NCH2CH2N), 1.37 (s, 3H, CH3), 1.30 (s, 3H, CH3), 1.15 (dm, 1H, 2J = 13.43 Hz, 
CH2CH2CH2); '3C NMR (CDCI3): 6 = 54.08, 51.95, 49.58, 48.42, 44.87, 42.05, 
26.23, 21.07, 13.49; IR (KBr, neat): v = 3289 (15  NH), 3232 (15  NH)cm'; El MS 214 
m/e (M). 
('5N) lOb,! Oc-Dimethyl-decahydro-3a,5a,8a, 1 Oa-tetraaza-pyrene ('5N-8) and 
(15N)cyclam ('5N-9). Following the literature method,8  K2CO3  (0.36 g, 2.58 mmol) 
and 1,3-dibromopropane (130.95 t1, 1.29 mmol) were added to a solution of '5N-7 in 
dry CH3CN (20 ml). The reaction mixture was stirred for 12 h. After the reaction, the 
insoluble material was filtered off and the solvent evaporated to give '5N-8 as a 
brown oil. Purification of the crude product was performed by dissolving the brown 
oil in dichioromethane (8 ml) and followed by addition of hexane (about 50 ml). A 
yellow precipitate which formed was filtered off, and the filtrate was evaporated to 
give '5N-8. The product was used without further purification in the next step. 
Compound '5N-8 was dissolved in ethanol (10 ml) and 10% hydrochloric acid 
(20 ml). The mixture was heated at 60 °C for 2 days. The mixed solvent was 
evaporated and the residue was recrystallised in EtOH to obtain the cyclam as the 
tetrahydrochioride salt. The residue was dissolved in a small amount of water (about 
1 ml) and the pH of the solution was adjusted by NaOH pellets to pH >13. Then the 
solution was extracted with CHC13 (4x 10 ml), and the solvent evaporated to give 
(15N)cyclam (0.14 g, 54% for steps 7, 8 and 9). 'H NMR (CDC13): 6 = 2.81 (t, J = 
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5.49 Hz, 8 H; 15NHCH2CH2CH2 '5NH), 2.77 (s, 8H; 15NHCH2CH215NH), 1.75 (m, 
4H; 15NHCH2CH2CH2 '5NH); '5N NMR (CDC13): 6 = 4.5; Selected IR (KBr, neat): v 
= 3260 (NH), 3178(NH), 2962 (CH2), 2921(CH2), 2868(CH2), 2803(CH2) cm; El 
MS 204 m/e (M). 
3.3 Results 
3.3.1 (15N)N,N'-Bis(2-aminoethyl)-1 ,3-propanediamine tetra-
hydrochloride (15N-6) 
The 2D ['H, '5N] HSQC NMR spectrum in 10% D20/ 90% H20 showed four 
cross-peaks for 'H, '5N correlations (Figure 3.1). Three 'H/'5N cross-peaks correlated 
with the '5N peak at 20.56 ppm and the remaining 'H/'5N cross-peak correlated with 
the '5N peak at 7.74 ppm. The 1D '3C- {'H} NMR spectrum for '5N-6 in 10% D20 / 
90% H20 showed four 13C peaks (Figure 3.2). The 2D ['H, '3C] HSQC NMR 
spectrum 10% D20 / 90% H20 also showed cross-peaks which were identified thus: 
Ha (6 2.18/'3C 25.46), Hb (6 3.25/' 3C 47.69), H (6 3.41/'3C 38.27) and Hd (6 
3.44/'3C 47.13). Both ['H, 'H] DQF-COSY and TOCSY NMR spectra show that Ha 
and Hb correlate with each other (Figures 3.3 and 3.4). 
Further NMR simulation was performed using SpinWorks (Version 1. 1, Kirk 
Marat) program (Figure 3.5). All coupling constants acquired from the simulation are 
listed in Table 3.1. 
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Figure 3.2 2D ['H, '3C] HSQC of '5N-6 in 10% D20 / 90% H20 (N = '5N) 
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Figure 3.4 2D ['H, 'H] TCOSY of '5N-6 in 10% D20/ 90% H20 
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I 	I• 	 I 	I• 
3.5 3.4 3.5 3.4 
(1H) 
Figure 3.5 Simulated (right) and experimental (left) 'H NMR spectra of '5N-6 in 
10% D20 / 90% H20. The coupling constants obtained from simulation are listed in 
Table 3.1. A fragment of '5N-6 is shown. 
Table 3.1 'H, 'H NMR coupling constants (Hz) for 15N-6 from simulation 
o ("H, Hz) Ha 
(500 MHz)  
Ha' Hb Hb' 
Ha 1710.7 
Ha' 1710.7 2J,9.0 
Hb 1720.0-7T, 1—.2 3J,3.5 
Hb 1720.0 3J, 4.2 3J, 1.2 2J, 9.0 
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3.3.2 	( 15N)9a,9b-Dimethyl-octahyclro-1 ,3a,6a,9-tetraaza- 
phenalene ( 15N-7) 
The 2D ['H, '3C] HSQC NMR spectrum showed cross-peaks corresponding 
to sixteen 'H NMR signals and nine 1 3C NMR signals (Figure 3.6). Geminal pairs of 
protons were identified thus: Ha (6 1.15)! Hf (6 2.32) ((8 13C 21.07), Hd (6 2.19) / 
HP (6 3.58) (6 '3C 48.42), He (6 2.27) I Hg (6 2.44) (6 3C 54.08), Hh (6 2.52)! H. 
(6 3.28) ((6 '3C 49.58), H, (6 2.58) / H0 (6 3.21) (6 '3C 42.05), H (6 2.59) / Hk 
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Figure 3.6 1D 'H (top) and 2D ['H, '3C] HSQC (bottom) spectra of '5N-7 in CDC13  
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Figure 3.8 2D ['H, 'H] TOCSY spectrum of '5N-7 in CDC13 
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cross-peaks (6 Hb/'3C  1.30/26.23) and (6 H/' 3 C 1.37/13.49), show that each '3C 
resonance corresponds to a single 'H resonance and therefore, they are from two 
methyl groups. This conclusion was confirmed by 2D ['H, 'H] DQF-COSY (Figure 
3.7) and TOCSY NMR (Figure 3.8) in which each of them does not correlate with 
any other resonances. 
The two singlets Hb and H are from two CH3 methyl groups. There are still 
three other spin systems besides the two methyl groups in 2D ['H, 'H] TOCSY NMR 
spectrum (Figure 3.8). Within the first spin-system (designated A), the main 
couplings appear to be as follows: H. couples to Hf, 11k  and H0 strongly and to Hh 
and Hj weakly, which also couple to one another. The second spin-system 
(designated B) is composed of 4 signals: Hd is coupled to H1 weakly and to H. and 
H strongly, which also couple to one another. The last spin system (designated C) 
also consists of 4 cross-peaks: 119  couples to He, and H1 and H. strongly, which also 
couple to one another. 
In general, introduction of '5N by synthetic labelling gives rise to couplings 
between '5N and 'H, or '5N and 13C which were measurable in 'H NMR and 13C 
NMR spectra, respectively. The coupling constants are listed in Table 3.2. 
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Table 3.2 Coupling constants for 15N labelled compounds 
compound solvent Coupling constant (Hz) 
J(' 3C, '5N) f('H, 15N) 
15N-1 CDC13  1.2 
'5N-2 D20/1-120 74.6 
15N-3 CD30D 5.l;5.5 0.5 
15N-6 D20/17120 5.5; 5.9 2.5 
3.4 Discussion 
3.4.1 (15N)N,N'-Bis(2-aminoethyl)-1 ,3-propanediamine tetra-
hydrochloride (15N-6) 
From chemical shifts and/or patterns of resonances in 'H NMR spectrum, Ha 
and Hb can be easily assigned to the middle CH2 and two side CH2 groups in the 
fragment of NHCH2CH2CH2NH, respectively. Both ['H, 'H] DQF-COSY and 
TOCSY NMR spectra show Ha and Hb correlate to each other and thus confirm this 
conclusion (Figures 3.3 and 3.4). The remaining resonances at 3.41 and 3.44 ppm 
correlating to two separate '3C resonances at 47.13 and 47.69 ppm, respectively, 
show an AB system for protons in fragment NHCH2CH2NH. The '5N peak at 20.56 
ppm in ['H, '5N] HSQC correlated to Ha, Hb and H. Therefore, H most likely 
comes from the fragment '5NHCH2CH215NH2 next to "NH. The '5N resonance at 
20.56 ppm couples to Ha and 11b on its neighbour carbons, and H through a 3-bond 
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coupling. 11d must come from CH2 next to 15NH2 in the fragment 
15NHCH2CH21 5  NH2. 
Unlike in the ethane molecule, the eclipsed conformation in the ethane 
fragment of '5N-6 becomes unfavourable because of electrostatic repulsion (see 
ethane fragment in Figure 3.9). Therefore, most ethane fragments in '5N-6 exist in the 
gauche and trans conformations (Figure 3.9). However, trans is the most stable and 
favourable conformer since NH3 and NH2 are in trans positions and, therefore, 
there is lowest electrostatic repulsion in trans conformer. This conclusion can be 
further confirmed by very low and equal 3J (HaHb) and 3J (Ha'Hb) coupling constants 
(1.2 Hz, see Table 3.1). As shown by the Newman projections, the rapid rotation 
between gauche and trans conformers about the C-C bond leads to an average NMR 
spectrum which appears as an AA'BB' type. The coupling constants in Table 3.1 are 
from the population-weighted average of those of the different conformers. 
NH3  











Hb' '  Hb 
Ha 
gauche 
Figure 3.9 Newman projections for the three low-energy conformations around the 
C-C bond of the ethane fragment in '5N-6. (N = '5N) 
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3.4.2 (15N)9a,9b-DmethyI-octahydro-1 ,3a,6a,9-tetraaza-
phenalene (15N-7) 
There are seven possible configurations for '5N-7 depending on the alignment 
of the two CH3 groups and lone electron pairs of the tetraamine nitrogen atoms 
(Figure 3.10). The two CH3 groups are denoted cis and trans according to the usual 
conventions. In the crystal structure, the compound 7 adopts configuration 2 (Figures 
3.10 and 3.11) in which all three six-membered rings adopt chair conformation.8 In 
solution, fourteen NMR resonances as well as two singlets from the two CH3 groups 
reveal that all seven geminal pairs of protons from one CH2CH2CH2 and two 
CH2CH2 fragments in three six-membered rings in '5N-7 are nonequivalent. 
Therefore, it is assumed that the compound adopts the same configuration as in the 
crystal structure shown in Figure 3.11. Therefore, the compound loses symmetry and 
all seven geminal pairs of protons are nonequivalent. 
"'C H)3 












Figure 3.10 Seven possible configurations for compound 7 
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Figure 3.11 Conformation of compound 7 in the crystal structure (ref. 8) 
From its chemical shift, Ha can be easily assigned to the middle CH2 of 
N(CH2)3N and six ['H,'H] DQF-COSY cross-peaks also confirmed that the spin-
system A belongs to the six-membered containing N(CH2)3N (see Figure 3.7). The 
other two spin-systems (B and C), therefore, can be assigned to the other two six-
membered rings which contain NH(CH2)2NH, and the four ['H,'H] DQF-COSY 
cross-peaks for each of them also confirmed this conclusion (see Figure 3.7). 
In 2D ['H, 'H] DQF-COSY NMR spectrum (Figure 3.7), Ha couples to Elf, 
Hk and H0 strongly and to Hh and Hj  weakly within the spin-system A. 2D [1H '13C] 
shows that Ha/Hf, HJ/Hk and Hh/H0 are geminal pairs of protons. It is more likely 
that the six-membered ring A exists in a twist-boat conformation in solution instead 
of the chair conformation in the solid state (Figure 3.12).8  In the twist conformation, 
the torsion angle between Ha of the middle CH2 group and H (or Hh) of the 
neighbouring CH2  group is close to 90°. Therefore, there is a weak coupling between 
Ha and H (or Hh). This also can be used to explain the weak coupling between Hf  
and Hk (or H0). In such highly strained system, although the ideal configuration will 
have as many rings as possible in chair conformation, however, the flexibility will 
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decrease at the same time. Therefore, although ring A with a twist-boat conformation 
in solution has a higher energy, it will have less strain as well. 
gauche 	 twist-boat 	 eclipsed 
Figure 3.12 Newman projections for the CH2CH2CH2 fragment in '5N-7 
In the 2D ['H, 'H] DQF-COSY NMR spectrum, ild  is coupled to H1 weakly 
and to H. and H strongly in spin system B. 2D ['H,'3C] shows that Hd/HP and 
Hi/Hm are geminal pairs of protons. It seems that ring B has a similar situation as 
ring A and also adopts a twist-boat conformation in solution. 
In the 2D ['H, 'H] DQF-COSY NMR spectrum, Hg couples to He, and Hi and 
H strongly in spin system C. 2D [1H, 13C]  shows that Hg/He and Hiffln  are geminal 
pairs of protons. Therefore, this shows that ring C still adopts chair conformation in 
solution. 
In general, 15N-7 adopts conformation 2 (Figure 10) the same as in the solid 
state. However, two rings including ring A adopt the twist-boat conformation and 
third ring remains in the chair conformation. 
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3.5 Conclusions 
15N-cyclam has been successfully synthesised by a very effective synthetic 
route. '5N isotopic enrichment (natural abundance '5N: only 0.37%) greatly improved 
the sensitivity of detection combined with the inverse ('H-detected) '5N method. 
1D and 2D 'H, '3C, and '5N NMR studies revealed that the ethane fragments 
in '5N-6 exist in the gauche and trans conformations in aqueous solution. The trans 
conformer is the most favourable. The rapid rotation between gauche and trans 
conformers about the C-C bond leads to an average NMR spectrum which appears as 
an AA'BB type. The coupling constants are also from the population-weighted 
average of those of the different conformers. 1D and 2D 'H and '3C NMR studies 
revealed that '5N-7 adopts conformation 2 (Figure 10) as in the solid state. However, 
two rings adopt the twist-boat conformations and the third ring remains in the chair 
conformation. 
Successful synthesis of 15N-cyclam allows us to probe the interaction of 15N-
cyclam complexes with the target protein by ['H,'5N] HSQC. 
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Chapter 4 
Cd Cyclam Complexes 
4. 1 Introduction to Cd Chemistry 
Cadmium has atomic number 48 and atomic weight 112.40.' The main 
coordination numbers are 4, 5, and 6.1  Together with zinc and mercury, Cd forms 
group 12; therefore it has two s-electrons outside filled d shells. Its usual oxidation 
state is +2, although Cd(I) species have been reported.2 Cadmium chemistry closely 
resembles that of zinc, but in some cases remarkable differences can be observed. 
The nuclear spin of "Cd and "3 Cd is V2 and their natural abundances are 12.75 and 
12.26%.2  Therefore, both "Cd and "3Cd NMR spectroscopy can be used to study 
complexes and to examine their binding sites in metalloproteins.3 
The metal centres of many metalloproteins play an active role in biological 
function so it is important to obtain as much structural information as we can about 
such sites. In recent years, "Cd and "'Cd NMR spectroscopy has been developed 
and utilised as 'spin spy' to study the Zn(II) sites in metalloproteins.4 The reason for 
this strategy is that the nuclear spin of 67 Z is 5/2 and therefore, Zn(II) has 
prohibitively broad lines in the solution NMR spectrum.4 Based on parallel chemistry 
and size considerations, Cd(II) can be employed as a surrogate probe to study these 
metals in this important class of biological system. NMR studies on 113Cd..substitued 
metalloproteins and 113Cd-substitued rubredoxin indicate a Karplus-type correlation 
between the 3J ("Cd, 'H) coupling constants and the H-C-S-Cd dihedral angle.5 
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Therefore, both vicinal proton-proton and proton-cadmium coupling constants can 
provide further structural information. 
The biological activity of metal (especially zinc) cyclam complexes,6 is 
likely to be related to their configurations in solution. However, the determination of 
cyclam configurations in solution is a difficult problem especially since a mixture of 
species can be present. I have investigated the possible use of Cd as a substitute for 
Zn because of its more favourable NMR properties (1=1/2 for "Cd and "3 Cd), 
although Cd cyclam (log K 11.7)7  is less stable than Zn cyclam (log K 15.5)8. 
Syntheses and characterisation by X-ray crystallography of two Cd 
complexes, [Cd(02COCH3)(Me4-cyclarn)] (CI 04) and [Cd(02COH)(Me4-cyclam)] 
(d04) have been reported.9 In these complexes, each cation has a distorted 
octahedral geometry of the cis-Cd02N4 type with the macrocyclic ligand folded and 
the four methyl groups on the same side as the carbonate ligand. The 
monomethylcarbonate and hydrogen-carbonate ions chelate the metal 
unsymmetrically with one short and one long Cd-O bond.9 The preliminary variable-
temperature '3C NMR studies revealed that [Cd(cyclam)(NO3)2] exists as a mixture 
of two isomers in solution.10 
4.2 Experimental 
4. 2. 1 Synthesis and crystallisation of Cd cyclam complexes 
Synthesis of Cd(cyclam)(004)2 (1). Cyclam (50.1 mg, 0.25 mmol) and 
Cd(C104)2 6H20 (104.9 mg, 0.25 mmol) were heated under reflux in CO2-free 
methanol (10 ml) for 2 h under argon. The volume was reduced (to Ca. 4 ml) under 
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reduced pressure until a white precipitate appeared. The precipitate was filtered off 
and washed with a small amount of methanol under argon to give the product. Yield 
83.4 mg (65.2%). Anal. Calcd for C,0H24N4CdC1208: C, 23.48; H, 4.73; N, 10.95%. 
Found: C, 23.69; H, 4.91; N, 11.07%. Selected JR (KBr, cm): 3306s (NH), 3282 in 
(NH), 2921 m(CH), 2861 in (CH), 1611 w(NH). 
Synthesis of Cd(cyclam)C12  (2). Cyclarn (50.1 mg, 0.25 mmol) and CdC12 (48.3 mg, 
0.25 mmol) were heated under reflux in CO2-free methanol (10 ml) for 2 h under 
argon. The volume was reduced (to Ca. 4 ml) under reduced pressure until a white 
precipitate appeared. The precipitate was filtered off and washed with a small amount 
of methanol under argon to give the product. Yield 81.7 mg (85.2%). Anal. Calcd for 
C10H24N4CdC12: C, 31.31; H, 6.31; N, 14.60%. Found: C, 31.03; H, 5.96; N, 14.39%. 
Selected JR (KBr, cm'): 3179 s (NH), 2906 m (CH), 2838 s (CH), 1623 w (NH). 
Synthesis of ICd3(cyclam)3(CO3)J(C104)4.3H20 (3). Complex 1 (1 g, 2 mmol) was 
dissolved in water and left standing in air at ambient temperature. After 7 days, 
colourless crystals of 3 were filtered off and washed with a small amount of methanol. 
Yield 0.62 g (62%). Anal. Caicd for C31H78N12Cd3C14022: C, 25.68; H, 5.42; N, 
11.59. Found: C, 26.09; H, 4.83; N, 11.45. Selected JR (KBr, cm'): 3431 s, br (OH), 
3303 s (NH), 3175 s (NH), 2909s (CH), 2852 s (CH), 1451 s (CO). 
4. 2. 2 NMR spectroscopy 
All data were acquired at a probe temperature of 298 K. 'H chemical shifts 
were internally referenced to the methyl singlet of TSP (3-trimethylsilyl- propionate-
d6) at 0 ppm; '3C chemical shifts were referenced externally also using TSP. All 
NIMR experiments were performed in 10% D20 / 90% H20 under argon with 1 at a 
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concentration of 36 mM, pH 7.9, and 2 at a concentration of 47 mM, pH 8.2 unless 
otherwise stated. 
1D 'H NMR data were acquired over a 'H frequency width of 5 kHz into 16 k 
data points (acquisition time = 1.64 s). The water resonance was suppressed by 
presaturation or via the WATERGATE pulsed-field-gradient sequence." 
1D "Cd-{'H} NMR data were typically acquired (using a broadband 
probehead) on a sample of 1 prepared with "Cd(C104)2 (generated from "CdO and 
HC104) over a "Cd frequency width of 15.9 kHz (150 ppm) centred at 246 ppm. 
"Cd peaks were referenced to external 1M "Cd(C104)2 in 10% D20/ 90% H20. 
Data were acquired with 100,000 transients into 4 k complex data points (acquisition 
time = 0.13 s). 
2D ['H, '3C] HSQC NMR data were typically acquired over a 'H frequency 
width of 5 kHz and a 13C frequency width of 5 kHz (40 ppm) centred at 43 ppm. 
Data were acquired with 64 transients into 2 k complex data points (acquisition time 
205 ms) for each of 128 t, increments (acquisition time 12.7 ms). 
2D ['H, '5N] HSQC NMR data were acquired over a 'H frequency width of 1 
kHz and a '5N frequency width of 250 Hz (5 ppm) centred at 12 ppm. Data were 
acquired with 240 transients into 2 k complex data points for each of 128 t, 
increments. 
21) ['H, "Cd] HSQC NMR data were acquired for "Cd labelled 1 over a 'H 
frequency width of 5 kHz (10 ppm) and a 111 C frequency width of 2.1 kHz (20 ppm) 
centred at 244 ppm. 2D ['H, "Cd] HSQC-TOCSY NMR data were acquired over a 
111 C frequency width of 1 kHz (10 ppm) centred at 246 ppm using a mixing period 
of 55 ms for the HSQC-TOCSY. Both experiments were adjusted for a 2J('HN,"Cd) 
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coupling of 30 Hz. Data were acquired with 8 transients (4 for HSQC-TOCSY) for 
each of 128 (64 for HSQC-TOCSY) t1 increments into 2 k complex data points 
(acquisition time 170 ms). For all inverse 2D experiments, the water resonance was 
eliminated as part of the coherence selection process. 
2D ['H, 'H] z-filtered TOCSY data were acquired at 600 MHz for "Cd 
labelled 1 and used for the measurement of 	coupling constants: 4096 
complex data points were acquired over an F2 frequency width of 3 kHz (acquisition 
time = 0.683 s); 16 transients were acquired for each of 2 x 512 t, increments in F! 
(frequency width = 1.5 kHz). A spin-lock time of 70 ms was employed. Solvent 
suppression was achieved using WET. 12 
All NMR data were processed using Xwin-nmr (version 2.0, Bruker U.K. 
Ltd.). 
4. 2. 3 NMR simulation 
Spin system simulations were carried out using the program Spinworks 
(version 1. 1, Kirk Marat, University of Manitoba, 1999). 
4.2. 4 Molecular Modelling 
A molecular model for the trans-I configuration of Cd-Cyclam was built 
using the program Sybyl (version 6.3, Tripos Inc.) based on the cis-I configuration in 
the crystal structure of 3. 
4. 2. 5 pH titration 
Complex 1 was dissolved in CO2-free 90% H20 / 10% D20. The pH was 
adjusted to 12.1 with 0.1 M NaOH in the NMR tube and the back titration was carried 
out from 12.1 to 5.3 by addition of 0.1 M HCI04. Values of pH were measured with a 
IS 
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Corning 145 pH-meter equipped with a micro-combination electrode calibrated with 
Aldrich standard buffers (pH 4, 7, and 10). No correction was made for deuterium 
isotope effects. All experiments were performed on samples saturated with argon. 
4. 2. 6 Carbonate binding study 
Na2 '3CO3 was dissolved in 90% H20 / 10% D20 to give a 40 mM solution in 
the presence of TSP. Stepwise addition of a concentrated solution of 1 was made to 
this solution to give '3C032 : 1 ratios from 1:0.2 to 1:3.5 in 10 steps. 13C_  11 H) NMR 
spectra were acquired at 150 MHz (512 transients, 31.44 kHz sweep width, 25216 
data points, 0.4 s acquisition time) after each addition of 1. In a similar experiment 
Na2CO3 was added stepwise to a solution of 1 (16 mM in 90% H20 / 10% D20) to 
give molar ratios 1:13C032 of 1:0.5, 1:1, 1:2, 1:4 and 'H NMR spectra were acquired 
after each addition. 
4. 2. 7 Crystallography 
The 	crystal 	data 	and 	refinement 	parameters 	for 
[Cd3(cyclam)3(CO3)](C104)4 3H20 (3) are summarised in Table 4.1. Colourless 
needles developed along (00 1) with other faces along the (I 10) and (-1 10) directions. 
Data were collected with Mo-Ka radiation on a Stoë Stadi-4 diffractometer equipped 
with an Oxford Cryosystems low-temperature device. An absorption correction was 
applied by Gaussian integration following refinement of the crystal dimensions 
against a set of w-scan (Stoë X-shape,'3 t = 1.435 mm 1, T = 0.915 - 0.937). The 
structure was solved by direct methods (S1R9214) and refined by full-matrix least-
squares against F2 (Shelxl9715). The perchlorate anions centred on C12 and C13 are 
disordered about a —3 special position, that centred on Cli is orientationally 
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disordered in the ratio 70:30 with a conirnon Cl position; equivalent CI-O and & 
distances were restrained to be similar. H-atoms were placed in calculated positions 
on C-atoms. The position for H-atoms attached to 01W (water of crystallisation) 
could not be calculated unambiguously and were therefore not placed at all. All non-
H atoms with the exception of the minor-occupancy 0-atoms in perchlorate- 1 were 
refined anisotropically. 
Table 4.1 Crystal data and refinement parameters for complex 3 
Formula C3 1H78Cd3C14N2022 
M 1309.95 
Crystal system Rhombohedral 
Space group R-3 




U/A3  8116.6(19) 
Z 6 
TI  150(2) 
D/ Mg m 3 1.608 
1.435 
Unique data 2341 
Observed data 3583 
R (R') 0.0660 (0.1444) 
4.3 Results 
Three Cd(II) cyclam complexes were prepared. The perchiorate complex 1, 
the chloride complex 2, and the carbonate complex 3 obtained from 1 via fixation of 
atmospheric CO2. The structures of these complexes were studied by JR and NMR 
spectroscopy and, for 3, by X-ray crystallography. 
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4. 3. 1 IR spectroscopy 
N-H stretching vibrations occur at 3306 and 3208 cm' for 1 and 3303 and 
3175 cm-1 for 3. A single intense N-H stretching vibration at 3179 cm' for 2 was 
observed. Complex 3 exhibits a strong CO stretching band at 1451 cm-1. 
4.3. 2 1 H, 13C, 15N and 111Cd NMR of Cd(cyclam)(C104)2 (1) in 
aqueous solution 
The 'H NMR spectrum of 1, acquired immediately after dissolving the 
sample in 10% D20 / 90% H2O, is shown in Figure 4.1. No changes were observed 
over a period of more than 2 weeks at ambient temperature. The 1D 1H NMR 
spectrum is limited to the 1.5 to 3.5 ppm spectral window and the signals fall into 
two regions. The first set of 3 multiplets appear between 1.5 and 2.0 ppm, two of 
which (1.59 and 1.90 ppm) are doublets of triplets. The second region of signals lies 
between 2.5 and 3.5 ppm. Few signals in this region were cleanly resolved. In order 
to overcome this problem, and to assign fully the 'H NMR spectrum, 2D 
homonuclear ['H, 'H] TOCSY and DQF-COSY NMR data sets and natural 
abundance 2D heteronuclear [1H, '3C] and ['H, '5N] HSQC NMR data were 
acquired. 
2D ['H, 'H] COSY NMR data (Figure 4.2) showed that the doublets of triplets 
at 1.59 (designated Ha) and 1.90 ppm (designated Hb)  are coupled to one another. 2D 
['H, 1H] TOCSY NMR data (Figure 4.3) revealed the presence of two spin-systems. 
Within the first spin-system (labelled I), the main couplings appear to be as follows: 
Ha couples to Hb and to H (2.69 ppm); Hb couples to Hf (3.23 ppm); H and Hf  
all 
Chapter 4 Cd Cyclam Complexes 
couple to one another. He (2.91 ppm) and Hd (2.75 ppm) couple to one another and 
also to the broad signal at 3.31 ppm. This signal also correlates strongly with H. The 
4.0 	3.5 	3.0 	2.5 	2.0 	1.5 	1.0 
Figure 4.1 'H NMR spectrum of complex 1 in 10% D20 / 90% H20. Resonances for 
the trans-I configuration are designated I and resonances for cis-V are designated V. 
* = free ligand. 
second spin-system (labelled V) is composed of 5 signals: H, (1.81 ppm) is coupled to 
H3 (2.86 ppm) and H5 (3.09 ppm), which also couple to one another; H2 (2.58 ppm) 
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Only one cross-peak was observed in the 2D [1 H, '5N] HSQC NMR spectrum 
of 1 in 90% H20 I 10% D20 (Figure 4.4b), a broad signal at 3.31 ppm. The main 
cross-peak for the natural abundance '5N signal was centred at 11.91 ppm and was 
Figure 4.2 2D ['H, 'H] COSY NMR spectrum of 1 in 10% D20 / 90% H20. 
Resonances for trans-I are designated by solid boxes and resonances for cis-V are 
designated by dashed boxes. 
accompanied by two satellite cross-peaks, arising from the presence of 11 1/113 	at 
natural abundance: 'J('5 N, 111/113Cd) = 118 Hz; 2J(1 HN, 1111113cd) = 27 Hz. Only the 
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H 1-H 5  did not show any relationship to this NH signal or to any of the signals HaHf 
leading to the speculation that the two identified spin-systems arise from two different 
configurations (I and V) of Cd(II) cyclam. Supporting evidence for this came from 
2D ['H, "Cd] HSQC, 2D ['H, "Cd] HSQC-TOCSY and 1D ... Cd-{'H} NMR data. 
Figure 4.3 2D ['H, 'H] TOCSY NMR spectrum of 1 in 10% D20 I 90% H20. 
Resonances for the trans-I configuration are designated by solid boxes and resonances 
for the cis-V configuration are designated by dashed boxes. 
The 1D ... Cd-{'H} NMR spectrum acquired for "Cd-labelled 1 (Figure 4.5) 
showed three major "Cd peaks at 248, 244, and 219 ppm with relative peak areas of 
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1:0.5:0.1, respectively. The latter minor species was not observed in 1D 'H and 2D 
NMR spectra. The 2D [1H, "Cd] HSQC NMR spectrum showed 7 cross-peaks for 
'H, "Cd correlations (Figure 4.6b). Four 'H/"Cd cross-peaks correlated with the 
major "Cd peak at 248 ppm, and the remaining three 'H/"Cd cross-peaks correlated 
with the "'Cd peak at 244 ppm. The 2D ['H, "Cd] HSQC-TOCSY NMR data 
(Figure 4.6a) confirmed the presence of the two spin systems identified from the 2D 
['H, 'H] TOCSY NMR data. Thus two major configurations of! (I: 8 "Cd 248, 'H 
Cd) 
. 
3 .6 3.4 	3.6 3.4 
6(1H) 
Figure 4.4 (a) 2D ['H, '5N] HSQC NMR spectrum of complex 2 and (b) 2D [1H, '5N] 
HSQC NMR spectrum of complex 1, in 10% D20 / 90% H20. 
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270 	250 	230 	210 
6 (111Cd) 






a) , . 
Jb) 
4.0 3.5 3.0 2.5 2.0 1.5 
Figure 4.6 (a) 2D ['H, "Cd] HSQC-TOCSY spectrum of '11Cd-labelled 1. (b) 2D 
['H, "Cd] HSQC NMR spectrum of "Cd-labelled 1. Connectivities to the minor 
111 C resonance at 219 ppm (not shown) are very weak. All samples were dissolved in 
10% D20 / 90% H20. 
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Table 4.2 'H NMR chemical shifts () for complexes 1, 2 and 3 in various solvents 
complex solvent config 6, assignment 
NCH2CH2N NCH2CH2CH2N NCH2CH2CH2N NH 
'H 2.91 	2.75 3.23 	2.69 1.90 	1.59 3.31 
13 C 49.73 54.53 31.12 
Trans-I 
'5N 11.91 
1 D20/H20 "Cd 248 
'H 2.94 	2.58 3.09 	2.86 1.81 a 
Cis-V 13C 49.08 52.29 27.68 
"Cd 244 
'H 2.91 	2.77 3.23 	2.72 1.91 	1.62 3.48 
Trans-I 13C 49.69 54.43 31.05 
2 D20/H20 
'5N 11.72   
'H 2.93 	2.62 3.07 	2.86 1.80 a 
Cis-V 
13c 49.65 51.95 27.52 
3 CD3CN Trans-I 'H 3.02 	2.84 3.34 	2.79 1.96 	1.74 2.92 
a Not observed. oresumablv broadened by exchange with solvent 
spin system HaHf, and V: S "Cd 244, 'H spin system H1-H5, Figure 4.2; Table 4.2) 
are present in aqueous solution. 
The 2D ['H, '3C] HSQC NMR spectrum also reflects this, showing cross-
peaks corresponding to the eleven 'H NMR signals described above and six ' 3C NMR 
signals (Figure 4.7; Table 4.2). Geminal pairs of protons were identified thus: for 
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configuration I, H/H, (ö '3C 31.12), H,/Hf (6 '3C 54.53), Hd/He ( 'C 49.73) and for 
configuration V, H,/H, (5 '3C 49.08), H3/H5 (6 '3C 52.29). Since all protons except 
NH belong to geminal pairs in this complex, the remaining cross-peak for 




30 	 Hb 
40 
o (13C) 	 ; JY .\  
50 	HH2 
:0: : 11d 
Hf0 	H 3'K<_ 
3.5 	 2.5 	 1.5 
3(1H) 
Figure 4.7 2D ['H, '3C] HSQC NMR spectrum of complex 1 in 10% D20 / 90% H20. 
Resonances (Ha to Hf) for the trans-I configuration are designated by solid boxes and 
resonances (H, to H5) for cis-V configuration are designated by dashed boxes. 1D 
slices are shown for the two '3C shifts of the 6-membered rings (NCH2CH2CH2N). 
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4. 3. 3 Titration of Cd(cyclam)(C104 )2 (1) with 13C03 2  
In a separate series of NMR experiments, the perchiorate complex 1 was 
added to a solution of 40 mM Na213CO3 in 10% D20/ 90% H20 at pH 11. This pH 
value was chosen because the complex exists predominantly as a single configuration 
at this pH (trans-I, see Discussion) and carbonate is fully deprotonated (pK1, 10.29; 
pK2, 6.3 5)16•  Ten separate additions of 1 were made to the Na2 ' 3CO3 solution to give 
Na213CO3:1 molar ratios from 1:0.2 to 1:3.5. The solution was re-adjusted to pH 11 







[1] I [C032] 
Figure 4.8 Plot of 13C chemical shift of '3C032 versus the molar ratio of 1 
Na213CO3 at pH 11. 
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Addition of aliquots of 1 to '3C032 resulted in a gradual shift of the '3C resonance of 
'3C032  from 170.4 to 171.33 ppm with an apparent end point at a 1:1 mol ratio 
(Figure 4.8). 
In a reverse titration, 'H NMR spectra of 1 were acquired in the presence of 
increasing quantities of Na2CO3 at pH 9 to give 1:Na2CO3 molar ratios of 1:0.5, 1:1, 
1:2, 1:4. The NH resonance for 1 in the absence of Na2CO3 appeared at 3.31 ppm. 
With increasing concentrations of C032 , the NH resonance gradually shifted to lower 






Complex J\J\J\J PLA 	I&ILJvL. 
3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 
6(1H) 
Figure 4.9 'H NMR spectrum of complex 1 and after addition of Na2CO3 in 10% 
D20 / 90% H20, pH 9. 
The reduction in the intensity of the 'H NMR signals H,-H5 with simultaneous 
growth of signals HaHf showed that configuration V converts almost entirely to 
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configuration I under these conditions (Figure 4.9). Although the ratio of 
configurations is strongly pH dependent, this effect appears to be due to the presence 




o 	2 	4 
[CO3 2-] I [1] 
Figure 4.10 Plot of NH 'H NMR chemical shift versus the molar ratio of Na2CO3 : 1. 
4. 3. 4 Effect of pH on Cd(cyclam)(C104)2 (1) studied by 1 H 
The 'H NMR spectrum of the perchiorate complex 1 in 10% D20 / 90% H20 
was strongly pH-dependent (Figure 4.11). Only three sharp 'H NMR peaks (3.11, 
3.02 and 1.90 ppm) were observed at pH 5.3, corresponding to the free ligand at this 
pH. No free ligand was observed at pH> 8.2, and at pH 12. 1, integration showed that 
94% of complex 1 existed in configuration I and 6% as configuration V. As the pH 
was lowered from 12.1, free ligand peaks appeared at pH 8.2, and at this pH 
104 
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accounted for 6% of the total cyclam, with the proportion of configuration V 
increasing to 39%. The process was reversible with lowering or raising pH. 
I 
3.5 3.0 2.5 2.0 1.5 
6 (1H) 
Figure 411 pH dependence of the 1 H NMR spectrum of 1 in 10% D20 / 10% H20. 
At pH 5.3 only free cyclam is present. Peaks for configuration V diminish as the pH 
increases and configuration I is predominant. 
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4. 3. 5 NMR analysis of [Cd3 (cyclam)3(CO3 )](Cl04 )4 3H20 (3) in 
solution 
The solution configuration of 3 was studied in CD3CN as solvent. Some 
organic solvents have been successfully used previously in circumstances where it 
was desirable to retain C032 bound to a complex in solution.'7 The 'H NMR 
spectrum of 3 was acquired immediately after dissolving crystals in acetonitrile 
(Figure 4.12). The 1D 1H NMR spectrum is similar to that of 1 in H20 but consists of 
a 
f i  
Cd 
H 	 * 
3.4 	3.2 	3.0 	2.8 	2.6 	2.4 	2.2 	2.0 	1.8 
6(1 H) 
Figure 4.12 'H NMR spectrum of complex 3 in CD3CN and the labelling scheme for 
protons in the 6-membered ring (chair conformation). * = CHD2CN. 
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only a single set of resonances. 2D ['H, 'H] COSY NMR data revealed the presence 
of three spin-systems (Figure 4.13). Within the first spin-system, resonance a (1.74 
ppm) couples to b (1.96 ppm) and to c (2.79 ppm) and weakly to f (3.34 ppm). 
Resonance b couples strongly to f and weakly to c. In the second spin-system, d (2.84 
ppm) couples to e (3.02 ppm). The last spin-system is composed of three minor peaks 
corresponding to the free cyclam ligand (m, n and 0: 3.20, 3.13, 1.99 ppm, 
respectively). Subsequent 'H NMR spectra acquired on the same sample at later times 
showed that the signals m to 0 had increased in intensity, indicating the release of free 
ligand with time. Minor cross-peaks were also observed, and may arise from a second 
species. 
2.0 







3.0 	 2.0 
Figure 4.13 2D ['H, 'H] COSY NMR spectrum of 3 in CD3CN. Resonances for the 
trans-I configuration are designated by solid boxes and resonances for the free ligand 
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High resolution, first-order resonances for Ha and H,, allowed direct 
measurement of coupling constants and the spectrum was also simulated. The 'H 
NMR resonance for Ha consists of a doublet of triplet of triplets (Figure 4.14d), the 














Figure 4.14 Experimental (bottom) and simulated 'H NMR for the 6-membered ring 
of complex 3. a) Hf in the presence of 111  C at natural abundance; b) H (resonance Hd 
is included in the experimental data, but was not included in the simulation); c) H,, - 
the resonance for CH2CJJCH2 of the free ligand is overlapped with Hb in this region; 
d) Ha. Coupling constants derived from the simulation are shown in Tables 4.3 and 
4.4. The value of 3j("Cd-Hf) = 25 Hz is comparable with the experimental value of 
29 Hz measured from a 2D ['H, '3C] HSQC NMR spectrum with natural abundance 
'3C but with 95.29% 111Cd. 
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respectively. The Hb 1H NMR resonance is also a doublet of triplet of triplets (Figure 
4.14c), the result of coupling to Ha, H, and Hd with coupling constants of 16.3, 5.7, 
and 1.4 Hz, respectively. 
4. 3. 6 Solution NMR studies of Cd(cyclam)C12 (2) 
'H, '3C and '5N NMR data were also acquired for the chloride complex 2 in 
10% D20 / 90% H20 (Figures 4.15 and 4.4a). The NMR data are summarised in 
Table 4.2. 
3.5 	3.0 	2.5 	2.0 	1.5 
Figure 4.15 'H NMR spectrum of complex 2 in 10% D20/90% H20. Resonances 
assigned to the trans-I configuration are designated I and resonances for cis-V 
configuration are designated V. For assignments see Table 4.2. 
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4. 3. 7 Conformational analysis of Cd(cyclam)(C104 )2 (1) and 
[Cd3 (cycIam)3(CO3)](Cl04 )4 3H20 (3) 
For 3, 3J ('H, 'H) coupling constants were derived from spin system 
simulations for signals a, b, c and f (Figure 4.14; Table 4.3). For "Cd-i, a fully 
"Cd-coupled ['H, 'H]-2D TOCSY NMR spectrum was used to measure 3j(  1H, 
"Cd) coupling constants (Table 4.4). 
Extension of the standard Kai-plus equation18 by Haasnoot'9 has permitted 
broader applications. The H-C-C-H fragment in the rings under study carries two non-
hydrogen substituents. In this case, the generalised Karplus equation takes the form 
shown in eq 1, 
3J('H, 'H) = 13.89cos2HH - 0.98cos 11 , + AXj { 1.02 - 3.4cos2( 	+ 14.9 1 AX j I )} (1) 
in which HH is the Klyne-Prelog defined 20  proton-proton torsion angle and Ax 
denotes the differences in electronegativity between the substituent Si and hydrogen 
on the Huggin's scale 21  corrected for the influence of f3 substituents'9; 	takes on a 
value of +1 or —1 according to the orientation of the substituent Si with respect to the 
coupling proton on the same carbon atom. 19 
The only reported Karplus—type correlation for 3J('H,13Cd) coupling 
constants appears to be that established for cysteine 0 protons and H- C- S- Cd 
dihedral angles.5 This takes the form shown in eq 2. 
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3J(113Cd, 'H) = 36cos2 - 13 cos + 1 	 (2) 
Table 4.3 3J and 2J ('H, 'H) coupling constants (Hz) and corresponding torsion angles 
(0)  for the six-membered rings of complex 3 
3J (Ha, H) 3J (Ha, Hf) 3J (Hb, H) 3J (H, Hf) 	2J (Ha Hb) 	2J (He, Hf) 
simulated 11.0 1.5 1.3 5.7 	16.3 	12.6 
measured 11.1 1.6 1.4 5.7 	16.3 
Torsion angles 164 69 81 39 
(NMR)a 
Torsion angles 164 78 81 37 
(X ray)b 
a  Torsion angles were calculated using the expression 3J('H, 'H) = 13.89cos24HH - 
0.98C0S4HH + Ax{ 1.02 - 3.4cos2( 	+ 14.9 1 Ay j I )}; A takes the values 0.97 and 
0.196 for C, and C2 respectively; = ± 1 according to the definition of position and 
negative substituents.2°  
b  Torsion angles in the X-ray crystal structure of 3. 
Table 4.4 3J ( "Cd, 'H) coupling constants (Hz) and corresponding torsion angles (0)  
for 3 
Six-membered ring 	 Five-membered ring 
3J(H, 'Cd) 3J(Hf, ' 'Cd) 3J(Hd, " Cd) 	3J(He, '''Cd) 
Coupling constant 
1.6 	27.4 	14.0 	15.3 
(measured) 
Torsion angle 
66 	134 	115 	118 
(NMR) 
Torsion angle 	
65 	177 	121 	123 
(measured)" 
a  Calculated using the expression 3J(' 11Cd, 'H) = 36cos24 - 13 cos + 1.5  
b  Torsion angles measured from a model for trans-I based on cis-V in the crystal 
structure of 3. 
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The coupling constants 3J( ... Cd, 'H) for 111 Cd labelled 1 and 3J('H, 'H) for 3 
were used to calculate torsion angles based on eqs 1 and 2. Calculated torsion angles 
and experimentally-measured coupling constants are listed in Tables 4.3 and 4.4. 
4. 3. 8 X-ray crystal structure of Cd cyclam complex with 
carbonate, [Cd3(cyclam)3(CO3)](C104)4•3H20 (3) 
Complex of 3 contains carbonate fixed from atmospheric CO2. The crystal 
structure of the cation is shown in Figure 4.16 together with the atomic numbering 
scheme, and is illustrated schematically in Figure 4.17a. Selected bond lengths and 
angles are listed in Table 4.5. The complex contains three independent [Cd(cyc1am)]2 
units. Each unit has a distorted octahedral geometry of the cis-Cd02N4 type. Each Cd 
ion is bound to four nitrogens of cyclam with bond lengths for Cd(1)-N(1), Cd(1)-
N(4), Cd(1)-N(8), Cd(l)-N(l1) of 2.323(12) A, 2.270(12) A, 2.289(12) A and 
2.311(12) A, respectively. Two oxygens of the carbonate anion occupy axial positions 
with Cd-O bond lengths of 2.373 and 2.412 A. Pairwise bidentate combinations of the 
three carbonate oxygens join the three Cd(cyclarn) units to form a C3 symmetric 
arrangement. In each unit, due to the cis coordination of carbonate, cyclam is folded. 
The configuration of each cyclam unit is cis-I (R,S,R,S; Figure 1.3). 
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Figure 4.16 X-ray crystal structure of the cation of complex 3 together with the atom 
numbering scheme. 
(a) 	 (b) 
Figure 4.17 Schematic illustrations of (a) the cis-I configuration, and (b) the mode 
of carbonate coordination, in the crystal structure of 3. 
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Cd(l) - N(8) 2.289(12) 
Cd(l)—N(l) 2.323(12) 
Cd(l) - O(1C)#1 2.412(7) 
N(4)—Cd(l)—N(l1) 124.5(4) 
N(4) - Cd(l) - N(l) 79.9(5) 
N(11)—Cd(l)—N(1) 89.7(5) 
N(8)—Cd(1)—N(11) 77.3(5) 
N(8) - Cd(l) —N(1) 	156.7(4) 
(#1 —x+y, -x, z) 
4. 4 Discussion 
4. 4. 1 IR spectroscopy 
The v3 vibration appears strongly at 1415 cm-' for free C032 with D31 
symmetry. 22  In most carbonato complexes, it splits into two bands due to loss of the 
symmetry.22'23 However, in the present case, the coordinated C032 in 
[Cd3(cyclam)3(CO3)](C104)4•3H20 has high symmetry and therefore, only a single v3  
band appears at 1451 cm' without split. This confirms the bridging bidentate C032 
coordination mode. 
4. 4. 2 Solution NMR analysis of Cd(cyclam)(C104 )2 (1) 
Analysis of the proton connectivities in the 2D ['H, 'H] COSY (Figure 4.2) 
and TOCSY (Figure 4.3) NMR spectra and the 'H/'3C connectivities in the 2D [1H, 
'3C] HSQC NMR spectrum of the perchiorate complex I show that the '3C NMR 
resonances at 31.12, 49.73 and 54.53 ppm are due to form I of the cyclam ligand and 
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those at 27.68, 49.08 and 52.29 ppm are due to ligand form V. The former three 13C 
NMR resonances from I correlate with six 1H NMR signals. The '3C NMR resonance 
at 31.12 ppm correlates with two 'H NMR peaks at 1.59 and 1.90 ppm, which are 
assignable on the basis of chemical shifts to the central methylene protons in the six-
membered Cd-cyclam rings. The latter three '3C NMR signals from V correlate with 
five 'H NMR resonances and the '3C NMR signal at 27.68 ppm correlates with only 
one 'H NMR resonance at 1.81 ppm. This is also assigned to the central methylene of 
the six-membered ring on the basis of chemical shift. Only the trans-I and trans-Ill 
configurations can give rise to six non-equivalent proton resonances, two of which 
correspond to the central methylene of the six-membered rings. Both six-membered 
rings adopt chair conformations in the trans-I and trans-Ill configurations in which 
Ha and H,, are nonequivalent and give rise to two 'H NMR resonances, respectively 
(see A in Figure 4.18). Since the trans-I configuration is considered to be the best fit 
for larger metal ions (see below Discussion), species I is likely to correspond to the 
trans-I configuration. The trans-TV and trans-V configurations have five non-
equivalent protons and give rise to five proton resonances, one of which corresponds 








Figure 4.18 A chair and B twist-boat conformations for the six-membered rings 
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of the six-membered rings. Both six-membered rings adopt twist-boat conformations 
in the trans-TV and trans-V configurations in which H and Hd are equivalent and 
give rise to only one 'H NMR resonance (see B in Figure 4.18). The cis-V 
configuration is strain-free and can exist as two equivalent states in fast exchange on 
the NMR timescale with averaging of the 'H chemical shifts for the central 
methylene group. Therefore, the species V can be assigned as the cis-V 
configuration. 
Further information about the configurations of the five- and six-membered 
rings of complex 1 in solution was obtained from the 3J('H, "Cd) couplings. For the 
six-membered rings, the large difference between two 3j(  'H, "Cd) couplings (27.4 
Hz, torsion angle "CdN..CH1 and 1.6 Hz, torsion angle ' 'Cd-N-C-He) results 
from Hc being axial and Hf being equatorial in a 6-membered ring with a chair 
conformation. Based on eq 2, the torsion angles Cd-N-C-Hf and 
were calculated to be 134° and 66°, respectively (Table 4.4). The latter value is 
similar to that determined from both the crystal structure (cis-I configuration) and 
from a model (trans-I configuration), but the former value deviates from the 
expected value of 180° by Ca. 45°. This is probably because eq 2 was established on 
the basis of Cd-S-C-H spin systems in proteins5 and requires modification for our 
Cd-N-C-H system in the region 120° to 180°. Unfortunately, too few data are 
available to establish a new equation for Cd-N-C-H systems. The 3J(Hd, "Cd) and 
3J(He, "Cd) couplings are very similar (14.0 and 15.3 Hz, respectively) indicating 
that the 5-membered ring is either in rapid equilibrium between two gauche 
configurations or adopts the eclipsed conformation. In either case the solution 
conformation of 3 differs significantly from that in the crystal. 
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The best-fit M-N bond length for metal coordination to cyclam is 2.06 A.1° 
Such a distance corresponds to a metal with an ionic radius of ca. 0.65-0.7 A.'° Due 
to the flexibility of the cyclam ring, smaller metal ions (ionic radius < 0.75 A - mainly 
those of the first row transition metal series) ensure that the cyclam ring adopts the 
most stable configuration, trans-111.24  With increasing ionic radius, metal ions no 
longer fit the cyclam cavity well. For example, the Hg(II) (1.10 A) cyclam exists in 
the trans-I configuration in which the metal lies above the cyclam plane,10 and Pb(II) 
(1.21 A) cyclam adopts a cis-V configuration.25 On this basis it is likely that Cd(II) 
(0.97 A) cyclam adopts the trans-I rather than trans-Ill configuration. The crystal 
structure of 3 shows that cadmium cyclam can also adopt the cis-I configuration when 
an additional chelating ligand is bound. 
In the trans-IV and trans-V configurations, due to conformational constraints 
of the macrocycle, both six-membered rings adopt skew-boat conformations in which 
the central methylene has two equivalent hydrogens (see Figures 1.3 and Figure 4.18). 
Possessing higher energy, the skew-boat conformation is not stable. The trans-V 
configuration can fold about the diagonals a or b (Chart 4.1) to form the more 
common cis-V configuration in which case the 6-membered-rings exist in chair 
conformation and 5-membered-rings in gauche conformation. The two forms 
represented in Figure 1.3 can inter-convert. The rapid inter-conversion gives rise to 
the averaging of these conformation. Such rapid inter-conversion on the NMR 
timescale have been observed for a number of nickel (II) complexes. 26  We did not 
observe an NH NMR signal for the cis-V configuration, which may be related either 
to the inter-conversion process or to fast exchange with the solvent. 
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a 	 b 
Chart 4.1 The folding of the trans-V configuration along axes a or b to give the cis-V 
configuration is shown (+ indicates NH proton above the cyclam plane, - below). 
From 1 3  C NMR titrations of "CO,'- with 1 (Figure 4.8) and 1 H NMR in the 
reverse titration (Figures 4.9 and 4.10), it can be concluded that carbonate 
coordinates to Cd(II) cyclam in aqueous solution. It appears that a 1:1 pyramidal 
complex [Cd(cyclam)CO3] is formed with an axially coordinated carbonate anion 
and cyclam in the trans-I configuration. 
4.4.3 Effect of pH on Cd(cyc1am)(C104)2 (1) 
Complex 1 is stable only at high pH. At pH < 8.2 dissociation of Cd(II) from 
cyclam was observed. Free ligand began to appear at pH 8.2 and the complex had 
dissociated completely by pH 5.3. The cis-V configuration converts to trans-I with 
increasing pH and trans-I dominates at highly basic pH. This process is reversible. A 
number of Cu(II), Zn(II), and Cd(II) macrocyclic complexes can readily form the 
C032 complexes from fixing the atmospheric CO2. 9,27,28 The mechanism for the 
formation of the carbonate complexes is as follows: the complexes can form L-M-
Off species at alkaline pH and the hydroxo complexes have a great affinity for 
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atmospheric CO2 to produce a hydrogen carbonate complex which can further react 
to form a trinuclear complex. 28  The isomerisation from cis-V to trans-I needs to 
convert the nitrogen configurations twice via trans-IT. The intermediate hydroxo 
complex, cyclam-Cd-0H in this case probably adopts trans-11 configuration. The 
formation of trans-11 from cis-V configuration are base-catalysed .29 The trans-11 
configuration for cyclam-Cd-0H continues to convert to trans-I and may be base-
catalysed as well. Therefore, the configurational inversion from cis-V to trans-I is 
very fast and no distribution change for each configuration was observed at any pH. 
4. 4. 4 NMR analysis of [Cd3(cyclam)3(CO3)](C104 )4•3H20 (3) in 
solution 
The exchange behaviour of the NH resonance at 2.92 ppm and the appearance 
of three resonances from the free ligand indicates that this cadmium complex is 
unstable in CD3CN. Two 'H NMR spin-systems exist for this complex in solution and 
can be assigned as follows: the first with resonances centred at 1.74, 1.96, 2.79 and 
3.34 ppm, corresponds to the six-membered rings, and the second with resonances 
centred at 2.84 and 3.02 ppm, corresponds to the five-membered rings (Figure 4.13). 
The multiplets at 1.74 and 1.96 ppm are assigned, on the basis of splitting patterns 
and chemical shifts, to the central methylene protons in the six-membered rings, 
namely Ha and Hb (Figure 4.14c/d). For Ha, the largest coupling constant 16.3 Hz can 
be deduced to result from a gerninal coupling, while 11.1 and 1.6 Hz can be deduced 
to be vicinal couplings. The large coupling of 11.1 Hz (3JHaHc) indicates a trans-
diaxial relationship between Ha and H. The Hb 'H NMR resonance is also a doublet 
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of triplet of triplets (Figure 4.14c), the result of coupling to Ha, H, and Hd with 
coupling constants of 16.3, 5.7, and 1.4 Hz, respectively. The largest splitting also 
results from a geminal coupling and the absence of other large splittings indicates that 
H,, and Hd bear an equatorial relationship to one another. These observations are 
consistent with a six-membered ring in the chair conformation. However, in the 
crystal structure the ligand is folded into a cis-I geometry. It therefore seems likely 
that the weaker Cd-O bond between carbonate and each monocyclam unit breaks and 
carbonate becomes a 3-CO3 2- bridged unit binding to three Cd(II) ions through each 
of three 0 atoms, as is typical of Zn(II) complexes with macrocyclic polyamines (e.g 
cyclen).3° Each monocyclam unit of 3 adopts the trans-I configuration in CD3CN. 
The torsion angles for the six-membered rings of 3 in CD3CN determined 
from 'H NMR data are close to those found in the crystal structure (Table 4.3). The 
six-membered rings therefore adopt a chair-conformation. In the crystal structure, the 
five-membered rings adopt the gauche-conformation, but the NMR data for 3 in 
solution indicate an eclipsed conformation for these rings. This can be explained in 
one of two ways. Either the five-membered rings exercise pseudo-rotational mobility 
and average their couplings, giving the appearance of an eclipsed conformation, or the 
five-membered rings are locked in an eclipsed conformation in the same way as the 
six-membered rings. 
4. 4. 5 Crystal structure of [Cd3 (cyclam)3(CO3 )](C104 )4•3H20 (3) 
Carbonate can adopt a variety of different coordination modes, as 
summarised by Einstein and Willis." Complex 3 and the trinuclear Gd(III) complex, 
Na2[{Gd(DO3A)}3CO3] (D03A = 1, 4, 7-tri(carboxymethyl)-1, 4, 7, 10- 
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tetraazacyclododecane), contain carbonate bound in a bidentate mode to each of 
three metal ions which form an equilateral triangle as shown in Figure 4.17b.32 
The very sharp bite angle 0(1)-Cd-0(2) of 55.5(4)' for complex 3 is similar to 
that for [Cd(02COH)(Me4[14]aneN4)](Cl04) (54.2').9 The angle N(4)-Cd-N(l 1) 
(124.5(4)°) is closer to the 1200  value expected for a trigonal bipyramidal structure 
than that for the hydrogencarbonate complex (128.9').9 The other N - Cd - N angles 
are normal and lie in the range 77900,  because the rigidity of the macrocycle causes 
narrow bite angles for the five-membered chelate rings. Complex 3 may be 
considered as trigonal bipyramidal with the two donor oxygen atoms occupying an 
apex of the in-plane triangle. 
Na2[{Gd(DO3A)}3CO3] differs from complex 3 in that Gd(III) is coordinated 
to each oxygen of the three carboxylate arms in the N-substituted cyclen in addition to 
four nitrogens and two carbonate oxygens. A recent survey of the Cambridge 
Structural Database indicated that complex 3 is the only known crystal structure of a 
cadmium complex containing unsubstituted cyclam, and the only known crystal 
structure of an unsubstituted cyclam complex with a cis-I configuration. 
4.5 Conclusions 
I have synthesised cadmium cyclam complexes with perchlorate (1), chloride 
(2) or carbonate (3) and have made the first detailed analysis of the solution 
configurations of Cd(II) cyclam in solution using NMR spectroscopy. Assignments 
of 'H, '3C, '5N and "Cd NMR signals were made for aqueous or CD3CN solutions 
using 1D and 2D methods. Complexes 1 and 2 both exist as equilibrium mixtures of 
cis-V and trans-I configurations in aqueous solution which were stable only at high 
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pH. As the pH was decreased below 8.2, dissociation of free ligand was observed, 
and the complexes were dissociated completely at pH 5.3. 111/113 Cd-'H coupling 
constants were used to derive Karplus-type conformational information about the 
chelate rings. The only previous application of this procedure appears to be that for 
Cd thiolate proteins.5 In the trans-I configuration, the 3J( "Cd, 'H) coupling 
constants for the two different five-membered rings in 'Cd-labelled 1 in aqueous 
solution were similar (14.0 and 15.3 Hz) consistent with eclipsed conformations. 
This contrasts with the diverse 3J('1 'Cd, 'H) coupling constants (1.6 and 27.4 Hz) 
associated with the six-membered rings of the trans-1 configuration which adopt 
chair conformations. Exposure of complex 1 to the atmosphere led to formation of 
the novel carbonate-bridged tn-cadmium complex 3 in which cyclam adopts the 
unusual cis-1 configuration with all the N-H bonds oriented in the same direction. 
NMR data show that complex 3 in CD3CN exists as only one species, the trans-1 
configuration, with eclipsed conformations for the five-membered rings. The torsion 
angles calculated using an extension of the standard Kai-plus relation indicate that the 
six-membered rings adopt conformations in solution close to those in the crystal 
structure (chair conformations). 
These studies of Cd cyclam complexes have allowed the characterisation of 
the trans-1 and cis-V configurations by NMR spectroscopy. This has enabled similar 
NMR studies to be carried for Zn cyclam complexes in Chapter 5. For Zn cyclam in 
aqueous solution, in addition to the trans-I and cis-V configurations, the trans-Ill 
configuration has also been detected, which becomes dominant since Zn(II) is a 
smaller metal ion than Cd(II) and is a better fit for the cyclam ring cavity. 
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Zn Cyclam Complexes 
5.1 Introduction 
The bicyclam AMD3 100 (see Figure 6.1) has highly potent and selective 
anti-HIV activity.' It consists of 2 monocyclam units linked by an aromatic linker. 
Therefore, studies on the properties of monocyclam and its complexes will assist 
understanding of the behaviour of bicyclam. There are five possible configurations 
for cyclam complexes depending on the alignment of NH protons (Figure l.3).2  Nine 
Zn cyclam complexes were found in the Cambridge Structural Database (CSD) (see 
Table 5.1). All these Zn(II) cyclam complexes adopt the most stable trans-Ill 
configuration, in which the 6-membered chelate rings take the chair conformation 
and the 5-membered rings are gauche. 









[Zn(cyclam)Cl]2 (ZnCl4) 9 
[Zn(cyclam)C12] 6 
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Three configurations, trans-I, trans-TI and trans-Ill have been detected in 
solution for a Ni(II) cyclam complex.'°" The trans-I and trans-Ill configurations 
equilibrate readily in donor solvents, presumably via the intermediate trans-11 
(RSRR) configuration. 10 The '3C NMR spectra for [Zn(cyc1am)Cl]2 (ZnCl4) show 
that there are two isomers with trans-I and trans-Ill configurations in aqueous 
solution. The trans-Ill form is most probably six coordinate with two axially bonded 
water molecules. A minor isomer with the trans-I configuration forms after 24 hours. 
It is likely that in the trans-I form the Zn(I1) is five coordinate, with the axial position 
occupied by a water molecule or chloride ion. 
In order to obtain structural information on Zn cyclam complexes in the solid 
state and in solution, and to investigate the interaction of Zn cyclam complexes with 
carboxylates which are present in the side-chains of the co-receptor CXCR4, 
[Zn(cyclam)(H20)2](OAc)2, 	Zn(cyclam)(C104)2, 	Zn(cyclam)C12 	and 
[Zn(cyclam)(phthalate)](CH30H)2  were synthesised and their conformation studied 
in the solid state by X-ray crystallography and in solution by 1D and 2D 'H, 13C, '5N 
NMR spectroscopy. Kinetic studies and pH titrations on them and studies of the 
interactions between Zn(cyclam)C12 and acetate were also performed. 
5.2 Experimental 
5.2.1 Synthesis and crystallisation of Zn cyclam complexes 
IZn(cyc1am)(H20)21(OA02 (4). Cyclam (100.2 mg, 0.5 mmol) and 
Zn(OAc)2 2H20 (109.6 mg, 0.5 mmol) were heated under reflux in 15 ml of 
methanol for 2 hours. The solution was reduced in volume to Ca. 4 ml by rotary 
evaporation. Crystals were grown by diffusion of Et20 into the solution at 20 °C. The 
crystals were filtered off to give the product. Yield 133.3 mg (63.5%). Found for 
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C14H34N4ZnO6: C, 40.21; H, 8.30; N, 13.51%. Caic.: C, 40.05; H, 8.16; N, 13.35%. 
Selected JR (KBr, cm'): 3225 s, (NH), 3213 s (NH), 3156 s, (NH), 2928 in (CH), 
2862 in (CH), 1577 s (CO). 
[Zn(cyc1am)(phthalate)J(CH30H)211 (5). Cyclam (150.3 mg, 0.75 mmol), 
ZnO (60.9 mg, 0.75 mmol), and phthalic acid (124.4 mg, 0.75 mmol) were stirred in 
15 ml of water for 6 hours. The water was removed by rotary evaporation. The 
residue was dissolved in about 4 ml of methanol. Then the crystals were grown by 
diffusion of Et20 into the solution at 20 °C. The crystals were filtered off to give the 
product. Yield 258.2 mg (70%). Found for C20H36N4ZnO6: C, 49.03; H, 7.50; N, 
11.52%. Calc.: C, 48.64; H, 7.35; N, 11.34%. Selected JR (KBr, cm'): 3418 m, br 
(OH), 3254 s (NH), 3211 s, (NH), 2906 s (CH), 2838 s (CH), 1594 s (CO), 1577 s 
(CO), 1377 s (CO), 1364 s (CO). 
Zn(cyclam)(C104)2 (6). Cyclam (100.2 mg, 0.5 mmol) and Zn(Cl04)2.6H20 
(185.9 mg, 0.5 mmol) were heated under reflux in 15 ml of methanol for 2 hours. 
The solution was kept in a refrigerator for overnight. Then the precipitate was 
filtered off to give the product. Yield 162.2 mg (70%). Found for C10H24N4ZnC1208: 
C, 25.60; H, 5.47; N, 12.20%. Caic.: C, 25.85; H, 5.21; N, 12.06%. Selected IR 
(KBr, cm'): 3271 s, (NH), 3214 w (NH), 2935 m (CH), 2876 m (CH). 
Zn(cyclam)C12 (7). Cyclam (240 mg, 1.2 mmol) and ZnC12 (163.3 mg, 1.2 
mmol) were heated under reflux in 15 ml of methanol for 2 hours. The solution was 
kept in a refrigerator for overnight. Then the crystals were filtered off to give the 
product. The solution was reduced to about 5 ml by rotary evaporation, and kept at 4 
°C in the refrigerator to collect more product after a period of 2 days. Yield 257.4 mg 
(64%). Found for C10H24N4ZnC12: C, 35.64; H, 6.56; N, 16.16%. Caic.: C, 35.68; H, 
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7.19; N, 16.64%. Selected JR (KBr, cm-'): 3223 s, (NH), 3161 in (NH), 2927 s (CH), 
2862 s (CH), 1647 w (NH). 
5.2.2 NMR spectroscopy 
All data were acquired at a probe temperature of 298 K. 'H chemical shifts 
were internally referenced to the methyl singlet of TSP (3-trimethylsilyl- propionate-
d6) at 0 ppm; 13C chemical shifts were referenced externally also using TSP. All 
NMR experiments were performed in 10% D20 / 90% H20 with 4, 5, 6 and 7 at a 
concentrations of 120 mM, pH 6.8, 7.4, 7.2, and 6.7, respectively, unless otherwise 
stated. 
'H NMR data were acquired over a 'H frequency width of 6 kHz into 32 k 
data points (acquisition time = 2.73 s). The water resonance was suppressed by 
presaturation or via the WATERGATE pulsed-field-gradient sequence.'2 
2D ['H, 13C] HSQC NMR data were typically acquired over a 'H frequency 
width of 5 kHz and a '3C frequency width of 5 kHz (40 ppm) centred at 43 ppm. 
Data were acquired with 64 transients into 2 k complex data points (acquisition time 
205 ms) for each of 128 t, increments (acquisition time 12.7 ms). 
2D ['H, '5N] HSQC NMR data were acquired over a 'H frequency width of 
3.5 kHz and a '5N frequency width of 2.5 kHz (50 ppm) centred at 10 ppm. Data 
were acquired with 240 transients into 2 k complex data points for each of 128 t, 
increments. 
All NMR data were processed using Xwin-nmr (version 2.0, Bruker). 
5.2.3 Kinetic studies 
Kinetic studies were carried out using 'H NMR spectroscopy. Complex 4 (40 
mM, pH 6.8) was dissolved in 10% D20 / 90% H20. After an initial period of mixing, 
sample insertion into the NMR probe, temperature equilibration (25 °C) and 
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shimming, 1D 'H NMR spectra were repeatedly acquired on the sample over a 24 h 
period in order to monitor its behaviour with time. 
The rate equations were set up assuming that the conformational changes to 
complex 4 occur by two parallel first-order reactions in which species III undergoes 
independent, concurrent isomerisation to yield two other different species I and V 
(see below). Rate constants were further obtained by fitting the rate equations using 
the program Scientist (MicroMath, Inc, version 2.0). 
The rate equation for the loss of III: 
dCjjj  - — 	+ k2 C11  - 	- 	 (1) 
dt 
The rate equations for the formation of I and V: 
dC1  
dt = k
1C- k,C1 	 (2) 
dcv  
dt = k
2 C111 - k2CV 	 (3) 
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5.2.4 pH dependence 
'H NMR spectroscopy was employed to study the effects of pH on complexes 
4 and 6 in the pH range of about 6.8 to 12.8 and 7.2 to 12.2, respectively, with TSP 
as internal reference. Values of pH were measured with a pH-meter (Coming 145) 
equipped with a microcombination electrode (Aldrich) calibrated with Aldrich 
standard buffers (pH 4, 7, and 10). pH values were adjusted with 0.1 M NaOH in the 
NMR tube. No attempt was made to correct for deuterium isotope effects. 'H NMR 
spectra were acquired for the sample at each pH. 
5.2.5 Effect of acetate on the configuration distribution of 
Zn(cyclam)C12  
Complex 7 (27 mM) was dissolved in 90% H20 / 10% D20 in the presence of 
TSP. Addition of CH3COONa was made to this solution in nine separate NMR tubes 
to give 7:CH3COO ratios of 1:0.5 to 1:9. Each solution was readjusted to pH 7.4 
using 0.1 M NaOH or 0.1 M HCL after addition of 1 M NaOAc in aqueous solution. 
'H NMR spectra were acquired overnight on these samples as well as for 7 itself in 10 
%D20/90%H20. 
5.2.6 X-ray crystal structures of [Zn(cyclam)(H20)2](OAc)2 and 
[Zn(cycIam)(phthaIate)](C H3OH)2  
Crystal data and details of data collection for complexes 4 and 5 are provided 
in Table 5.2. Data were collected and the structures were solved by Dr. Simon 
Parsons and Pamela A. McGregor An absorption correction was performed by 
Gaussian integration following refinement of the crystal face-indices and dimensions 
against a set of W-scans (Stoë X-shape'3). Data were collected to 20max = 140° and 
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the structure solved by direct methods (Shelx-97)14 and refined by full matrix least 
squares against F2. Methyl groups were treated as rotating rigid groups. H-atoms 
attached to coordinated water in complex 4 were located in a difference map and 
refined freely; other H-atoms were placed in calculated positions and allowed to ride 
on their parent atoms. Hydroxyl groups in complex 5 refined freely, and H-atoms 
were placed in calculated positions and allowed to ride on their parent atoms. All 
non-H atoms were refined with anisotropic displacement parameters, to give 
convergence RI and wR2 values as indicated in Table 5.2. The final difference map 
extremes are also provided in Table 5.2. 
Table 5.2 Crystal data and data collection for complexes 4 and 5 
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5.3 Results 
5.3.1 1 H, ' 3C and 15 N NMR studies of [Zn(cyclam)(H20)2](0Ac)2  
in aqueous solution 
As can be seen in Figure 5. 1, the 'H NMR spectrum of the crystalline Zn 
acetate complex, [Zn(cyclam)(H20)2](OAc)2 (4) dissolved in 10% D20 / 90% H20 at 
pH 6.8, consists of two distinct regions. A set of multiplets and a very strong singlet 
appear between 1.5 and 2.1 ppm. The second region of signals lies between 2.4 and 
3.6 ppm. The 1D 'H NMR spectrum is very complicated. In order to fully assign the 
'H NMR spectrum, 2D homonuclear ['H, 'H] TOCSY and DQF-COSY NMR data 
sets and natural abundance 2D heteronuclear ['H, '3C] and ['H, '5N] HSQC NMR 
data were acquired. 
Three spin-systems were found in the 2D ['H, 'H] TCOSY spectrum (Figure 
5.2). 2D ['H, 'H] COSY NMR data (Figure 5.3) showed that the couplings in the first 
spin-system (designated III) appeared as follows: Ha (1.64 ppm) couples to Hb (1.90 
ppm), to Hd (2.70ppm) and to Hg (3.20 ppm) and Hb couples to Hf (3.18 ppm); H 
(2.48 ppm) and He (3.03 ppm) couple to one another and they both also couple to Hg. 
The second spin-system (designated V) is composed of 5 signals: H1 (1.74 ppm) is 
coupled to 113 (2.79 ppm), H5 (3.08 ppm), and weakly to a broad signal H6 (3.35 
ppm); H2 (2.56 ppm) and 114 (2.91 ppm) couple to each other. Both H2 and H4 also 
couple to the broad signal H6. The third spin-system (designated I) consists of seven 
signals: HA (1.69 ppm), HB (1.92 ppm), H (2.73 ppm), HD (2.76 ppm), HE (2.91 
ppm), HIT  (3.16 ppm) and a broad signal HG (3.50 ppm) in the TCOSY NMR 
spectrum. The last spin-system can not easily be observed in the COSY NMR data 
due to extensive overlap and low intensity. The strong singlet (1.93 ppm) can be 
assigned to OAc since it does not couple to any other resonances. 
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OAc 
3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 
(H) 
Figure 5.1 'H NMR spectrum of complex 4 in 10% D20 / 90% H20. Resonances for 






3.5 	3.0 	2.5 	2.0 	1.5 
Figure 5.2 2D ['H, 'H] TOCSY NMR spectrum of 4 in 10% D20 / 90% H20. 
Resonances for trans-I (HG), trans-Ill (Ha to Hg) and cis-V (H, to H6) are designated 
by circles, solid and dashed boxes, respectively. 
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H1 
p.•uI 
3.5 	3.0 	2.5 	2.0 	1.5 
Figure 5.3 2D ['H, 'H] COSY NMR spectrum of 4 in 10% D20 / 90% H20. 
Resonances for trans-I (HG), trans-Ill (Ha to Hg) and cis-V (H, to H6) are designated 






3.6 	3.4 	3.2 
Figure 5.4 2D ['H, '5N] HSQC NMR spectrum of complex 4 in 10% D20 / 90% H20. 
NH resonances for the trans-I (HG), trans-Ill (Hg) and cis-V (H6) configurations are 
designated by circles, solid and dashed boxes, respectively. 
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Figure 5.5 2D ['H, '3C] HSQC NMR spectrum of complex 4 in 10% D20 / 90% H20. 
Resonances for the trans-I (HA to HG), trans-Ill (Ha to Hg) and cis-V (H1 to 146) 
configurations are designated by circles, solid and dashed boxes, respectively. 
Three NH signals can be found in the 2D ['H, '5N] HSQC NMR spectrum 
(Figure 5.4). The spin-system HaHf showed correlations to the NH signal Hg; the 
spin-system H,-H5 relates to the broad NH signal H6; the third spin-system HA-HB 
relates to the broad NH signal HG. Three identified spin-systems arise from three 
different configurations (I, III and V) of complex 4. Time and pH dependent 
experiments also support this conclusion. 
The 2D ['H, '3C] HSQC NMR spectrum (Figure 5.5) revealed the presence of 
17 proton signals corresponding to those described above, which were correlated to a 
total of nine 13C NMR signals (Table 5.3). Geminal pairs of protons were identified as 
follows: HaIHb (6 '3C: 30.77 ppm); H,/H, (6 '3C: 5 0.5 9 ppm); Hd/Hf (6 '3C: 52.82 
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Table 5.3 Total assignment of 'H, '3C and '5N NMR resonances of complexes 4, 5, 6 
and 7 
Complex 	solvent config. ö (1H), (13C) and ('5N) and assignment 
NCH2CH2N NCH2CH 2CH2N 	NCH2CH2CH2N NH 
4 	DO/HO trans-I 'H 2.91 	2.73 3.16 2.76 1.92 1.69 3.50 
(pH 6.8) 13C 49.22 53.34 30.32 
'5N 11.0 
trans-Ill 'H 3.03 	2.48 3.18 2.70 1.90 1.64 3.20 
13C 50.59 52.82 30.77 
14.2 
cis-V 'H 2.91 	2.56 3.08 2.79 1.74 3.35 
13C 49.28 52.19 27.68 
'5N 11.5 
5 	D20/H0 trans-I 'H 2.99 	2.74 3.20 2.78 1.93 1.78 3.59 
(pH 7.4) 13C 49.29 53.39 30.34 
'5N 10.8 
trans-Ill 'H 3.02 	2.55 3.18 2.74 1.88 1.66 3.28 
13c 50.58 52.95 30.70 
'5N 14.0 
cis-V 'H 2.97 	2.63 3.14 2.86 1.76 3.48 
13C 49.27 52.20 27.08 
'5N 11.0 
6 	D20/H20 trans-I 'H 2.92 	2.76 3.16 2.81 1.96 1.71 3.59 
(pH 7.2) 13C 49.17 53.24 30.17 
' 5N 10.2 
trans-Ill 'H 3,04 	2.48 3.20 2.70 1.90 1.64 3.12 
Dc  50.52 52.75 30.71 
'5N 14.3 
cis-V 'H 2.92 	2.61 3.12 2.84 1.76 3.29 
13C 48.77 51.85 26.39 
'5N 11.2 
7 	DO/HO trans-I 'H 2.93 	2.76 3.16 2.80 1.95 1.72 3.58 
(pH6.7) 13C 49.10 53.34 30.20 
'5N 11.4 
trans-ill 'H 3.03 	2.50 3.19 2.73 1.90 1.65 3.15 
50.53 52.76 30.75 
'5N 14.9 
cis-V 1H 2.93 	2.63 3.13 2.84 1.77 3.39 
48.81 51.81 26.47 
5N 11.6 
Note: 	1.93 	ppm for 	OAc in 	4; 	7.52 and 7.46 ppm 	for 	Ph in 	5. 
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ppm); HA/HB (6 13C: 30.32 ppm); Hc/HE (6 13C: 49.22 ppm), HD/HF (6 13C: 53.34 
ppm); H2/H4 (6 '3C: 49.28 ppm); H3/115 (6 '3C: 52.19 ppm). Since all protons except 
for three Ni! signals belong to geminal pairs in this complex, the remaining signal, H, 
(6 '3C: 27.68 ppm) corresponds to two equivalent protons. 
5.3.2 Solution NMR studies of three Zn cyclam complexes, 
[Zn(cyclam)(phthalate)](CH3 0H)2 , Zn(cyclam)(C104 )2 and 
Zn(cyclam)C12  
1H, '3C and '5N NMR data were also acquired for complexes 5, 6 and 7 in 
10% D20 / 90% H20 (Figures 5.6, 5.7 and 5.8). The NMR data are summarised in 
Table 5.3. 
5.3.3 Kinetic studies 
The time dependence of the Zn cyclam complex with acetate (4) in water was 
observed by 1D 'H NMR spectroscopy. During the initial period, only one major form 
(III) was observed by 1D 'H NMR spectroscopy (Figure 5.9). Two other forms (I and 
V) appeared and increased with time. Form V increased strongly and form I increased 
slightly as form III decreased over time. Form I approached equilibrium faster than 
form V. 
5.3.4 Effect of pH on Zn complexes, [Zn(cyclam)(H20)2](OAc)2  
and Zn(cyclam)(C104 )2  
The NMR spectra of complexes 4 and 6 were highly pH dependent. As the pH 
was increased, form V decreased and form I increased whereas form III was almost 
constant for 4 (Figure 5.10). As the pH increased, form III decreased and form I 
increased whereas form V was almost constant for 6 (Figure 5.11). 
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V 	 v/I 
3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1:4 
(H) 
Figure 5.6 'H NMR spectrum of [Zn(cyc1am)(phtha1ate)](CH30H)2 (5) in 10% D20 
and 90% H20. Resonances for trans-I, trans-Ill and cis-V are designated I, III and V, 
respectively. 
3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 
(H) 
Figure 5.7 'H NMR spectrum of Zn(cyclam)(004)2 (6) in 10% D20 and 90% H20. 
Resonances for trans-I, trans-Ill and cis-V are designated I, III and V, respectively. 
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3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 
Figure 5.8 'H NMR spectrum of Zn(cyclarn)C12 (7) in 10% D20 and 90% H20. 





30 60 90 120 
Time (mm) 
Figure 5.9 Time dependent configurational changes of resonances for complex 4 in 
water as determined from integration of the 1H NMR peaks (see Figure 5.1). The 
solid lines represent best fits to the data and the following rate constants: k,, 2.54 x 
10 min'; k 1, 2.70x10 3 min-' for cis-V and k2, 1.33x10 3 min-'; k 2, 3.24x10 3 min-' 
for trans-I. 
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pH 
Figure 5.10 pH dependent configurational changes for complex 4 in water. Trans-I, 
trans-Ill and cis-V configurations are designated by black circles, black squares and 






7 8 9 10 11 12 
pH 
Figure 5.11 pH dependent configurational changes for complex 6 in water. Trans-I, 
trans-Ill and cis-V configurations are designated black circles, black squares and 
white squares, respectively. 
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5.3.5 Effect of carboxylates on Zn(cyclam)C12 
All four Zn cyclam complexes can be categorised into two groups according 
to the distribution of three different configurations in aqueous solution at equilibrium 
(Table 5.4). Form V is predominant for Zn cyclam complexes with acetate (4) and 
phthalate (5). Form III is predominant whereas form V is minor for Zn cyclam 
complexes with perchlorate (6) and chloride (7). These results show that anions can 
affect the distribution of three configurations of Zn cyclam complexes and 
carboxylate can increase form V. 
Table 5.4 Distribution of configurations of complexes 4-7 (40 mM) in 10% D20 / 
90% H20 at equilibrium 
complex trans-I trans-Ill cis-V 
Zn(cyclam)(OAc)2 (4) 11.9% 45.3% 42.8% 
{Zn(cyclam)(phthalate)] (5) 22.7% 31.9% 45.3% 
Zn(cyclam)(C104)2 (6) 8.2% 83.2% 8.6% 
Zn(cyclam)C12 (7) 11.2% 79.6% 9.2% 
Subsequently, 'H NMR spectra of 7 were acquired in the presence of increasing 
quantities of NaOAc to thirteen separate NMR tubes to give 7:NaOAc molar ratios of 
1:0.5 to 1:9. 'H NMR observations showed that form III decreases and form V 
increases whereas form I is almost constant with increasing NaOAc concentration in 
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Figure 5.12 Effect of acetate on the distribution of complex 7 in water as determined 
by integration of the 'H NMR resonances. Trans-I, trans-Ill and cis-V configurations 
are designated by black circles, black squares and white squares, respectively. 
5.3.6 X-ray crystal structures of [Zn(cyclam)(H20)2](OAc)2 and 
[Zn(cycIam)(phthaIate)](CH3 0H)2  
[Zn(cyclam)(H20)2](OAc)2  (4) and [Zn(cyclam)(phthalate)](CH30H)211 (5) 
were characterised by X-ray crystallography. The crystal structure of complex 4 
consists of [Zn(cyclam)(H20)2]2 cations, and uncoordinated OAc anions, which are 
linked by a network of hydrogen bonds. The Zn(II) ion sits at a centre of symmetry 
and is surrounded octahedrally by four nitrogen atoms of the macrocyclic ligand in a 
plane with the distances of 2.08 and 2.12 A and by two water molecules occupying 
the axial positions with the same distance of 2.27 A (Figure 5.13). The overall 
structure of the cation is the trans-Ill conformation with two adjacent N-H hydrogen 
atoms directed toward one side of the cyclarn plane and the other two directed toward 
the opposite side of the plane. The trans-Ill configuration is the most stable one for 
cyclam complexes in which the two six-membered chelate rings are in chair 
conformations and the two five-membered rings are in gauche conformations and is 
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found in a number of cyclam complexes. 3,15,16  All bond lengths and angles are listed 
in Table 5.5. 
Figure 5.13 X-ray crystal structure of the cation of [Zn(cyclam)(H20)2](OAc)2 (4) 
together with the atom numbering scheme. 
Figure 5.14 Packing of [Zn(cyclarn)(H20)2](OAc)2 (4). Hydrogen bonds are shown 
by dotted lines. 
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Table 5.5 Selected bond distances (A) and angles (deg) for complexes 4 and 5 
Complex 4 
Zn(1)—N(l) 	 2.1198(15) 
Zn(l)—N(4) 2.0809 (15) 
Zn(l)-0(1W) 	2.2719(14) 
N(1) - Zn(l) - N(1) 180.00(8) 
N(4) - Zn(l) - N(1) 84.94(6) 
N(4) - Zn(l) - N(l) 95.06(6) 
Complex 5 
Zn(l) —N(3) 2.097(2) 
Zn(1)—N(6) 2.100(2) 
Zn(2) —N(21) 2.100(2) 
Zn(2) —N(17) 2.108(3) 
Zn(l) - 0(2) 2.220(2) 
Zn(2) - 0(3) 2.190(2) 
N(3) - Zn(l) - N(3) 180.0(2) 
N(3) - Zn(l) - N(6) 95.75(9) 
N(3) - Zn(1) - N(6) 84.25(9) 
a#1 -x, -y, -z; b#1  -x,-y+1,-z+1 
The 	crystal packing 	and hydrogen-bonding 	scheme 	for 
{Zn(cyclam)(H20)2](OAc)2 (4) are shown in Figure 5.14. In this structure, eight 
intermolecular interactions link a complex cation to eight neighbouring complex 
cations via six acetate anions to form a 3-dimensional network of hydrogen bonds. 
There are two types of hydrogen bonds: 0 - H 0 with H 0 distances ranging 
from 1.84 to 1.95 A and 0 - H 0 angles ranging from 169 to 176° and N - H 0 
with H 0 distances ranging from 1.99 to 2.24 A and 0 - H 0 angles ranging 
from 158 to 1640. Both carboxyl oxygen atoms act as acceptors, with one of them 
participating in three intermolecular hydrogen bonds. All four H atoms of the 
secondary amine groups for each complex cation and all four H atoms of two water 
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molecules coordinated to the Zn(II) atom act as donors. The details of hydrogen 
bonds are shown in Table 5.6. 
The crystal structure of complex 5 consists of an infinite chain of 
[Zn(cyclam)phthalate)] with methanol molecules from the solvent which are linked 
by hydrogen bonds (Figure 5.15). The phthalate anion plays the role of a bridging 
ligand, forming a linear chain structure. Each Zn(II) ion sits at a centre of symmetry 
and is surrounded octahedrally by four nitrogen atoms of the macrocyclic ligand in a 
plane with a Zn-N distance of 2.10 A and by two oxygen atoms of phthalate 
molecules occupying the axial positions with an N-0 distance of 2.22 A. All bond 
lengths and angles are listed in Table 5.5. 
Table 5.6 Hydrogen bonds in complexes 4 and 5 (bond length A and angle 0)  
complex D - H 	D d (11 	A) ZDHA D (D 	A) 
O1W—H1W ... olAa 1.953 169.36 2.736 
01W_H2W ... 01Ab 
4 
1.843 176.10 2.727 
Nl —HI ... 0lAc 2.242 163.51 3.136 
N4_H4 ... 02Ad 1.994 158.36 2.869 
N3 - H3 	02M 2.079 161.77 2.976 
N6—H601 2.012 152.63 2.870 
N17 - H17 	04 
5 
2.314 146.56 3.132 
N21 —H21 	01 1.963 169.43 2.882 
O1M - HIM 	04 1.939 168.45 2.770 
02M - H2M 	04 1.885 173.47 2.715 
(MA F-x+1. -v. -zi: b  OIA 1-x+1. v-1/2. -z+1121: 	O1A Ix-1. v. zi: d  02A F-x+1. v-1/2. -z+1/2 
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There are three different intramolecular hydrogen bonds between two free oxygen 
atoms (01 and 04) of each carboxylate and two H atoms (1121 and H17) of the 
secondary amine groups from one cyc lam ligand and one H atom (H6) of the 
secondary amine group from the other cyclam ligand. 01 is shared by H6 and H21. 
The methanol solvent molecules form two hydrogen bonds to 04: HIM 04, 1.94 
A; HIM 04, 1.89 A. The other intermolecular hydrogen bond involves 02M as an 
acceptor and H3 as a donor. The details of hydrogen bonds are shown in Table 5.6. 
Figure 5.15 X-ray crystal structure of [Zn(cyclam)(phthalate)](CH30H)2 (5) 
together with the atom numbering scheme. Hydrogen bonds are shown by dotted 
lines. 
5.4 Discussion 
5.4.1 Solution NMR studies of [Zn(cyclam)(H20)2](OAc)2  
The three cross-peaks from separate spin-systems of complex 4 in the 2D ['H, 
'5N] HSQC spectrum revealed that there are three configurations I, III, V in aqueous 
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solution. The signals between 2.4 and 3.6 ppm can be easily assigned to the central 
methylene in the six membered-rings by their chemical shifts. In the first spin-system 
(form III), therefore, Ha and 11b  are assigned to NCH2CH2CH2N in the six 
membered-rings. 2D ['H, 'H] COSY showed that lid and Hf correlate to Ha and Hb. 
Hence, it can be concluded that H, j and Hl. are from NCH2CH2CH2N in the six 
membered-rings. The remaining two signals H and He, therefore, are assigned to 
NCH2CH2N in the five membered-rings. Fig can be clearly distinguished as a NH 
signal in the 2D ['H, '5N] HSQC spectrum whereas it overlaps with H,' in the 1D 'H 
NMR spectrum. For the second spin-system (form V), it can similarly be concluded 
that H1 is from NCH2CH2CH2N and ll3 and H5 are from the NCH2CH2CH2N in the 
six membered-rings. H2 and H4 are from the NcH2CH2N in the five membered-
rings. In the third spin-system (form I), two weak signals HA and HB of seven signals 
including one broad NH signal can be assigned to NCH2CH2CH2N in the six 
membered-rings. 
Cyclam complexes can adopt five different configurations depending on the 
spatial alignment of the NH protons (Figure 1.3). After analysis of the structure of 
these possible configurations, it can be seen that only trans-I and trans-Ill can 
produce six —CH2- proton signals, and two of them for the central methylene of the 
six membered-rings. Both six-membered rings in trans-I and trans-Ill configurations 
adopt a chair conformation and Ha and Hb are nonequivalent and give rise to two 'H 
NMR resonances (see Figure 1.3 and A in Figure 5.16). From the time-dependent 
experiment, form III can be easily assigned to trans-Ill since complex 4 adopts the 
most stable configuration trans-Ill in the crystals. Therefore, form I is assigned to 
trans-I. 
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Figure 5.16 Chair and twist-boat conformations for six-membered rings 
Configuration analysis also indicates that only trans-IV and trans-V have five 
non-equivalent —CH2- protons which can produce five —CH2- proton signals and only 
one of them for the central methylene of the six membered-rings. Both six-membered 
rings in trans-IV and trans-V adopt twist-boat conformation and H and Hd are 
equivalent and give rise to only one 1 H NMR resonance (see Figure 1.3 and B in 
Figure 5.16). However, both trans-IV and lraiis-V do not appear to be stable because 
of two six membered-rings with high energy in the twist-boat conformation for each 
of them. Cis-V is the strain free option and only trans-V can easily fold along 
diagonal a or b (Chart 4.1) to form the more common cis-V configuration with two 
six membered-rings in the chair conformation. These two enantiomeric forms can 
exchange rapidly to give the appearance of a trans-V configuration. Therefore, it is 
proposed that form V could be the cis-V configuration. 
5.42 Kinetic studies 
Isomerisation from trans-111 to cis-V and trans-I for 
[Zn(cyclam)(H20)2](OAc)2 in aqueous solution requires the successive inversion of 
two amine nitrogens via an intermediate trans-11 configuration (see Figure 1.3). It is 
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slow for configurations to reach the equilibrium in this process (at neutral pH). 
However, the configuration trans-11 can not be detected in aqueous solution. It seems 
that the formation of the trans-IT configuration is the slow step and determines the 
isomerisation speed. Trans-11 is not stable and rapidly converts to the other 
configurations (Scheme 5.1). 
slow 
trans-ill - 	 trans-Il 
trans-I 
faa~st cis-V 
Scheme 5.1 Isomerisation from 11-aiis-111 to cis-V and trans-I at neutral pH 
5.4.3 Effect of acetate on Zn(cyclam)C12 
In aqueous solution, the distribution of the three configurations for Zn cyclam 
complexes is strongly dependent on the counter-ion present (Table 5.4). Aqueous 
solutions of 6 and 7 consist mainly of trans-Ill whereas for the carboxylato 
complexes 4 and 5, the cis-V form is predominant. Titration of complex 7 with a 
carboxylate also gives rise to an increase of cis-V at the expense of trans-Ill (Figure 
5.12). It seems that carboxylate can act as a bidentate ligand, with hydrogen bonds 
between carboxylate and the secondary amine NH stabilising cis-V in aqueous 
solution. Hence, the cis-V configuration becomes more stable than trans-Ill in 
aqueous solution in the presence of carboxylates, and trans-Ill isomerizes to cis-V. 
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5.4.4 Effect of pH on [Zn(cyclam)(H20)2](OAc)2 and 
Zn(cyclam)(C104)2  
As the pH increases, the cis-V form decreases and trans-I increases, whereas 
trans-Ill is almost constant for 4, whilst trans-Ill decreases and trans-I increases, 
whereas cis-V is almost constant, for 6 (Figures 5.10 and 5.11). As Cd(II) cyclam 
complexes discussed in 4.4.3, Zn(II) complexes can also form cyclam-Zn-Off species 
in trans-11 configuration. The inversion from cis-V to trans-I for complex 4 is 
identical to that for Cd cyclam complexes (see Section 4.4.3). The inversion from 
trans-Ill to trans-I for 6 as shown in Scheme 5.1 also needs to convert the nitrogen 
configurations twice via trans-11. The formation of trans-11 for cyclam-Zn-Off from 
trans-Ill is base-catalysed as well. 17  The trans-11 configuration for cyclam-Zn-0H 
continues to convert to trans-I and is base-catalysed. Therefore, the isomerisation 
from trans-Ill to trans-I for complex 6 is very fast at high pH since no proportion 
change for each configuration observed at each pH. The base-catalysed mechanism 
can be confirmed by the slow inversion from trans-Ill to trans-I for 4 at neutral pH 
(see Section 5.4.2). The trans-I configuration may also involve a carbonate complex 
after fixing the atmospheric CO2. 
5.4.5 X-ray crystal structures of [Zn(cyclam)(H20)2](OAc)2 (4) 
and [Zn(cyclam)(phthalate)J(CH3 0H)2 (5) 
Compared with the Zn-U bond distances for bound water in the other Zn(II) 
complexes in the Cambridge Structural Database, complex 4 has one of the longest 
axial Zn-U distances (2.27 A). The elongation of the Zn-U bond distance in the 
complex may be attributed to the competition of two acetate anions for hydrogen 
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bonds with water. The Zn-N bond lengths of 2.08 A and 2.12 A are comparable with 
those in the complex Zn(cyclam)(004) G  The average value for Zn-N bond length 
of 2.10 A is very close to the "ideal" metal-nitrogen bond length (2.07 A)'8 in trans-
cyclam complexes and to the bond lengths in a number of complexes containing 1,2- 
ethanediamine and 1 ,3-propanediamine.'9 
The Zn-O distance of 2.22 A in complex 5 is slightly longer than the normal 
value for Zn(II) binds to the oxygen atom of C032 .3 Two cyclam ZnN4 planes 
associated with a phthalate ion are not parallel, therefore, steric constraints may exist 
between the neighboring cyclam ligands. Each complex cation in complex 5 is quite 
similar to that in complex 4. It also takes the most stable conformation trans-Ill and 
has the same value of average Zn-N bond length as in complex 4. Bond distances and 
angles within the chelate rings correspond closely to the same measurements in 
complex 4 as well. 
Among the hydrogen-bonds for both 4 and 5, the secondary amine NH of 
cyclam and OH in water molecules, or methanol molecules act as proton donor 
groups, and the hydrogen-bonding acceptors are the C=O groups of carboxyl 
residues and the OH group from methanol. The OH group in methanol molecules 
displays dual hydrogen bond functionality and therefore can give rise to hydrogen-
bond cooperativity and form multi-centre hydrogen bonds. As we expected, both 4 
and 5 form an infinite supra-molecular network structure and an infinite supra-
molecular chain, respectively, through hydrogen bonds. There are two strong 
hydrogen bonds 0 1 W - H2W 01A (H 0, 1.84 A) in complex 4 and 02M - H2M 
04 (H 0, 1.89 A) in complex 5 with near linear geometry (176 and 168°, 
respectively). 
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5.5 Conclusions 
The crystal structures of [Zn(cyclani)(H20)2](OAc)2 (4) and 
[Zn(cyclam)(phthalate)] (CH3OH)2 (5) indicate that cyclam complexes adopt the 
most stable conformation trans-Ill in which six mcmbered-rings are in the chair 
conformation and five membered-rings are in the gauche conformation. Three 
isomers trans-I, trans-Ill, and cis-V were found in aqueous solution by NMR for 
complexes 4, 5, 6 and 7. 'H NMR spectra were fully assigned by combining 2D 
NMR data. Both time dependence experiments and titration of the chloride cyclam 
complex with carboxylates indicate that the interaction with carboxylates gives rise 
to a large increase in the proportion of cis-V and a slight increase in trans-I. This 
result shows that carboxylates have high con formationally recognition abilities. A 
large number of hydrogen bonds exist in both aqueous solution and solid state, and 
may also play an important role in the anti-HIV activity of cyclams. This result 
implies that carboxylates in the side-chains of the target protein CXCR4 may also 
have high conformational recognition ability. This conclusion is further confirmed 
by the similar studies on the bicyclam complexes in Chapter 6. 
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Zn Bicyclam Complexes 
6.1 Introduction 
There is current medical interest in the drug AMD3100, a bicyclam 
containing two cyclam units connected by a p-phenylenebis(methylene) linker 
(AMD3I00, bicyclam8HCl, Figure 6.1). AMD3100 is in phase I clinical trials for 
stem cell transplantation used in the treatment of patients who have cancers 
involving the blood and immune system. It is also one of the most potent anti-HIV 
agents known,' blocking entry of T-lyniphotropic HIV-1 and HIV-2 strains by 
specific binding to the CXCR4 co-receptor.2 CXCR4 is a member of the classical G-










Figure 6.1 Bicyclam, 1-1 -[1 ,4-phenylenebis(methylene)]-bis( 1,4,8,11 -tetraazacyclo-
tetradecane). The octa-HC1 salt is the anti-HIV drug AMD3 100. 
Cyclams are strong metal chelating agents. The concentration of Zn(II) in 
blood plasma is Ca. 20 1iM,3 and Zn(II) binds strongly to cyclam (log K 20.12). 
Taking account of cyclam PKa values, this gives a conditional dissociation constant 
(I(d) at blood plasma pH (7.4) of Ca. 0.1 pM. Since the level of free Zn(II) in plasma 
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is Ca. 1 nM,3 and the affinity of alkyl-substituted cyclarns is likely to be even higher 
than for cyclam itself, it is reasonable to expect that bicyclam can exist as a Zn(II) 
complex in vivo. 
The Zn(II) complex of bicyclarn is lOx more active than AMD3 100 in its 
interaction with the CXCR4 receptor,5  and there is a close correlation between anti-
HIV activity and CXCR4 interaction, decreasing in the order: 
Zn(II)2 > AMD3 100 > Ni(1I)2 > Cu(II)2 >>Pd(II)2 (as perchiorate salts). 
This has led to the suggestion that the Zn(II) complex is an important antagonist in 
vivo. 5 
Configurations with H atoms pointing in the same direction at the end of a 
diagonal can fold to generate a trigonal bipyramid or a cis structure. Thus the R,R,S,S 
configuration can form only a trans-Ill complex, whereas trans-V can fold to cis-V. 
Energy calculations on Ni(II) complexes  show that trans-Ill has the lowest energy, 
but trans-I becomes more stable relative to trans-Ill on decreasing the metal 
coordination number from 6 (octahedral) to 5 to 4 (square-planar), in agreement with 
a recent survey of X-ray structures.7 
Studies on bicyclam complexes have mostly focused on compounds as shown 
in Chapter 1 which two monocyclam units are linked together by bridging the carbon 
atoms of the cyclam backbone by crystallography.8 In their complexes, each 
monocyclam ring adopts the trans-Ill configuration. Bicyclam complexes in which 
two monocyclam units are linked together by bridging the amine nitrogen atoms of 
the cyclam backbone are the other type of bicyclam. The redox chemistry of some of 
these dinickel(II) and dicopper(II) complexes has been investigated with regard to 
the M(II) to M(III) oxidation process.9  No crystals or NMR studies of such bicyclam 
complexes have been reported. 
157 
Chapter 6 Zn Bicyclam Complexes 
The aim of the work described in this thesis was to elucidate the nature of 
potential first and second coordination sphere interactions of metal (bi)cyclam 
complexes with the CXCR4 receptor. The investigations include solid state and 
dynamic solution studies as well as modelling. Interactions of metal bicyclams with 
acetate were studied since there is strong evidence'0 from receptor mutagenesis 
studies that bicyclam blocking of CXCR4 is dependent on the carboxylate side-
chains of Aspl7l and Asp262 in trans-membrane helices IV and VI. The findings in 
this study provide a new basis for the improved design of receptor-targeted 
macrocycles. I prepared the bicyclam AMD3 100 by the route in Scheme 6.1 which 
constitutes a simple extension of the previously published mono N-alkylation 
procedure using phosphoryl-protected cyclam.' 
r"-) 	 r) 
(NH HN P(NMe2)3 N HN 
NH HN 	 Li 
1  








Br 	 Br 
CNH 
DMF, K2CO3 
Scheme 6.1 The synthetic route for bicyclam 
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6.2 Experimental 
6.2.1 Synthesis and crystallisation of Zn bicyclam complexes 
Synthesis of bicyclam Following the reported method,'1 cyclam (0.5 g, 2.5 
mmol) in 100 nil of dry toluene was heated under reflux with hexamethyiphosphoric 
triamide (454 iil, 2.5 mmol) overnight. After cooling to 0 °C, dry CCI4 (375 tl, 3.9 
mmol) was added whereupon a white precipitate separated. The solvent was 
evaporated under high vacuum and the residue 2 treated with 25 ml of 10% sodium 
hydroxide. The aqueous phase was extracted with chloroform (4x100 ml). The 
combined organic phases were dried over MgSO4, and then evaporated and dried 
under vacuum to give a white powder 3 (580 rng, 94.8%). 
The protected cyclam 3 (580 mg, 2.4 mmol), 1, 4-bis-bromomethyl-benzene 
(313 mg, 1.2 mmol) and potassium carbonate (520 mg, 3.8 mmol) were heated at 120 
°C in 70 ml of dry DMF for 20 hours. After removing the solvent, 40 nil of 10% 
hydrochloric acid was added into the residue of 4 and refluxed for 2 days. The 
solution was washed with 20 ml of toluene and the volume reduced to about 15 nil. 
Then pH was adjusted to >13 with sodium hydroxide pellets and extracted with 
chloroform (3 x 100 nil). The organic phase was dried over anhydrous sodium sulfate. 
The solvent was evaporated to give a pale yellow powder 5 (0.62 g, 52%). 'H NMR 
(CDC13): 7.23 (m, 4H, C6H4; 3.53 (s, 4H, CH2C6 H4CH2); 2.98 - 2.39 (m, 32H, 
NCH?); 1.85 (m, 4H, NCH2CH2CH2N); 1.68 (m, 4H, NCH2CH2CH2N). El MS 503 
m/e (M). 
Zn2(bicyclam)(004)4 (8) Bicyclam (387.15 mg, 0.77 mmol) and 
Zn(C104)2•6H20 (571 mg, 1.53 mmol) were stirred in 10 ml of methanol at 60°C (oil 
bath) for one hour. The precipitate was filtered off and washed with a small amount 
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of methanol to give Zn2(bicyclam)(ClO)4 (707.6 mg, 89.1%). Selected IR (KEr, 
cm'): v= 3435 (NH), 3246 (NH), 2930 (CH2), 2875 (CH2), 1653 (NH); elemental 
analysis calcd for C28H54C14N8016Zn2 (%): C 32.61, H 5.28, N 10.86; found: C 
32.19, H 5.35, N 10.22. 
IZn2(bicyclam)(OAc)21(OAc)2 2CH30H (9) Bicyclam (49.6 mg, 0.1 mmol) 
and Zn(OAc)2 (43.34 mg, 0.2 mmol) in methanol (3 ml) were heated under reflux for 
one hour. The solvent was evaporated on a rotary evaporator and the residue was 
dissolved in methanol, then recrystallised by diffusion of Et20 into the solution to 
give the crystals of Zn2[(bicyclam)(OAc)2](OAc)2 (66.67 mg, 57.8%). Selected JR 
(KBr, cm'): v= 3486 (NH), 3436 (NH), 3147 (NH), 2920 (CH2), 2867 (CH2), 1576 
(CO), 1410 (CO); elemental analysis calcd for C38H74N80,0Zn2 (%): C 48.88, H 
7.99, N 12.00; found: C 48.99, H 7.68, 11.86. 
6.2.2 NMR spectroscopy 
All data were acquired at a temperature of 298 K unless otherwise stated. 'H 
chemical shifts were internally referenced to the methyl singlet of TSP (3-
trimethylsilyl- propionate-d6) at 0 ppm; 13C chemical shifts were referenced 
externally for 2D ['H, '3C] and internally for 1D '3C NMR spectra also using TSP. 
'5N chemical shifts were referenced externally for 2D ['H, '5N] using NH4CI at 0 
ppm. All NMR experiments were performed in 10% D20 / 90% H20 with complex 8 
at a concentration of 5 mM, pH 6.6, and complex 9 at a concentration of 16 mM, pH 
7. 1, unless otherwise stated. 
1D 'H NMR data were acquired over a 'H frequency width of 4.4 kHz into 64 
k data points (acquisition time = 2.34 s). The water resonance was suppressed by 
presaturation or via WET. 12 
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'3C-{'H}NMR data were acquired over a 13C frequency width of 31.44 kHz 
into 25154 data points (acquisition time = 0.4 s). 
2D ['H, '3C] HSQC NMR data were typically acquired with gradient 
coherence selection over a 'H frequency width of 4.4 kHz, and a '3C frequency width 
of 25 kHz (167 ppm) centred at 72 ppm. Data were acquired with 32 transients into 
2048 complex data points (acquisition time 232 ms) for each of 2x256 t, increments 
(acquisition time = 10.2 ms). Solvent suppression was achieved using WET. A 
relaxation delay of 1.6 s was applied between transients. 
2D ['H, 15  N] HSQC NMR data were acquired over a 'H frequency width of 
4.4 kHz and a '5N frequency width of 1000 Hz (17 ppm) centred at 0 ppm. Data were 
acquired with 256 transients into 2 k complex data points for each of 2x64 t, 
increments. Relaxation delay and solvent suppression were the same as for the 
equivalent '3C experiment. 
Homonuclear 2D ['H, 'H] (z-filtered)-TOCSY, NOESY and DQF-COSY 
NMR data were acquired at 600 MHz over a 'H frequency width of 4.4 kHz into 
2048 complex data points (acquisition time = 232 ms); 8, 8 and 16 transients per FID 
were acquired for each experiment respectively. Data were acquired with 2x512 t, 
increments in Fl (frequency width = 4.4 kHz). A relaxation delay of 1.6 s was 
allowed between transients, and solvent suppression was achieved using WET. For 
the TOCSY experiment, a spin-lock time of 70 ms was used. For the NOESY 
experiment, a mixing time of 750 ms was used. All data were converted to Xwinnmr 
(Version 2.0, Bruker U.K. Ltd.) format prior to Fourier transformation. 
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6.2.3 X-ray crystal structure of 
[Zn2(bicyclam)(OAc)2](OAc)2•2CH30H (9) 
Crystals suitable for X-ray diffraction were grown by slow diffusion of ether 
into a methanol solution of 9. A colourless block 0.17 x 0.12 x 0.10mm was selected 
for X-ray crystallographic studies. Unit cell parameters were as follows: 
C38H74N80,0Zn2, triclinic, space group P 1, a = 9.652(2), b = 10.089(2), c = 
14.429(2) A, cx = 105.741(3), f3 = 10 1.629(3), y = 94.304(4)°, V= 1311.9(4) A3, Z = 
2, Pcalcd = 1.111 mg m 3, MOKa radiation (A. = 0.71073 A), 2enax = 52.8°. A total of 
8482 data points were collected on a Bruker SMART diffractorneter at 150(2) K. 
Absorption and Lp corrections were applied using the program SADABS13 Tmji = 
0.80. Merging gave 5226 independent data points. The structure was solved by Dr. 
Robert 0. Gould using DIRDIF14, which gave an automatic solution and expansion 
to show all 27 atoms in the asymmetric unit. Refinement of 292 parameters by full- 
matrix least squares on F2 using SHELX9715 gave wR2 = 0.116 based on all data and 
R, = 0.047, based on 3995 data with I ~! 2o1), GOF = 0.929, max 	on last cycle 
0.08, max residual electron density = 1.5 e A-3. All non-hydrogen atoms refined 
anisotropically; hydrogen atoms were placed in calculated positions and allowed to 
ride on atoms of the complex. Other hydrogen atoms were located, idealised and also 
allowed to ride. 
6.2.4 Kinetic studies 
Kinetic studies were carried out using 'H NMR spectroscopy. Complexes 8 
and 9 were dissolved in 10% D20 / 90% H20 separately. After an initial period of 
mixing, sample insertion into the NMR probe, temperature equilibration (298 K) and 
shimming, 1D 'H NMR spectra were repeatedly acquired over a 24 h period for both 
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complexes in order to monitor their behaviour with time. However, the process was 
much more rapid for complex 9, and could be followed by 1 H NMR spectroscopy 
only for complex 8. 
The rate equations were set up assuming that the conformational changes to 
complex 8 occur by two parallel first-order reactions in which species Ill undergoes 
independent, concurrent isomerisation to yield two other different species I and V 
(see below). Rate constants were further obtained by fitting the rate equations using 
the program Scientist (MicroMath, Inc, version 2.0). 
The rate equation for the loss of III: 
dC111  
- 	= k 1C111 + k2 C - k1C1 - k 2C 	 (6-1) 
dt 
The rate equations for the formation of! and V: 
di'- k
1C111- k 1 C1 	 (6-2) 
dC 
dt 	
k2 C111 k2Cv 	 (6-3) 
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6.2.5 Effect of acetate on Zn2(bicyclam)(C104)4 
CH313COONa (2 mM) was dissolved in 90% H20 / 10% D20 in the presence 
of dioxane. Stepwise addition of 8 was made to this solution to give '3C-acetate: 8 
molar ratios of 1:1, 1:2, 1:3 and 1:4. Further reverse addition of CH313COONa to this 
solution was made to give '3C-acetate: 8 ratios of 2:4, 3:4, 4:4, 6:4, 8:4 and 12:4. '3C-
{'H} NMR spectra were acquired after each addition. In a similar experiment, 
NaOAc was added stepwise to a 5 mM solution of Zn2(bicyclam)(Cl04)4 in 10% 
D20 / 90% H20 at 298 K to give molar ratios Zn2(bi eye lam) (C104)4:acetate of 1:1, 
1:2 and 1:4, and 'H NMR spectra were acquired at each molar ratio. The pH of the 
solutions was within the range 6.6 to 7.4 and in each case equilibrium was reached 
within an hour. The proportions of species present at the 1:4 mol ratio are similar to 
those for a solution of crystalline 9. 
6.2.6 Molecular modelling 
An homology model of human CXCR4 (sequence SWISS_PROT: 
CCR4_HUMAN, P30991) based on the X-ray structure of bovine rhodopsin (PBD 
accession code 1F88)'6 was built using the Homology module of Insight II (Version 
2000, Biosym Technologies) by Drs. Claudia Blindauer, Hye-seo Park, and Stephen 
J. Paisey. The sequence alignment is shown in Table 6.1. The loops were generated 
de novo and selected so as to avoid clashes with Zn2-bicyclam which had been 
incorporated into the rhodopsin template. The Discover simulation package (Biosyni 
Technologies) with the consistent valence force-field was employed for energy 
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minimisation. The final step employed 500 cycles of the steepest descent method 
until the r.m.s. derivative of the energy was <0.001. 
Since the NMR studies indicated that the major solution configuration of Zn 
bicyclam acetate is cis-V/trans-I, this was built by Dr. John Parkinson from the X-
ray coordinates of 9 with modification of the second ring to trans-1 (based on the 
published X-ray structure 17  of [Zn( 1,4,8,11 -tetramethyl-tetraazacyclotetradecane 
(CH3C00O2)]Cl04 followed by energy minimisation using Sybyl (Version 6.7, 
Tripos Inc.). Zn,)-bicyclam was manually docked with the receptor so as to bring the 
cis-V ring near to Asp262 and trans-I ring close to Asp171. Following docking, the 
ligand was fixed relative to the receptor, and distance restraints of 2.2 A with an 
average force constant of 500 kcal niol' A 2 were applied to the Zn-U bonds to Asp 
171 and Asp 262. Bad contacts between the protein and metal bicyclam were then 
relieved by energy-minimising the protein whilst maintaining the original structure 
for the metal bicyclam. During the minimisation, the side-chains of Aspl7l and 
Asp262 moved into more favourable positions for binding to Zn without additional 
restraints. A similar procedure was used to optimise the H-bonds between the 
carboxylate oxygens of Glu288 and the diagonal NH protons on the cis-V ring using 
distance restraints of 2.0 A and an average force constant of 200 kcal moL' A 2. 
WebLab ViewerPro 4 (Molecular Simulations Inc.) and MOLMOL (Version 2K.1)'8 
were also used for modelling and graphics. 
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Table 6.1 Sequence alignment of human CXCR4 and bovine rhodopsin obtained 
using the homology module of insight II. 
1F88 : 	MNGTEGPMFYVP- -FSNKTGVVRSPFEAPQYYL- -AEPWQFSMLAAY (1-43) 
CXCR4 MEGISIYTSDNyTEEMGSGDyDSMKEpCFREENFNKIFLpTI (1-44) 
1F88 : MFLLIMLGFPINFLTLYVTVQHKKLRTPLMYILLNLAVADLFMVFGGFTT (44-93) 
CXCR4 YSIIFLTGIVGNGLVILVMGYQKKLRSMTDKyRLHLSVADLLFVITLpFW (45-94) 
1F88 : 	 (94-143) 
CXCR4 AVDAVANWYF- -GNFLCKAVHVIYTVNLYSSVLILAFISLDRyLAIVHAT (95-142) 
1F88 	SNFRF-GENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYY (144-192) 
CXCR4 : NSQRPRKLLAEKVVyVGVWIpALLLTIpDFI-FVsEADDRyIcDRFy (143-190) 
1F88 	TPHEETNNESFVIYMFVVHFIIpLIvIFFcyGQLvFTvKE 	SATTQK (193-245) 
CXCR4 -P-NDLWVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQ. (191-233) 
1F88 	AEKEVTRMVIIMvIAFLICWLPYAGVAFyIFTHQGSDFGP --------- I (246-286) 
CXCR4 : -KRKALKTTVILILAFFACWLPYYIGIS IDS FILLEIIKQGCEFENTVHK (234-282) 
1F88 	FMTIPAFFAKTSAvYNPvIYIMMNKQFRNcMvTTLccGpI STTVSKTE (287-341) 
CXCR4 : WISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKG (283-332) 
1F88 : TSQVAPA 	 (342-348) 
CXCR4 : KRGGHSSVSTESESSSFHSS 	 (333-352) 
6.3 Results 
6.3.1 1H, 13C and 15N NMR of Zn2(bicyclam)(C104)4 (8) in 
aqueous solution 
'H NMR spectrum of Zn bicyclam perchiorate in 10% D20 / 90% H20 
acquired on a 600 MHz NMR instrument is very complicated (Figure 6.2). The 
resonances in the spectrum can be categorised into four types: resonances from the 
NH protons, resonances from the protons in the bridging aromatic ring, resonances 
from the bridging CH2 groups, and resonances from the protons in the cyclam rings. 
In order to fully assign the 'H NMR spectrum, 2D ['H, 'H] TOCSY and DQF- 
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COSY, and ['H, '3C] and ['H, '5N] HSQC data were further acquired on a 600 MHz 
NMR instrument by Dr. John Parkinson. Data for Zn-Bz-cyclam chloride, [Zn(Bz-
cyclam)C1]Cl2.5CDC13  are also included for comparison. This complex was 
prepared by Dr. Stephen Paisey who also acquired the NMR data on it. 
Aromatic area 
CH2 in cydani rings 
LI1 
Bridging CH2 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 
H) 
Figure 6.2 'H NMR spectrum of Zn2(bicyclam)(C104)4 in 10% D20 and 90% H20 
1. NH proton resonances 
The 2D ['H, 15N] HSQC NMR data for an equilibrium solution of Zn bicyclam 
perchiorate in 10% D20 / 90% H20 show the presence of 9 'H/15N correlations 
(Figure 6.3a and Table 6.2). NHF, NHG and NHH (designated by triangles) have very 
low intensity and therefore belong to the same group. ['H,'H] COSY and TOCSY 
data show that the other NH protons fall into the following two groups: NHA, NHB 
and NHD (designated by squares); NHc, NHE and NH1  (designated by circles) 
(Figures 6.4 and 6.5). 
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Figure 6.3 Comparison of ['H, '5N] HSQC spectra of (a) Zn bicyclam perchiorate 
(8), (b) Zn-Bz-cyclam chloride, and (c) Zn bicyclam acetate (9) in 10% D20 / 90% 
H20. In each case, 3 sets of NH peaks can be identified (due to their connectivities in 
COSY and TOCSY spectra, and by integration) corresponding to 3 major cyclam 
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ö(1 H) 
Figure 6.4 2D ['H,'H] TOCSY NMR spectrum of NH region for 
Zn2(bicyclarn)(C104)4 in 10% D20/90% H20 
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Figure 6.5 2D ['H,'H] TOCSY NMR spectrum of NH region for 
Zn2(bicyclam)(C104)4 in 10% D20 and 90% H20 
Table 6.2 'H and '5N NMR data for Zn bicyclarn perchiorate in 10% D20 / 90% 
H20, at equilibrium. 
Chemical Shift (ppm) 
Peak Label 	 1H 	 '5N 
NHA 4.20 -4.00 
NHB  4.04 0.04 
NHc  3.74 -0.04 
NHD 3.55 -0.01 
NHE 3.46 4.80 
NHF 3.42 -0.24 
NHG 3.30 3.93 
NHH 3.18 3.67 
NH, 3.08 4.20 
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2. Bridging methylene proton resonances 
Six resonances for bridging methylene protons are clearly visible in the 2D 
['H,'3C] HSQC NMR spectrum (Figure 6.6a): Ml and M6 are a geminal pair (ö 
'H/'3C: 4.29/58.8 and 3.97/58.8, respectively); M2 and M5 are a geminal pair(ö 
'H/'3C: 4.28/56.2 and 3.97/56.2 respectively); M3 and M4 are a geminal pair ( 
'H/'3C: 4.12/52.0 and 4.04/52.0 respectively). In this data set, Ml and M6 are of 
lower intensity compared with the other methylene CH2 resonances. 
M3 and M4 show nOes to Ar(l) from one cyclam ring (ö 1 H: 7.37) and 
M2/M5 show nOes to another cyclam ring Ar(2) (Figure 6.7). Hence it is apparent 
that the two main configurations of bicyclam involve M2/M5 and M3/M4, 
respectively and the minor configuration involve M1/M6 which can not be observed 
in the ['H,'H] NOESY NMR spectrum (Figure 6.7). 
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Figure 6.6 2D ['H, '3C] HSQC NMR spectra of the aromatic ring linker CH2 region 
for (a) Zn bicyclam perchlorate (8), (b) Zn-Bz-cyclam chloride, and (c) Zn bicyclam 
acetate (9). Top: slices taken at each of the 3 13C chemical shifts showing the 2 non-
equivalent gerninal protons. 
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Figure 6.7 2D ['H,'H] NOESY NMR spectrum of aromatic and linker CH2 regions 
for Zn2(bicyclam)(C!04)4 in 10% D20 and 90% H20. 
3. Proton resonances from the cyclam rings 
Three sets of NH peaks and three sets of linking CH2 groups show that there 
are three types of cyclam rings, which are designated here as I, III and V, present in 
the solution of Zn2(bicyclam)(C104)4 in 10% D20 / 90% H20. It is therefore possible 
for a mixture of I-I, I-Ill, I-V, 111-111, 111-V and V-V bicyclam molecules to coexist 
in solution. Two types of cyclam rings, III and I predominate, which relate to 
M3/M4; and M2/M5, respectively. The third type of cyclam ring, which relates to 
M1/M6, is minor. Of particular interest are M3/M4 from configuration III. These 
appear in the data for Zn bicyclam acetate in aqueous solution at equilibrium at a 
much lower concentration but at identical 1H/ 13C  chemical shifts. It was not possible 
to elucidate the nature of the configuration to which M3 and M4 belonged in the Zn 
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bicyclam acetate case. From the 2D [hH,hII]  TOCSY and COSY, and ['H,'3C] HSQC 
spectra, the detailed conformational information was required for configuration III 
for Zn2(bicyclam)(C104)4 in solution (see Appendix I). A model for the trans-HI 
configuration was set up based on the NMR data (Figure 6.8). 
r 
Figure 6.8 Model of trans-Ill configuration for Zn2(bicyclam)(Cl04)4 in aqueous 
solution. Dotted black lines denote selected observed NOESY interactions and solid 
red lines refer to strong 'H, 'H COSY NMR interactions. 
6.3.2 Solution 11-1, 13C and 15N NMR of 
[Zn2(bicyclam)(OAc)2](OAc)2 2CH30H (9) 
The 'H NMR spectrum of crystalline complex 9, 
[Zn2(bicyclam)(OAc)2](OAc)2 2CH30H was acquired in 10% D20 / 90% 1120 at 
equilibrium (Figure 6.9). The resonances in the spectrum can be categorised into four 
types: resonances from the NH protons, resonances from the protons in the bridging 
aromatic ring, resonances from the bridging CH2 groups, and resonances from the 
protons in the cyclam rings. The resonances in the whole spectrum overlap severely. 
In order to fully assign the 'H NMR spectrum, 2D ['H, 'H] TOCSY and DQF- 
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COSY, and ['H, '3C] and ['H, '5N] HSQC data were further acquired on the 600 
MHz instrument by Dr. John Parkinson. 
OAc 
7.0 	6.0 	5.0 	4.0 	3.0 	2.0 
o(1H) 
Figure 6.9 'H NMR spectrum of[Zn2(bicyc lam) (OAc)2}(OAc)2 in 10% D20 and 
90% H20 
1. NH proton resonances 
The 2D ['H, '5N] HSQC NMR data show the presence of 9 'H/'5N 
correlations (Figure 6.3c and Table 6.3). From the volume integral values shown in 
Table 6.3, the NH signals can be grouped as follows: ABD, CEF, and GHI. Analysis 
of these data in their most basic form leads to the conclusion that there are 3 types of 
cyclam ring, which are designated here as I, III and V, present in the solution of Zn 
bicyclam acetate dissolved in 10% D20 / 90% H20. Two types of cyclam rings, I and 
V predominate. 
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Table 6.3 'H and '5N NMR data for Zn bicyclarn acetate crystals in 10% D20 / 90% 
H20, at equilibrium 
Chemical Shift (ppm) Relative Volume 
Integral Peak Label 'H 'N 
NHA 3.95 -2.00 1.00 
NHB  3.87 2.30 0.9 
NHc 3.54 2.80 1.37 
NHD 3.48 -0.20 1.06 
NHE 3.40 1.40 1.38 
NHF 3.36 3.00 1.53 
NHG 3.87 -0.30 0.24 
NHE, 3.51 4.80 0.20 
NH, 3.15 4.50 0.18 
2. Resonances for bridging methylene protons 
Three sets of bridging methylene CH2 signals appeared clearly in both 2D 
homonuclear ['H, 'H] 2D NMR TOCSY and DQF-COSY data, and 2D ['H, 13C] 
HSQC NMR data (Figure 6.3c): Ml and M5 ( 'H/'3C: 4.26/57.4 and 3.81/57.4 
respectively); M3 and M4 (6 'H/'3C: 4.12/52.1 and 4.04/52.1 respectively); M2 and 
M6 (6 'H/ö '3C: 4.19/58.3 and 3.70/58.3 respectively). The integrals of these sets of 
peaks follow the order M2/M6> MI/M5 >> M3/M4. Hence the 'H/'3C NMR data 
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for the bridging methylene groups matches that of the 'H/'5N data in relative 
intensities and supports the assertion that two main types of cyclam ring 
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Figure 6.10 Models of cis-V and trans-I configurations for 
[Zn2(bicyclam)(OAc)21(OA02 in aqueous solution. Dotted black lines denote 
selected observed NOESY interactions and solid red lines refer to strong 'H, 'H 
COSY NMR interactions. 
3. Proton resonances in the cyclam rings 
Three sets of NH peaks and three sets of linking CH2 groups show that there 
are three types of cyclam rings, which are also from three configurations I, III and 
V, present in the solution of [Zn2(bicyclam)(OAc)2](OAc)2 in 10% D20 I 90% H20. 
Two types of cyclam rings, V and I predominate, which relate to M2/M6; and 
M1/M5, respectively. The third type of cyclam ring, which relates to M3/M4 from 
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configuration III, is minor. From the 2D [1 H,'H] TOCSY and COSY, and [1H, 13C] 
HSQC spectra, the detailed conformation information was acquired for 
configurations V and I for [Zn2(bicyclam)(OAc)2](OAc)2 in solution (see Appendix 
II). 
4. Proton resonances for the aromatic ring 
The assignment of the aromatic 'H NMR resonances is completely dependent on 
a knowledge of the assignment of the rest of the 'H NMR data. The relationship 
between the cyclam ring and the aromatic ring is given only by nOes. 
Two large nOes exist between the aromatic protons and proton resonances 
assigned to configuration V. An aromatic resonance Ar(1) (6 	7.33) shows strong 
nOes to both A and W in green colour for configuration V in Figure 6.lOa. 
Another aromatic resonance Ar(2) (6 1 H: 7.37) also shows nOes to T and W in 
red colour for configuration I shown in Figure 6.lOb. 
6.3.3 Crystallography 
The crystal structure of {Zn2(bicyclarn)(OAc)2] (OAc)2 2CH3 OH (9) was 
determined by single crystal X-ray crystallography. The crystal structure of the 
complex cation along with the atom-labelling scheme is shown in Figure 6.l la. 
Selected bond lengths and angles are listed in Table 6.4. The crystal structure of 
complex 9 comprises [Zn2(bicyclam)(OAc)2]2 cations, acetate anions and MeOH 
molecules as solvent of crystallisation. The aromatic linker symmetrically bridges the 
cyclam rings. Each monocyclam ring resides on a centre of inversion, is folded 
diagonally about N (4)/N (11) and adopts a cis-V configuration with chelation by 
acetate on one cyclam face and double H-bonding on the other. Five- and six- 
176 
Chapter 6 Zn Bicyclam Complexes 
membered rings are in gauche and chair conformations, respectively. Zn(II) has a 
distorted octahedral geometry. 
Table 6.4 Selected bond distances (A) and angles (°) for complex 9 
Zn(l)—N(l) 2.252(2) N(4)—Zn(1)—N(11) 105.32(10) 
Zn(1)—N(4) 2.087(3) N(4)—Zn(l)--N(1) 83.37(9) 
Zn(1)—N(8) 2.161(3) N(I1)—Zn(1)--N(l) 93.94(9) 
Zn(1)—N(11) 2.071(2) N(8)—Zn(1)—N(11) 83.49(10) 
Zn(1)-0(1 1A) 2.089(2) N(8)—Zn(l)—N(1) 174.67(4) 
Zn( I )-0( 1 2A) 2.407(2) 0(11 A)—Zn( 1 )-0( I 2A) 58.34(8) 
Table 6.5 Distances (A) and angles (°) for possible hydrogen bonds in complex 9 
D—HA HA(A) DA(A) LD—HA 
N(4)—H(4) 	0(11B' 2.06 2.953(3) 162 
N(8)—H(8B) 	O(lC)b 2.06 2.972(4) 168 
N(ll)_H(11B) ... 0(12B)a 1.90 2.831(4) 174 
0(1C)_H(1C) ... 0(11B)c 1.81(2) 2.697(4) 168(4) 
Symmetry transformations used to generate equivalent atoms: 
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Figure 6.11 (a) X-ray crystal structure of [Zn2(bicyclam)(OAc)2](OA02 2CH30H 
(9) (CH30H not shown). (b) Space-filling model. 
A notable feature of the structure is the pair of relatively strong Fl-bonds 
N(4)H(4) "O(11B) (2.06 A, 1620 and N(ll)H(11) "O(12B) (1.90 A, 1740) between 
acetate oxygens of a non-coordinated acetate anion and cyclam NH protons on the 
cyclam face opposite to coordinated acetate (Figure 6.11). On the coordination side, 
N(8)H(8B) forms an H-bond to solvent MeOH (2.06 A, 1680). The H-bond 
interactions of methanol molecules and acetate anions with NH protons of cyclam 
units link the bicyclam complex molecules into a supramolecule (Figure 6.12). All 
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these H-bonds also stabilise the supramolecular polymer. Hydrogen bond data are 
also listed in Table 6.5. 
Figure 6.12 Crystal packing of [Zn2(bicyclam)(OAc)2](OAc)2 2CH30H (9). 
6.3.4 Kinetic studies 
Aqueous solutions of 8 attained equilibrium in Ca. 6 h, and consisted of Ca. 45 
% trans-I, 34 % trans-ITT and 21 % cis-V, determined from integration of the 1 H 
NMR peaks for the linker CH2 protons (see Figure 6.6a). These configurational 
changes had half-lives of 14-87 min at 298 K (Figure 6.13). The solid lines in Figure 
6.13 represent best fits to the data and the following rate constants: k1, 3.58x10 3  
rnin; k-1 6.01x10 3 mind for forward and reverse rate constants of the trans-I11Icis- 
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V equilibrium, and k2, 8.07x10 3 min- ; k-2, 6.35x10 3 min-' for the trans-Ill/trans-I 
equilibrium (assuming each end of bicyclam behaves independently). 
Complex 9 adopts the cis-V/cis-V conformation in the crystal. After 
dissolution of the crystalline in 90% H20 / 10% D20, equilibrium was reached 
rapidly within 20 minutes (Figure 6.14). The distribution of three configurations cis-
V (58%), trans-I (35%) and trans-Ill (7%) was acquired by integration of the 
corresponding resonance of the linker methyl protons in 'H NMR spectrum at 
equilibrium (Figure 6.6c). At the same time, the percentages of the predominating 
cis-V/trans-T configuration (44%) and cis-V/cis-V, the crystal configuration, 
accounting for ca. 29% of the total bicyclam configurations were also obtained by 
integration of the resonances of the aromatic region in the 1 H NMR spectrum. The 
curves in Figure 6.14 represent fits but the rates are ca. IN faster and there are too 
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Figure 6.13 Dependence of the distribution of configurations of 8 (perchiorate 
complex) on time after dissolving in 10% D20/90% H20. 
KII 







0 	10 	20 	30 	40 	50 
Time (mm) 
Figure 6.14 Dependence of the distribution of configurations of crystalline 9 (acetate 
complex) on time after dissolving in 10% D20 / 90% H20. 
6.3.5 Effect of acetate on Zn2(bicyclam)(C104)4  
Addition of acetate to aqueous solutions of 8, Zn2(Xyl-bicyclam)(C104)4 
produced dramatic changes in the 'HNMR spectrum, as illustrated in Figure 6.15 for 
the aromatic linker resonances. Equilibria were reached within 1 h (at 298 K). The 
proportion of the cis-V/cis-V configuration increased from 0 % to ca. 19% on 
addition of 4 mol equivalents of acetate, and that of the cis-V/trans-J configuration 
from 26% to 38% (Figure 6.16). The aromatic resonances are sensitive to both of the 
attached cyclam units, being singlets when the two units are the same, but AB 
quartets when they are different. Acetate induces a marked increase in the proportion 
of cis-V/cis-V and cis-V/trans-I species (see Figure 6.16). 
Acetate binding to Zn2-bicyclam was shown by '3C. The 13C NMR resonance 
for '3C-labelled CH313cOONa in the absence of 8 appears at 183.49 ppm relative to 
internal dioxane (69.3 ppm). Gradual addition of CH313 OO to 8 until 1:4 molar 
'Eli 
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ratio of CH313C00 to 8 resulted in the gradual shift of the CH313 COO- resonance to 
high frequency (184.13 ppm) (Figure 6.17). However, further reverse addition of 8 to 
this solution resulted in a gradual reverse shift of the signal to 183.73 ppm at a 12:4 
molar ratio of CH313çOO- to 8. Only one 13C peak was observed, indicative of fast 
exchange on the NMR timescale between acetate bound in the first and second 
coordination spheres and free acetate. 
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Figure 6.15 Effect of acetate on the configurations of the cyclam rings of Zn2-
bicyclam. The aromatic linker region of resolution-enhanced 1 H NMR spectra of 
aqueous solutions of (a) Zn bicyclarn perchlorate (8), (b) as (a) but after addition of 4 
mol equiv of acetate, and (c) crystalline Zn bicyclam acetate (9). The solvent was 
10% D20 / 90% H20 and all samples were at equilibrium. Labels: El trans-I, 0 
trans-Ill, 	cis-V. 
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Figure 6.16 Effect of acetate on the distribution of cyclam configurations of Zn2-
bicyclam as determined by integration of the 1 H NMR resonances for the aromatic 
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Figure 6.17 Plot of 13C chemical shift versus the molar ratio of 8 : CH313COONa. 
CH313COONa (2 mM) was dissolved in 10% D20 / 90% H20 (pH 6.6) in the 
presence of dioxane. 
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6.3.6 Recognition of zinc bicyclam by the viral coreceptor 
CXCR4 
The cis-V/trans-I Zn2-bicyclam model was docked onto an homology model 
of CXCR4 based on the 7-helical trans-membrane structure of bovine rhodopsin.'°"6 
In the energy-minimised model (Figure 6.18 and 6.19), one of the Zn(II) cyclams is 
in the cis-V configuration and has axial coordination to the oxygens of Asp262 with 
Zn(II)-carboxylate bonds of similar length (2.27 A) to the average for 9 and double 
H-bonds between two of its NH groups and the oxygens of Glu288 (COO" 
2.01 A) on the opposite cyclam face, resembling that in the crystal structure of 9 
(Figure 6.11). The second Zn(II) cyclam is trans-I with axial coordination to Asp 171 
(Zn-O 2.28 A). The cis-V cyclam is visible through a channel on one side of the 
protein (Figure 6.19). 
U 
Figure 6.18 Model of Zn2-bicyclam bound to the CXCR4 coreceptor. 
Transmembrane helices are red cylinders except helix IV which is depicted as a 
ribbon for clarity. 
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Figure 6.19 View of the model of CXCR4 showing the location of the proposed Zn2-
bicyclam binding site. The likely position of the membrane is indicated in grey, Zn2-
bicyclam is green, electrostatic potentials are coloured blue-positive, red-negative 
and white-neutral. The unstructured N-terminus (residues 1-38) and C-terminus 
(residues 320-352) have been omitted. 
6.4 Discussion 
6.4.1 Conformation of Zn2(bicyclam)(C104)4 (8) in aqueous 
solution 
Analysis of the NMR spectra of 8 was aided by the assignment of the NMR 
peaks for a monocyclam complex, Zn(II)-Bz-cyclam chloride, effectively complex 8 
with one methylene-Zn(II)-cyclam removed. The X-ray crystal structure of the 
Zn(II)-Bz-cyclam chloride, [Zn(Bz-cyclam)Cl]CF2.5CDCI3 showed it to be 5-
coordinate with an axial Cl ligand and NMR data for a CDC13 solution were 
consistent with the presence of a single configuration, trans-Ill, as in the crystal. 
Over a period of 3 h after dissolution of Zn(II)-Bz-cyclam chloride in water at 298 K, 
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the initially-intense set of peaks assignable to trans-ITT gave rise to 3 sets of peaks 
(Figures 6.3b and 6.6b) assignable to trans-Ill (43%), trans-I (42%; planar 5-
membered rings, Figure 1.3) and a minor configuration (15%, possibly cis-V). The 
2D ['H,'5N] (Figures 6.3) and aliphatic region of the 2D ['H,13C] NMR (Figure 6.6) 
spectra for equilibrium aqueous solutions of Zn-Bz-cyclam chloride and Zn bicyclam 
perchlorate were almost identical. This suggests that the cyclam units in the bicyclam 
complex 8 have little influence on each other in aqueous solution. Therefore, the 
configuration for Zn bicyclam perchlorate in the solid state involving M3/M4 was 
assumed to be trans-Ill as in most cyclam complexes. 19,20  The resonances for the 
other main configuration involving the bridging CH2 resonances, M2/M5 was 
assumed to be trans-I, but cannot be well observed due to severe overlap of the NMR 
signals. The minor configuration involving M1/M6 was assumed to be cis-V. Both 
cis-V and trans-I configurations are predominant and well-observed in the acetate Zn 
bicyclam complex in aqueous solution. 
6.4.2 Conformation of [Zn2(bicyclam)(OAc)2](OAc)2 (9) in 
aqueous solution 
Three sets of NH peaks and three sets of linking CH2 groups show that there 
are also three configurations, trans-I, trans-Ill and cis-V, present in the solution of 
[Zn2(bicyclam)(OAc)2](OAc)2 in 10% D20 / 90% H20. Over a period of 20 minutes 
after dissolution of crystalline [Zn2(bicyclam)(OAc)2](OAc)2 in water at 298 K, the 
initially-intense set of peaks from cis-V in the solid state gave rise to 3 sets of peaks 
(Figures 6.3c and 6.6c) assignable to cis-V (62%), trans-I (32%) and a minor 
configuration, trans-Ill (6%). It is therefore possible for a mixture of trans-1/trans-I, 
'ISiS' 
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trans- I/trans-ITT, trans-I/cis-V, trans-III/trans-111, trans-IIIIcis-V and cis-V/cis-V 
bicyclam molecules to coexist in solution. When the sample is first dissolved, it 
quickly changes from pure cis-V/cis-V to a mixture of cis-V/cis-V, cis-V/trans-I and 
trans-I/trans-I, with a smaller contribution from trans-III/trans-III, trans-Ill/trans-I 
and trans-III/cis-V, all of which exist at equilibrium (based on integration) in the 
following approximate ratios: cis-V/cis-V(29%), cis-V/trans-I (44%), and trans-
III/trans-I(12%) (Figure 6.20). 
100 
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Figure 6.20 Dependence of the distribution of cyclam configurations of crystalline 
[Zn2(bicyclam)(OAc)2](OAc)2 on time after dissolving in 10% D20/90% H20. 
6.4.3 Kinetic studies 
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As discussed for Zn cyclam complexes in Section 5.4.2, isomerisation from 
trans-Ill to cis-V and trans-I (Scheme 6.2) for complex 8 in aqueous solution 
requires the successive inversion of two amine nitrogens via an intermediate trans-11 
configuration (see Figure 1.3). The formation of trans-IT configuration is the slow 
step and determines the rate of isomerisation. Trans-11 is not stable and converts 
rapidly to the other configurations. The isomerisation from cis-V to trans-Ill and 
trans-I (Scheme 6.2) for complex 9 in aqueous solution also requires the successive 
inversion of two amine nitrogens via an intermediate trans-11 configuration (see 
Figure 1.3). Both steps, from cis-V to trans-I via trans-11, are fast, therefore, the 
trans-I configuration predominates at equilibrium and trans-Ill is minor in aqueous 
solution at equilibrium due to slow reaction from trans-11 to trans-Ill. 
slow 
trans-Ill 	 trans-IT 
fast trans-I 
cis-V 
Scheme 6.2 Isomerisation of trans-Ill to cis-V and trans-I at neutral pH 
6.4.4 Acetate triggered rapid configurational change of zinc 
bicyclam perchiorate 
This distribution is very similar to that obtained after addition of 4 mol 
equivalents of acetate to complex 8 (Figure 6.16). It is evident that acetate stabilises 
the folded cis-V configuration in solution and increases its distribution. 
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Binding of acetate was confirmed by both '3C NMR studies in the titration of 
CH313C00 with 8 (Figure 6.17), and by 'H NMR studies in the reverse titration. The 
increasing proportion of the cis-V configuration with addition of sodium acetate to 
the solution of complex 8 can be explained by strong binding of the carboxylate to 
Zn 2+ by chelation. Also, extensive hydrogen bonds can stabilise the cis-V 
configuration. Thus, the trans-Ill configuration in solutions of complex 8 can readily 
change to the cis-V configuration. 
6.4.5 [Zn2(bicyclam)(OAc)2](OAc)2 2CH3 0H (9) adopts the 
unusual cis-V configuration in the solid state 
There are five possible configurations for cyclam complexes (Figure 1.3). 
Normally, trans-Ill is the most stable configuration and very common. However, 
only cis-V configuration in which the six-membered rings adopts gauche 
conformation and the six-membered rings adopts the chair conformation was found 
for each cyclam unit in [Zn2(bicyclam)(OAc)2](OAc)2 2CH30H. Cyclam nitrogens 
N(1) and N(8) can be considered to occupy axial Zn(II) coordination sites, and N(4) 
and N(l 1) and two acetate oxygens the equatorial positions. The equatorial Zn-N 
bond lengths (2.07, 2.09 A, Table 1) are normal for Zn cyclam complexes, but the 
axial bonds are long (Zn-N(1) 2.25 A, Zn-N(8) 2.16 A). One of the Zn-O bonds is 
also long (2.41 A) compared to the other (2.09 A) which is normal in length. 17 
The cis-V configuration is unusual for Zn cyclam complexes. In a search of 
the Cambridge Structural Database, I found 46 structures for Zn(II) cyclam 
complexes: 4 trans-I, 33 trans-Ill, 1 cis-IV, I trans-V and 7 cis-V, but of the latter, 6 
contain highly-constrained cyclams (e.g. N,N linker across macrocycle) and the 7 1h  is 
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highly substituted on the periphery. No cis-V Zn cyclams with carboxylates as 
ligands appear to have been reported previously. The reported studies on bicyclam 
complexes have mostly focused on which two monocyclam units are linked together 
by bridging the carbon atoms of the cyclam backbone by crystallography. It seems 
that a C-substituent affects the properties of the cyclam units in this type of bicyclam 
complexes only slightly. Each cyclam unit just like monocyclam still adopts the 
trans-Ill configuration for such bicyclam complexes as reported in the solid state. 21 
Bicyclam complexes in which two monocyclam units are linked together by bridging 
the amine nitrogen atoms of the cyclam backbone are the other type of bicyclam. No 
crystals or NMR studies of such bicyclam complexes have been reported. 
As shown in Table 6.5, there are four pairs of strong hydrogen-bonding 
interactions between the secondary amine protons and the two free acetate anions. 
Such extensive hydrogen bonds may also play an important role in the target protein 
recognition for anti-HIV bicyclam. 
6.4.6 Recognition of zinc bicyclam by the viral coreceptor 
CXCR4 
The high anti-HIV potency of Zn2-bicyclam can be accounted for by its 
ability to block the CXCR4 co-receptor via interactions with 3 specific sites, Asp 171, 
Asp262, and G1u288. Aspl7l and Asp262 in trans-membrane helices IV and VI, 
respectively, have already been identified by receptor mutagenesis studies as key 
sites for bicyclam blocking. 10 
Mutation of Glu288 in helix VII, which may be involved in interactions with 
the V3 loop of the HIV envelope protein gpl20,22 is relatively close to the cell 
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surface, impairs coreceptor activity. The hydrophobic para-substituted p-
phenylenebis(methylene) linker is known to be important for the high anti-HIV 
activity of cyclams23 and it is notable that there is a high population of aromatic 
amino acid side-chains in the extracellular loop regions of our homology model of 
CXCR4. Aromatic m-m stacking interactions may be important for stabilizing 
intermediate binding steps along the pathway through the extracellular loops. Lack of 
loop flexibility prevented docking of Zn2-bicyclam into a similar site in a CXCR4 
model with a C109-C186 disulfide bond analogous to that found in rhodopsin. This 
might suggest that in vivo docking will be enhanced under reducing conditions, a 
Postulate which could be explored in cell systems, and which might have 
implications for combination therapy. 
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Model Protein Target 
7.1 Introduction 
It was demonstrated recently that AMD3 100 inhibits HIV entry through the 
coreceptor CXCR4.' CXCR4 is a G-protein-coupled, 7-transmembrane domain receptor 
with a disulfide bridge (-S-S-) between positions (109 and 178). Recent experiments 
have revealed that the affinity of the bicyclam AMD3 100 to the target protein CXCR4 is 
dependent on both Aspl7l and Asp262 residues of CXCR4.2 Cyclam has a strong 
propensity to interact with carboxylate groups which suggests that each of the cyclam 
moieties of the bicyclam binds to each of these two Asp residues located in TM-IV and 
TM-VT of CXCR4, respectively.2 
Lysozyme is a relatively small secretory enzyme (129 residues, 14 KD) that 
catalyses the hydrolysis of specific kinds of polysaccharides comprising the cell walls of 
bacteria and exceptionally abundant in egg whites. Hen egg white lysozyme (HEWL) 
was the first enzyme to have its three-dimensional structure determined by X-ray 
diffraction techniques.3  The primary structure of HEWL is a single polypeptide chain of 
129 amino acids. It has an alpha+beta fold, consisting of five to seven alpha helices and 
a three-stranded antiparallel beta sheet (Figure 7.1). The enzyme is approximately 
ellipsoidal in shape, with a large cleft on one side forming the active site. There are four 
pairs of cysteines that form disulfide bridges (-S-S-) between amino acid residue 
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positions 6 and 127, 30 and 115, 64 and 80, and 76 and 94. HEWL forms globular and 
compact particles rigidified by four disulfide bonds.4'5 The most reactive groups of 
lysozyme are the carboxyl groups of glutamic acid at position 35 (G1u35) and aspartic 
acid at position 52 (Asp52).6 Parsons and Raftery determined experimentally that Asp52 
and G1u35 are the important carboxyls by determining the enzymatic activity of hen egg 
white lysozyme.7 HEWL binding to various anions,8 e.g. Cl- was recently described for 
high-resolution crystal forms eight chlorides were identified as binding to the residues of 
lysozyme.9 
or 
Figure 7.1 (a) Ribbon drawing showing -S.-S- disulfide bridges (in yellow), G1u35 (in 
green), Asp48 (in blue) and Asp52 (in magenta), and (b) showing the cleft which forms 
the active site of HEWL. The X-ray data were downloaded from the PDB (Code: 193L). 
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Negatively charged free carboxylate groups of Asp 171 and Asp262 act as binding 
sites in CXCR4. Similarly, Asp52 and G1u35 with free carboxylates form the active site 
in the large cleft of HEWL and they are close to each other. The cleft allows other 
molecules to approach these active site residues. In addition, both proteins have disulfide 
bridges (-S-S-) whose presence in certain secondary structural conformation may result 
in the interaction of the carboxylate groups of amino acid residues with other molecules. 
Therefore, HEWL was used as a model protein target in this study of zinc bicyclam 
interaction. 
72 Experimental 
72.1 Crystallisation of lysozyme in the presence of 
(Zn2(bicyclam)(OAc)21(OAc)2  
1. Method: The most common method to grow protein crystals is by the hanging drop 
technique. A few microliters of protein solution are mixed with an about equal amount 
of reservoir solution containing the precipitants. A drop of this mixture is put on a glass 
slide which covers the reservoir (Figure 7.2). As the protein / precipitant mixture in the 
drop is less concentrated than the reservoir solution, water evaporates from the drop into 
the reservoir. As a result the concentration of both protein and precipitant in the drop 




Figure 7.2 A Linbro crystallisation plate (left) and a well with hanging drop (right). 
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2. Preparation of crystals 
The crystals were grown using the hanging drop vapour diffusion method at 277 K 
in the refrigerator by mixing 2.5 .il of 50 mg/ml HEWL, 2.5 p.1 of 60.9 mg/ml 
[Zn2(bicyclam)(OAc)2](OAc)2, and 5 p.1 of reservoir solution containing 100 p.1 of 0.5 M 
NaH2PO4INa2HPO4 buffer (pH 8.3), 200 p.1 of saturated NaCl, and 700 p.1 of distilled 
water. A further 3 different complex concentrations were prepared and used for the 
crystal growth by the same method as used for the above samples. The final molar ratios 
of [Zn2(bicyclam)(OAc)2](OAc)2 to HEWL in the hanging drops were 20, 17.5, 15 and 
10. The control sample was prepared using the same amount distilled water instead of 
the complex solution in the drops. A large number of crystals were observed after two 
days in almost all wells including the controls. All of them have the same shape as 
shown in Figure 7.3. The crystals were big enough for diffraction after 2 weeks' growth. 
Figure 7.3 The crystal of HEWL grown by hanging up vapour diffusion method in the 
presence of [Zn2(bicyclam)(OAc)2](OAc)2 
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72.2 Microanalysis of the crystals by SEM/EDX spectroscopy 
The determination was performed by Dr. Paula McDade in the Department of 
Geology. Samples of hen egg white lysozyme crystallised in the presence of 
[Zn2(bicyclam)(OAc)2](OAc)2 and a control sample of lysozyme were washed with 
distilled water. Then a crystal was mounted firmly and coated so they are electrically 
conductive. The crystal was examined with a scanning electron microscope (SEM, 
Philips XL30CP) equipped with an energy dispersive X-ray microanalyser (EDX, 
Oxford Instruments Isis 300). The elemental analysis by EDX was carried out with an 
acceleration voltage of 20 keV, probe current of 0.3 nA and dead time of 20 - 30%. The 
take-off angle for the EDX detector was fixed at 350•  These conditions were found to be 
suitable for good X-ray analysis and allowed reasonable secondary electron imaging. 
The electron beam was usually directed at the central part of an individual particle to 
obtain the average composition, and the data were accumulated for 100 s. For the 
qualitative analysis, an element in the particle was determined when the characteristic X-
ray intensity was three times the standard deviation () of the background intensity near 
the peak. For the quantitative analysis, X-ray analysis data were processed by a 
standardless (pz) routine supplied by Horiba, and the results were normalised to 100% 
on the basis of oxide composition.'°  
7.2.3 ESI-MS 
ESI-MS spectra were acquired on a Platform II mass spectrometer (Micromass, 
Manchester, U.K). A collision energy of 4 eV, a source temperature of 353 K, a 
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capillary voltage of 1.5 kV, and a cone voltage of 90 V were applied to produce the 
spectrum. The protein sample was dissolved in water at a concentration of 0.35 mM and 
pH was adjusted to 6.4 using dilute of NaOH. One molar equivalent of lysozyme in the 
stock solution was added in Zn2(bicyclam)(C104)2 aqueous solution (0.5 mM) to achieve 
a concentration of 0.21 mM. The mixture was further diluted by a mixed solvent (1:1 
(v/v) acetonitrile/water) and then 10-20 tl sample was injected using a syringe pump. 
7.3 Results and Discussion 
7.3.1 Microanalysis of the crystals by SEMIEDX spectroscopy 
Figure 7.4 shows EDX spectra for crystals of hen egg white lysozyme grown in 
the presence of Zn2(bicyclam)(C104)2, and for hen egg white lysozyme itself. Four 
elements, C, 0, S and Cl were detected with high intensity. 
Trace amounts of Si was also detected in both spectra. Both Na and Zn have very 
low intensity in spectrum (a) in Figure 7.4. However, elements, Na and Zn have higher 
intensity in spectrum (b) in Figure 7.4. 
It can be seen in Figure 7.4 (a), that the elements, S and Cl, are predominant in 
the crystals of lysozyme itself, while elements Zn and Na are minor. These results are 
consistent with the elemental composition of lysozyme. There are four cysteine amino 
acid residues (8 S atoms) and eight CY anions found in the X-ray crystal structure of 
HEWL. In Figure 7.4 (b), both elements, S and Cl are still predominant, while the 
overlapping peaks from Na and Zn increased in intensity. A reasonable explanation for 
this is that Zn2(bicyclam)4 is bound to lysozyme and therefore, Zn, not Na, has very 
high distribution in the crystals of lysozyme with Zn2(bicyclam)4 
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Figure 7.4 EDX spectra of (a) a crystal of hen egg white lysozyme, and (b) a crystal of 
HEWL grown in the presence of Zn2(bicyclam)(C104)2 
7.3.2 ESI-MS 
ESI-MS produces multiply charged gas-phase ions from protein molecules in 
solution. The mass spectrum of a 1:1 mixture of lysozyme and Zn2(bicyclam)(C104)2 is 
shown in Figure 7.5. The spectrum gives two well-resolved series of charged states and 
two peaks appear with mlz: 14307.73 ± 0.68 and 14943.24 ± 9.04. 
The detected ion at m/z 14307.73 ± 0.68 (calculated: 14300) is from 1-IIEWL, 
while the ion detected at m/z 14943.24 ± 9.04 is from an adduct of the complex 
Zn2(bicyclam)4 with the protein. The mass difference between two peaks is 635.51 
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(calculated for Zn2(bicycIam)4 : 633.4). Therefore, it is likely that Zn2 in cyclam rings 
binds to three free carboxylate groups of three separate amino acid residues of lysozyme 
due to the high affinity of Zn2(bicyclam)4 for carboxylate, most probably Asp52, 
G1u35, and Asp48. These three amino acid residues are close to one another and in the 
large cleft of HEWL which allows Zn2(bicyclam)4 to approach these three amino acid 
residues. Two of them may bind to one cyclam unit in trans-1 (or trans-Ill) configuration 
and the other amino acid residue may bind to the other cyclam unit in cis-V 
configuration. This result confirms that Zn2(bicyclam)4 does bind to the model target 
protein lysozyme in solution. 
% 
mlz 
Figure 7.5 ES-MS spectrum of a 1:1 mixture of lysozyme with Zn2(bicyclam)(C104)2. 
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7.3.3 X-ray crystallography 
X-ray data were collected and a Fourier map calculated. However, no binding 
bicyclam molecules were observed in the crystal. A reason for this could be that acetate 
binds Zn(II) in [Zn2(bicyclam)(OAc)2](OAc)2 strongly and therefore, carboxylates on 
the side-chain of the model target protein can not replace the bounded acetates. More 
work still needs to be done. 
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8.1 Synthesis of 15N-cyclam and bicyclam 
A very convenient and efficient synthesis of (5N)cyclam has been described 
in Chapter 3. The synthetic route is outlined in the Scheme I in Chapter 3. (15N)1,3-
Diaminopropane (2) was synthesised by the well-known Gabriel method' in a 
modified literature procedure from 1 ,3-dibromopropane and (15N)phthalimide with 
subsequent alkaline degradation of the 15N-diphthalimidopropafle (1). Another '5N 
source, '5N labelled glycine is commercially available. The amino group of 
(15N)glycine was protected by a trityl group throughout the reactions where 
necessary. The formation reaction of (15N)tritylglycine (3) was very slow due to the 
low solubility of trityl chloride in the isopropanol-water solvent system. Therefore, 
the reaction time was further prolonged and was reduced. As a result, the yield was 
improved from 61.6% to 77%. The coupling reagent TBTU was employed in the 
coupling reaction of (15N)1,3-diaminopropane (2) and (15N)tritylglycine (3), 
affording 	(1 N)bistritylglycyl)-(
15  N)diaminopropane 	(4). 	Reduction 	of 
(1 N)bistritylg1ycyl)-(15N)diaminOpr0Pafle (4) with BH3 TFIF in refluxing anhydrous 
THF 	led ('5N) 1,11 -ditrityl- 1,4,8,11 -tetraazaundecane (5) and subsequent 
deprotection of ('5N) 1,11 -ditrityl- 1,4,8,11 -tetraazaundecane (5) was achieved by 
heating ('5N) 1,11 -ditrityl- 1,4,8,11 -tetraazaundecane (5) in the diluted aqueous 
solution of HC1 to give (15N)1,4,8,11-tetraazaundeCafle4HCl (6). Purification of 
(15N)1,4,8,11-tetraazaundecane4HCl (6) was achieved by addition of ethanol to the 
aqueous solution of ('5N)1,4,8,11-tetraazaundecane4flCl (6) to produce a white 
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precipitate. The aqueous solution of ('5N)l,4,8,1 1-tetraazaundecane4HCl (6) was 
adjusted by solid NaOH to a pH exceeding 13, and extracted by CHCI3. The 
following bis-aminal (15N)diacetyl protected 1,4,8,11 -tetraazaundecane (7) was 
easily obtained through a simple condensation of butanedione with ('5N)1,4,8,11-
tetraazaundecane4llCl (6) in CH3CN. The reaction of 1 ,3-dibromopropane with 
(13N)diacetyl protected 1,4,8,11 -tetraazaundecane (7) in CH3CN gave (bN)diacetyl 
protected cyclam (8) in good yield. An acid hydrolysis under mild conditions, i.e. 
diluted HC1 solution, released (15N)cyclam tetrahydrochloride. The aqueous solution 
of('5N)cyclam tetrahydrochloride was washed by benzol, adjusted by solid NaOH to 
a pH exceeding 13, and extracted by CHC13. The solution was evaporated to give the 
final product (15N)cyclam (9). 
8.2 Conformation of (bi)cyclam complexes 
There are five possible configurations for cyclam complexes (Figure 1.3), 
2 
only three of them are detected for Zn cyclam complexes in aqueous solution (trans-
I, trans-Ill and cis-V). Energy calculations reveal that these three configurations 
have the lower energy  and supports our conclusion. A Ni complex with the 
tetramethyl substituted cyclam was reported to adopt three configurations trans-I, 
trans-Ill and trans-11 in aqueous solution.4 The behaviour of this Ni complex may be 
affected by the methyl groups and trans-TI configuration becomes stable instead of 
cis-V which was detected in Zn unsubstituted cyclam complexes. Therefore, it adopts 
a trans-11 configuration rather than a cis-V configuration in aqueous solution. Alcock 
and co-workers have detected trans-I and trans-Ill configurations for 
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[Zn(cyclam)Cl]n by '3C NMR spectroscopy. The reason for the difference from the 
results in this work could be that trans-Ill can convert to trans-1 and cis-V after 
dissolving in water, however, trans-Ill still predominates in solution and the amounts 
of cis-V and trans-I are very low at equilibrium. Only trans-Ill and cis-V are 
detectable by 13C NMR rather than trans-Ill and trans-I since the distribution of cis-
V is higher than that of trans-I and the latter is too low to be detectable. 
[Zn(cyclam)(H20)2](OAc)2 and [Zn(cyclam)(phthalate)]n(CH30H)2n in the crystals, 
like the reported Zn cyclam complexes 6,  adopt the most stable conformation, trans-
III in which six membered-rings are in the chair conformation and five membered-
rings are in the gauche conformation. However, the trans-Ill configuration which is 
the most stable conformation for small metal ions is no longer stable for large metals, 
e.g., Cd(II). [Pb(cyclam)](NO3)2 with cis-V configuration  and [Hg(cyclam)Cl]Cl 
with trans-1 configuration  support our conclusion. Therefore, only other two 
configurations exist for Cd cyclam complexes. The six-membered rings still adopt 
the chair conformation as in the solid state and the five-membered rings adopt an 
eclipsed conformation in solution for the trans-I configuration. Cd cyclam adopts the 
cis-I configuration in the solid state after fixing atmospheric CO2. 
The xylylbicyclam AMD3 100 has two cyclam rings and three configurations 
of the cyclam ring, trans-I, trans-Ill and cis-V are detected in aqueous solution. 
Bicyclam is therefore a mixture of trans-I/trans-I, trans-I/trans-ill, trans-Ilcis-V, 
trans-Ill/trans-Ill, trans-IIIIcis-V and cis-V/cis-V which coexist in aqueous solution. 
Only two types of cyclam ring (trans-I and cis-V) predominate for the acetate 
complex, while trans-I and trans-Ill predominate for the perchlorate complex. Two 
cyclam rings in the bicyclam acetate complex adopt cis-V configurations in the solid 
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state. As far as I am aware, previous studies on bicyclam complexes mostly focused 
on derivatives in which two monocyclam units are linked together by bridging the 
carbon atoms of the cyclam backbone as shown by crystallography.9 In the later case, 
each monocyclam ring adopts the trans-Ill configuration in the crystals. Bicyclam 
complexes in which two monocyclam units are linked together by bridging the amine 
nitrogen atoms of the cyclam backbone is the other type. The redox chemistry of 
some of these dinickel(II) and dicopper(II) complexes has been investigated with 
regard to the M(II) to M(III) oxidation process. 10 No X-ray crystal structural or NMR 
studies have been reported. 
Isomerisation from trans-Ill to cis-V and trans-I or from cis-V to trans-I and 
trans-Ill for (bi)cyclam complexes is slow at neutral pH. The conversion from cis-V 
to trans-I or from trans-Ill to trans-I can be base-catalysed at high pH and is fast. 
The configurations for both cyclam and bicyclam complexes have been 
successfully characterised using ID and 2D NMR spectroscopy. However, the axial 
ligands of each configuration can not be distinguished. It is hard to determine which 
and how many ligands bind axially to each Zn cyclam complex by NMR 
spectroscopy. Some other methods may be needed to investigate. 
8.3 Structure-activity relationships 
The structure-function relationship with respect to the antiviral effect of the 
bicyclams has been generalised". However, there is a lack of deep insight into 
structural information of cyclams and their complexes. Based on our structural 
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studies, we propose a possible mechanism to explain the effect of the aromatic linker 
on the anti-HIV activity of bicyclam. 
Cyclams could be viewed as prodrugs for Zn complexes since Zn complexes 
with cyclams are stable, having higher anti-HIV activity than cyclams on their own 
12
and Zn is available in the human body. 
Anions can affect the distribution of the three configurations, and the cis-V 
configuration predominates for Zn (bi)cyclam complexes with carboxylates in 
aqueous solution. The titration of acetate with Zn (bi)cyclam complexes also 
confirms that carboxylates really can increase the proportion of the cis-V 
configuration. Two aspartic acid residues asp 171 and asp262 of the target protein 
CXCR4 are the binding sites for (bi)cyclam'3  and this could be related to binding to 
the free carboxylate group of the aspartates. Therefore, we assume that the cis-V 
configuration is very important for the anti-HIV activity of (bi)cyclam complexes. 
After coordination to Zn(II), monocyclam adopts the most stable 
configuration trans-Ill in the solid state. In Zn xylylbicyclam complexes, the 
aromatic ring is too close to the two flat monocyclam rings if they are in trans 
configurations, which forces each monocyclam to fold to be cis-V configuration. 
Acetate can further stabilise the cis-V configuration by bidentate coordination and 
formation of hydrogen bonds. Therefore, the Zn bicyclam complex with acetate in 
contrast to the Zn cyclam complex with acetate adopts the cis-V configuration in the 
solid state. Hence, two cyclam rings connected via a 1 ,4-phenylenebis(methylene) 
linker have their anti-HIV activity increased by about 70-fold. Thus the aromatic ring 
plays an important role in the anti-HIV activity for bicyclam complexes. 
208 
Chapter 8 Conclusions 
It should be possible to modify the design of (bi)cyclam drugs to increase 
their selectivity even further. In particular it is important to optimise inhibition of 
HIV recognition without affecting chemokine receptor activity. For example, 
consideration could be given to the use of pre-formed metal (bi)cyclam complexes 
since bicyclam may be able to bind to a range of metal ions in vivo (e.g. Cu(II), and 
Ni(II) as well as Zn(II)), and also to configurational locking of one cyclam unit in the 
potentially active cis-V configuration since we detected at least 6 configurations for 
Zn(II) bicyclam in aqueous solution. These new insights into the general principles 
governing the configurational control of cyclams are also likely to be of use in the 
design of macrocycles for many other specific purposes. 
8.4 Future work 
Analysis of the coordination number of zinc in the observed configurations by 
EXAFS. 
Studies of the dynamic processes between the different isomers and their 
thermodynamic parameters by NMR via quantitative two-dimensional exchange 
spectroscopy (EXSY). 
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Appendix I. Configuration Trans-HI for Zn2(bicyclam)(Cl04)4 in 
Aqueous Solution 
The conformational analysis of trans-Ill for Zn2(bicyclam)(C104)4 was 
carried out based on 2D ['H,'H] COSY, TOCSY, and NOESY and ['H,'3C] HSQC 
(Figures I-i to 1-4). 
M3 shows a strong nOe to C (6 'H: 2.34). The geminal partner for C is D (6 
'H: 1.82,6 '3C: 26.1). Based on chemical shifts and nOe correlation between M3 and 
C, it can be concluded that C and D belong to a central methylene unit in a propyl 
group (6-membered ring) adjacent to the benzyl bridge. The large difference in 
chemical shift between C and D indicates that C is almost certainly axial and belongs 
to a chair conformation. The chemical shift of C is strongly affected by the presence 
of a benzene ring nearby and shifted to low field. C shows a large axial-axial 
coupling to B (6 'H: 2.73) and F (6 'H: 2.84). D, on the other hand, shows very weak 
coupling to both B and F. B has a geminal partner A (6 'H: 2.96). F has a gerninal 
partner E (6 'H: 3.34). F shows a large coupling to NHc (6 'H: 3.74). E shows a 
small coupling to NHc. B is not coupled to via DQF-COSY to an NH signal, 
consistent with B/A being adjacent to N-benzyl. 
An interesteing twist in the NMR data is the following. B shows a very strong 
nOe to V (6 'H: 2.43), which shows a TOCSY correlation to NHE. NilE is clearly 
associated with another 6-membered ring. V has a gerninal partner W (6 'H: 2.95, 6 
'3C: 55.0). U (6 'H: 2.99, axial) is directly overlapped with another resonance, but 
shows a large coupling to NilE. U shows a nOe to M4, placing U axially in a 5-
membered ring adjacent to the benzyl group. The geminal partner of U cannot be 
distinguished due to resonance overlap. 
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NHE shows a large coupling to R (ö 'H: 2.81). R shows a large coupling to 0 
( 'H: 1.73, axial), which has a geminal partener P (ö 'H: 1.99, 6  'SC: 30.3). P and 0 
are the central methylene pair in a 6-membered ring. 0 couples to N ( T I-I: 2.87, 
axial). N is coincident with a resonance, which couples to NHB (which is associated 
with the other cyclam ring). Geminal partners of R and N are not assigned due to 
resonance overlap in both 'H-'H correlations and in 2D ['H, '3C] HSQC correlations. 
NHc and NH, correlate to one another via TOCSY. NH, shows a strong 
coupling to J (ö 'H: 2.56, axial), which has a geminal partner K 	'H: 3.01, ö 13C: 
49.6). NHc shows a large coupling to I (ö 'H: 2.54), which has geminal partner H (ö 
'H: 3.66, ö '3C: 51.1). H shows small coupling to NHc. I and H show TOCSY 
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Figure I-I. 2D [1 H,13C] HSQC NMR spectrum of Zn2(bicyclam)(C104)4 (8) in 10% 
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Figure 1-2. 2D ['H,'H] NOESY NMR spectrum of Zn2(bicyclam)(C104)4 (8) in 10% 
D20/90% H20 at equilibrium (aromatic region not shown). 
Figure 1-3. 2D ['H,'H] COSY NMR spectrum of Zn2(bicyclam)(C104)4 (8) in 10% 









Figure 1-4. 2D [1 H,'H] TOCSY NMR spectrum of Zn2(bicyclam)(C!04)4 (8) in 10% 
D20/90% H20 at equilibrium (aromatic region not shown). 
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Appendix II. Configurations Cis-V and Trans-1 for 
[Zn2(bicyclam)(OAc)2](OAc)2 in Aqueous Solution 
The conformational analysis of configurations cis-V and trans-Ill for 
[Zn2(bicyclam)(OA02](OAc)2 was carried out based on 2D ['H,'H] COSY, TOCSY, 
and NOESY and ['H,'3C] HSQC (Figures lI-i to 11-4). 
(A) Configuration trans-1 
Six-membered ring A: Ml shows a large nOe to C (6 'H: 2.34). C shows a large 
coupling to D (6 'H: 1.83). The 2D ['H, '3C] HSQC NMR data show that C/D are a 
geminal pair (6 '3C: 26.0). Their chemical shifts enable assignment of these cross-
peakss to a CH 2-CH2-CH2 methylene group (6-membered ring). Due to the nOe Ml-
C, this 6-membered ring is located adjacent to a benzyl methylene group. C shows a 
large coupling (DQF-COSY) to F (6 'H: 2.86) whereas D, the geminal partner of C, 
shows no DQF-COSY cross-peak to F (although D and F do show a TOCSY 
correlations to Q. E (6 'H: 3.32) is strongly coupled to F; F and E are a geminal pair 
(6 '3C: 55.9). The 13C chemical shift places the F/E methylene group adjacent to a 
nitrogen atom. Together with the large coupling F to C, this enables assignment of 
F/E to N-CH2-CH2-CH2-N. F shows a large coupling to NHA to which E only shows 
a small coupling. M5 shows a long range DQF-COSY correlation (W-coupling) to 
resonance B (6 'H: 2.82) which is heavily overlapped with 2 other resonances. A 
resonance at this chemical shift couples to C consistent with a B-C coupling. It is not 
possible to assign the geminal partner of B due to resonance overlap. 
5-membered ring B (adjacent to A): NHA couples to H (8 'H: 3.07) and I (6 'H: 
2.83). H and I form a geminal pair (6 '3C: 49.4). It is not possible to assign the 
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relative positions of H or I due to resonance overlap. It is also difficult to assign 
resonances to the methylene group adjacent to H/I. 
6-membered ring C: That NUB and NHD belong together is provided by the 
presence of a TOCSY correlation between their two proton resonances. NHD notably 
shows a direct nOe correlation to P (6 'H: 1.73). From its chemical shift, P is clearly 
part of a propyl unit (CH2-CH2-CH2). The nOe places NHD and P on the same face 
of the cyclam ring as one another. The geminal partner of P is 0 (6 'H: 1.94, 6 13C: 
30.14). Both P and 0 couple to four other protons with different sized couplings. P 
couples weakly and 0 couples strongly to R (6 'H: 3.30). P couples weakly and 0 
couples strongly to N (6 'H: 3.13). P couples strongly and 0 couples weakly to Q (6 
'H: 2.82). P couples strongly and 0 couples weakly to M (6 'H: 2.75). N and M are 
gerninal partners (6 '3C: 52.22), and Q and R are geminal partners (6 '3C: 54.92). 
NUB shows a large coupling to Q, which in turn shows a large coupling to P. In 
contrast, R shows a small coupling to NHB and P. In a similar way, NHD shows a 
large coupling to M, which in turn shows a large coupling to P. N shows a small 
coupling to both NHD  and P. 
5-membered ring D: Assignment of resonances for protons in ring D is hampered 
by resonance overlap. It is clear that NUB shows TOCSY correlations to W (6 'H: 
3.02) and V (6 'H: 2.44), which are also a geminal pair of protons (6 '3C: 56.9). No 
DQF-COSY correlations appear between NUB and W/V implying that protons W/V 
are remote from NHB i.e. adjacent to the nitrogen bearing the benzyl linker. V shows 
an nOe to B. The relationship between B and MS has already been demonstrated in 
which B is axial on the 6-membered ring A. Hence the nOe V to B should result 
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from V and B being in axial positions on rings D and A respectively. The strong nOe 
W to M5 places proton W close to the methylene proton M5. 
(B) Configuration cis-V 
5-membered ring A: The benzyl methylene M2 shows a strong nOe to U (6 'H: 
3.08). U is strongly coupled to NH, to V (6 'H: 2.62) and to T (6 'H: 3.01), which 
also couples to NH with a small coupling. U and T are geminal partners (6 13C: 
47.65). V shows a W-coupling to M6 and a strong coupling to W (6 'H: 2.49). W 
also shows a weak nOe to M2, which is reasonable given that V and W are geminal 
partners (6 '3C: 48.7). 
6-membered ring B: NHc shows an nOe to NHF but no nOe or TOCSY correlation 
to NHE. NHc is strongly coupled to R (6 'H: 2.90) and weakly coupled to Q (6 'H: 
3.21). Q and R are geminal partners (6 '3C: 53.0); R is axial and Q is equatorial 
relative to NHc. R shows a large coupling to 0 (6 'H: 1.86, axial) and a small 
coupling to P (6 'H: 1.79, equatorial), which are at chemical shifts characteristic of 
N-CH2-CH2-CH2-N. P and 0 are geminal partners (6 '3C: 27.06). NHE shows 
TOCSY correlations to P and 0 placing NHE in the 6-membered ring B. N (6 'H: 
3.09, axial) shows a large coupling to 0 but a medium sized coupling to NHE. M (6 
'H: 2.91) is the geminal partner of N (6 '3C: 51.19). M shows only very small 
couplings to NHE,  
5-membered ring C: NHE shows a large coupling to J (6 'H: 2.65, axial) and a 
small coupling to K (6 'H: 2.86, equatorial). J and K form a geminal pair (6 13C: 
47.0). J shows a large coupling to I (6 'H: 2.57), which also shows a large coupling 
to NHF. J is therefore axial to both NHE and I, and I is axial to NHF. H (6 'H: 3.05) 
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is the geminal partner oft (6 '3C: 51.32). I shows an nOe to NHE, firmly placing I 
and NHE on the same side of 5-membered ring C. 
6-membered ring D: NHF shows a large coupling to F (6 'H: 2.77, axial) and a 
small coupling to E (6 'H: 3.18, equatorial). F and E form a geminal pair (6 13C: 
52.56). F shows a large coupling to C (6 'H: 1.75, axial) and a small coupling to D (6 
'H: 1.84). C and D are geminal partners (6 '3C: 26.8). C shows an nOe to NHF 
placing C and NHF on the same side of the cyclam ring. C shows an nOe to V 
confirming the fold of the molecule along the linear N-Zn-N axis. C shows a large 
coupling to B (6 'H: 3.02), which also shows a strong nOe to M6, thereby 
confirming that M6 and B are close in space to one another. B shows a large 
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Figure Il-i. 2D [1H,13C] HSQC NMR spectrum of [Zn2(bicyclam)(OAc)2](OAc)2 







4.0 	3.0 	2.0 
(1H) 
Figure 11-2.2D ['H,'H] NOSEY NMR spectrum of[Zn2(bicyclam)(OAc)2](OAc)2 
(9) in 10% D20/90% H20 at equilibrium (aromatic region not shown). 
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6(1 H) 
Figure 11-3. 2D [1 H,'H] COSY NMR spectrum of [Zn2(bicyclam)(OAc)2](OAc)2 (9) 
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(1H) 
Figure 11-4. 2D [1 H,1 H] TOCSY NMR spectrum of [Zn2(bicyclarn)(OAc)2](OAc)2 
(9) in 10% D20/90% H20 at equilibrium (aromatic region not shown). 
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